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Quantitative models are increasingly being used to interrogate the metabolic path-
ways that are contained within complex biological processes, and at a higher level, these
models are used to explore questions in evolution with complex physiological processes
absent in typical, idealized population genetic models. In this work, we focus both on
the application of quantitative models in evolution and the development of new quan-
titative methods for metabolism. An overview of constraint-based modeling and its
purview in the field of metabolic modeling is given in Chapter 1. By using a simple
version of constraint-based modeling known as flux balance analysis (FBA), we eluci-
date patterns that occur in gene-gene interactions of deleterious mutations (Chapters 2
and 3). Because many biological problems relate to systems that are not well-suited
to FBA, especially when establishing a physiologically accurate flux is desirable, we
address the problem of estimating metabolic fluxes using constraint-based models and
readily available gene expression data by developing a new methodology and software
(called FALCON; Chapter 4). We then take advantage of the FALCON method by using
it in the development of approaches that enable the simulation of beneficial mutations
and reveal some of the influences that metabolic networks bring to bear on the study of
adaptation (Chapter 5).
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There has been a surge of interest in understanding the regulation of metabolic net-
works involved in disease in recent years. Quantitative models are increasingly be-
ing used to interrogate the metabolic pathways that are contained within this complex
disease biology. At the core of this effort is the mathematical modeling of central
carbon metabolism involving glycolysis and the citric acid cycle (referred to as en-
ergy metabolism). Here we discuss several approaches used to quantitatively model
metabolic pathways relating to energy metabolism and discuss their formalisms, suc-
cesses, and limitations 1.
The accumulated amount of biochemical work carried out over the years has elab-
orated complex metabolic systems and networks. This information includes the net-
work architecture encoded in chemical reactions that are carried out by metabolic en-
zymes and the kinetic parameters that determine reaction mechanisms involved in each
of these chemical reactions. Application of this knowledge has led to tremendous pre-
dictive capability in characterizing metabolic regulation in normal physiology including
the growth of unicellular organisms and the successful simulation of energy metabolism
in healthy red blood cells. However, there are far fewer instances in which these models
have been applied to the characterization of pathophysiology. Applying our knowledge
of metabolic regulation to the investigation of disease states such as cancer or neurode-
generation is currently a scientific frontier. In this review, we will revisit several classic
techniques for the mathematical modeling of metabolic pathways and discuss instances
1This chapter is taken from material in Shestov et al. 2. Brandon Barker is the primary author of all
material found herein.
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where their application to biomedical science is beginning to yield fruitful dividends.
1.1 Linear Systems, Flux Balance Analysis
Linear models are mathematical models that contain a set of algebraic equations
based on the stoichiometric relationships that define conservation relationships within a
metabolic network. Linear models, to our knowledge, were first applied to biochem-
ical systems in 1961 by Howard Shapiro [10]. Shapiro discussed the possibility of
using optimization in biochemical linear models in a 1969 publication [11]. In 1984,
a model incorporating glycolysis and the TCA cycle was employed running a variant of
Dantzigs algorithm with the assumed biological objective of minimized free energy dis-
sipation [12, 13]. An enduring research program was initiated by Bernhard Palsson half
a decade later [14, 15]. One of Palsson’s early works showed that growth maximiza-
tion in an E. coli model could correctly match 86% of 79 gene essentialities examined
[16]. Subsequent modeling in S. cerevisiae was able to closely predict growth rates and
exometabolic fluxes in various media, and nearly capture the in vivo phosphate/oxygen
(P/O) ratio of 0.95 with a simulated P/O value of 1.04, showing that models of eukary-
otes were also feasible [17]. If one chooses the biological objective function to reflect the
appropriate physiological demands then it is possible to predict features of adaptation;
this was shown to be the case for growth optimization in several E. coli mutants [18].
By this time it had become apparent that linear models held much promise, particularly
when coupled with optimization.
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1.2 Genome Scale Modeling
Today, when we refer to linear models, we most often mean Constraint Based Models
(CBMs). We refer to a CBM as any model making use of the stoichiometric matrix,
S, as a linear matrix constraint, e.g. SF = 0, where F is a flux vector2. In fact, this is
a nearly universal constraint, as it guarantees conservation of mass during steady state
processes such as exponential growth or tissue maintenance [19]. Other constraints com-
monly used include reversibility constraints when the direction of a reaction is known
for physiological conditions of interest, bounds on the uptake of nutrients or eﬄux rates
due to regulation or physiology, or bounds on enzyme reactions when the maximum
enzyme velocity Vmax is known.
Because these constraints give rise to an underdetermined system, it will not be
possible to identify a unique solution for the flux vector. A unique solution is often de-
sirable as it allows investigators to analyze a putative metabolic phenotype. Indeed, this
is one of the more convenient features of linear optimization: the ability to get mean-
ingful solutions without explicitly taking into account any, or at least very few, free
parameters. Flux Balance Analysis, or FBA, assumes a linear combination of fluxes to
be maximized or minimized (Figure 1.1). In microbes, perhaps the most popular FBA
objective has been growth maximization, which consists of the biomass precursors and
products formulated as a single pseudo-reaction. Additionally, an ATP maintenance
constraint should be formulated as a sink reaction with the molar ATP required to keep
one gram of dry weight biomass living for one hour [20]. This empirically determined
constraint, although assumed, is less discussed, perhaps due to its dependence on indi-
vidual strains and environments. We note that for many expression-based methods in
the CBM framework, the ATP maintenance constraint is not required (see Table 1.1 and
2F is usually used to denote a steady state flux, whereas v is used for fluxes more generally. In much
of the genome-scale constraint-based modeling literature, v is used in all cases
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Figure 1.1: A simple geometric illustration of an FBA problem (a). Constant constraints
on the Fi limit the feasible solution to an n-dimensional cube (shown in grey). Further
linear constraints from the S matrix create a cone of feasible solutions (blue). Linear
programming algorithms find an optimal solution on a vertex (illustrated with orange
circle). Depiction of a simple metabolic network with compartmentalization and its
associated stoichiometric matrix (b, c). The three compartments denoted with subscripts
b, e and c represent the boundary, extracellular environment, and cytosol, respectively.
The boundary is what separates the model from its environment, and mass balance is
not assumed at the boundary; this allows for the implementation of source and sink
reactions.
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Figure 1.2 for examples). Fixed biomass objectives by themselves also have some un-
desirable qualities; biomass composition likely has some measure of variability based
on genetic background and environment. Robust FBA attempts to address this problem
by allowing some variation in the biomass composition, as determined by variation of
empirical assays of biomass [21]. Despite these caveats, FBA has recently been found
to not only predict growth in microbes, but also has good agreement with gold standard
13C flux assays in vivo when the growth objective is used along with ATP synthesis
maximization and minimization of absolute fluxes [7].
Minimization of absolute flux is a commonly used objective employed alongside
other objectives, forming a minimax problem (i.e. finding the minimum absolute flux
profile among all flux profiles that maximize biomass). This approximates the biological
goal of being efficient with enzyme production costs and enzyme crowding constraints
while also guaranteeing that no thermodynamically impossible loops are present, that
is, ruling out some fluxes that might otherwise violate Kirchoffs loop rule [8, 25]. This
constraint will work whenever a sink reaction, such as growth, is being optimized. How-
ever, maximizing an internal flux, as in Flux Variability Analysis [22], could still result
in internal cycles [25]. Initial thermodynamic approaches involved nonlinear optimiza-
tion [26, 27, 35, 36]. Constraints satisfying Kirchoffs loop rule were later developed
that were faster and more generally applicable than prior methods [25, 37]. Still, these
involve integer constraints that put this problem in a slower class of algorithms than
the convex minimized absolute flux problem. When available, thermodynamic data is
valuable; it can not only be used to guarantee there are no internal cycles, but can also
aid in determining reaction direction and potential regulatory targets [25, 35, 38, 39].
Application of this framework to concentration data allows unmeasured metabolite con-
centrations to be inferred and global concentrations to be resolved at the organelle level
[36]. CBMs have also found use in tracing individual atoms through pathways, which
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Table 1.1: Families of methods for constraint-based models. Broad classes of methods
are described, along with references to some individual implementations or studies.
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Figure 1.2: Schematic representation of fluxomics tools. Important to fluxomics are
both the mathematical and computational tools for nonlabeled and labeled techniques,
as well as the analytical methods used to obtain data and parameters. In the cur-
rent work we focus only on nonlabeled genome-scale steady state and related ana-
lytical methods, but a full description can be found [2]. Sequence data is employed
in the construction of organism models, whereas proteomics and expression data find
use in the creation of tissue or cell-type-specific models. High-quality expression data
such as RNA-seq and ribosomal footprinting are beginning to find uses in flux predic-
tion. Several prominent genome-scale techniques include flux balance analysis (FBA),
minimization of metabolic adjustment (MoMA), energy balance analysis (EBA), Ex-
Pas (extreme pathways), and elementary mode analysis (EMA). Nonlabeled techniques
along with genome-scale analysis include biochemical kinetics modeling tools to study
metabolic and signaling networks and their regulation architecture with established tools
like metabolic control analysis (MCA) and global sensitivity analysis (GSA). Additional
sensitivity analysis should be conducted, e.g., with Monte-Carlo techniques like Markov
chain Monte-Carlo (MCMC, Bayesian) analysis to check the reliability of extracted
metabolic parameters, including fluxes.
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provides a more appealing framework for performing Metabolic Flux Analysis (MFA;
discussed below) on stable isotope data due to the lack of bias compared to typical MFA
models, which are often an order of magnitude smaller than genome-scale reconstruc-
tions [40]. Recent insightful work has made it possible to simplify the computational
complexity of loopless FBA to be nearly the same as conventional FBA, but some math-
ematical difficulties must still be overcome before bounds on exchange fluxes can be
suitably incorporated for genome-scale modeling [19, 41].
The metabolism of different tissues within the same organism is diverse; whereas
the metabolism in liver is anabolic, neurons or red blood cells have a much more limited
catabolic regime [28, 42, 43].The creation of tissue specific models for multicellular or-
ganism has become an important problem, and several automated algorithms taking as
inputs tissue expression data and a generic model for the organism have been developed
[28, 29, 30]. Coupling multiple cellular models together will enable multi-scale model-
ing of tissues in multicellular models or entire ecosystems for microbes [42, 44, 45, 46].
Automated generation of metabolic networks from genome sequence and pathway
databases, especially in prokaryotes, has been developed [47, 48, 49, 50]. This will offer
many advantages to modelers: a starting point for curated models (a draft reconstruc-
tion is estimated to often take several months even in prokaryotes), a means for doing
population or ecological simulation [46], and personalized genomic modeling for pa-
tients with metabolic syndromes such as cancer where both the patient and possibly the
disease have diverse genotypes [51, 52]. Eukaryotic models are somewhat more diffi-
cult to generate due to the necessity of protein localization and metabolite transporter
information [47]. Automatic reconstruction going beyond enzymatic gene information,
such as rFBA models, should also be possible [53, 54]; the automated generation of
Boolean and higher-order discrete regulatory models using time-series expression data
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has been explored as well, though to date these regulatory models have not been coupled
to metabolic reconstructions [55, 56, 57, 58]. These approaches and other families of
genome-scale methods are discussed in Table 1.1.
Several approaches have been used in applying CBMs to cancer and the Warburg
effect, the preference for glycolytic ATP production over glucose-derived mitochondrial
ATP production in cancer cells [59, 60, 61]. An important study working with a sim-
plified, small model of central-carbon metabolism showed that, while the TCA cycle
predicts better ATP yield than glycolysis when only available glucose is considered as
a constraint, the addition of enzyme solvent-capacity constraints creates a preference
for ATP synthesis through glycolysis [61]. More recently, the work of Vazquez et al.
was extended to include a genome-scale model along with enzyme solvent-capacity
constraints, which was able to show significant correlations between fluxes and expres-
sion in the NCI-60 cell line panel, as well as predicting an intermediate state in cancer
metabolism transition exhibiting a temporary increase in OxPhos that was supported
by two prior experimental observations [60]. All of these approaches correctly pre-
dicted lactate production. Concurrent research on predicting cancer targets by screening
for simulated negative epistasis in cancer tissue-specific models that have at least one
known-drug target and no known effect on normal tissue revealed many epistatic in-
teractions [52]. A related study confirmed one of these synthetic lethalities between
hemeoxygenase and fumarate hydratase, a mutation found in certain kidney cancers
[62]. The recent publication of Human Recon 2 promises to aid in the understanding
of many human diseases; already 65 cell-type specific models based on it are available,
and the model reports 77% accuracy in identifying metabolic markers across 49 inborn
errors of metabolism [63]. Although this model is a great step forward in consolidating
much of the knowledge about human metabolism, it is only one of many steps to come.
For instance, this model is still primarily only amenable to steady-state approaches,
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lacks corresponding enzyme-regulatory and signaling architecture, and has introduced
more dead-end metabolites than it removed (1,176 versus 339).
1.3 Conclusions for the State of Linear and Genome-Scale Models
Kinetic models for smaller pathways are possible when the data are present, but many
energetic questions concern the entire cell, leaving only incorporation of CBMs as a
viable option. The original efficiency and ease of use of FBA have helped propagate
a field of more diverse algorithms that are often tractable on todays computers using
the same modeling and software frameworks [64, 65]. Numerous methods and success-
ful applications in energy metabolism exist, including prevalent diseases such as heart
disease, cancer, and Alzheimers [66].
Multiscale models, as were used in the Alzheimers models, will undoubtedly be-
come more common. At the intracellular scale, CBMs are also beginning to incorporate
information other than metabolic stoichiometry [67, 68, 69]. A whole cell model for
Mycoplasma genitalium incorporating information about all classes of macromolecu-
lar synthesis and degradation, in addition to stoichiometric and regulatory information,
found a non-stochastic coupling between metabolism and the cell-cycle where DNA
replication rates depended on the concentration of dNTP [68]. Models like these are not
easy to build, but substantial endeavors are underway to assist in their draft construction
and refinement, and together with an increase in use of jamboree meetings of organ-
ism and model experts and online collaborative tools, will likely aid in creating public
models of higher quality and the understanding of many biological processes outside the
traditional scope of metabolism [48, 63, 70, 71, 72, 73, 74].
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CHAPTER 2
DYNAMIC EPISTASIS FOR DIFFERENT ALLELES OF THE SAME GENE
Epistasis refers to the phenomenon in which phenotypic consequences caused by muta-
tion of one gene depend on one or more mutations at another gene. Epistasis is critical
for understanding many genetic and evolutionary processes, including pathway organi-
zation, evolution of sexual reproduction, mutational load, ploidy, genomic complexity,
speciation, and the origin of life. Nevertheless, current understandings for the genome-
wide distribution of epistasis are mostly inferred from interactions among one mutant
type per gene, whereas how epistatic interaction partners change dynamically for dif-
ferent mutant alleles of the same gene is largely unknown. Here we address this issue
by combining predictions from flux balance analysis and data from a recently published
high-throughput experiment. Our results show that different alleles can epistatically in-
teract with very different gene sets. Furthermore, between two random mutant alleles
of the same gene, the chance for the allele with more severe mutational consequence
to develop a higher percentage of negative epistasis than the other allele is 50-70% in
eukaryotic organisms, but only 20-30% in bacteria and archaea. We developed a popu-
lation genetics model that predicts that the observed distribution for the sign of epistasis
can speed up the process of purging deleterious mutations in eukaryotic organisms. Our
results indicate that epistasis among genes can be dynamically rewired at the genome
level, and call on future efforts to revisit theories that can integrate epistatic dynamics
among genes in biological systems1.
1This chapter is published as Xu et al. [9]. Brandon Barker and Lin Xu contributed equally to this
work. It is additionally available in Xu [75, chapter 4].
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2.1 Introduction
Epistasis between two deleterious mutations is positive when a double mutant causes a
weaker mutational defect than predicted from individual deleterious mutations, and is
negative when the double mutant causes a larger defect [76, 77]. In a population with
sexual reproduction, positive epistasis alleviates the total harm when multiple deleteri-
ous mutations combine together and thus reduces the effectiveness of natural selection
in removing these deleterious mutations, whereas negative epistasis can lower average
mutational load by efficiently purging deleterious mutants [78]. As a consequence, se-
lective elimination of deleterious mutations would be especially effective if negative
epistasis is prevalent. It is important to understand the distribution of epistasis among
mutations, which plays a central role in genetics and theoretical descriptions for many
evolutionary processes [76, 77].
Tremendous efforts have been put into genome-wide measurements for the sign
and magnitude of epistasis among different genes in various species [79, 80, 81, 82,
83, 84, 85, 86, 87, 88, 89, 90]. A series of high-throughput experimental platforms
have been developed, such as synthetic genetic array (SGA; Costanzo et al. 79, Tong
et al. 80), diploid-based synthetic lethality analysis with microarrays [81, 82], synthetic
dosage-suppression and lethality screen [83, 84, 85], and epistatic miniarray profiles
[86, 87, 88]. The epistatic relations in these experiments were mostly measured based
on one mutant type (deletion mutant) per gene. Few studies constructed multiple mutant
alleles for single genes to examine the dynamics of epistatic relations among genes un-
der different genetic perturbations. As a consequence, the global landscape of epistasis
for different alleles of the same gene remains largely uninvestigated.
We address this issue by exploring epistatic differences among alleles in the same
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gene for a large part of the genome by combining experimental data with mathemati-
cal modeling using flux balance analysis (FBA). FBA involves the optimization of cel-
lular objective functions and allows prediction of in silico flux values and/or growth
[8, 91, 92]. FBA has been used to investigate the fitness consequence of single-deletion
mutants [93, 94] and epistatic relations between metabolic reactions, genes, and func-
tional modules [34, 95, 96, 97]. The FBA predictions show good agreement with
genome-wide experimental studies [23, 24, 98, 99, 100, 101, 102, 103]. One essen-
tial advantage of FBA modeling is that it can simulate epistasis between genes based on
different genetic mutants. Using this platform, together with data from a recently pub-
lished experiment [79], we were able to show that epistasis can be rewired among genes,
and that the sign of epistasis can change dramatically at the global scale, depending on
the mutant alleles involved in the processes. Our study provides a genome-wide picture
on the dynamic epistatic landscape of various mutant alleles for the same gene.
2.2 Results
2.2.1 Epistatic Relations Between Genes Are Largely Allele-
Specific.
We first used the yeast Saccharomyces cerevisiae metabolic reconstruction iMM904
[91] to examine the distribution of epistasis under various genetic mutant alleles. The
reconstruction is a genome-scale metabolic model, having 904 metabolic genes associ-
ated with 1,412 reactions. For each gene, we simulated genetic perturbations that retain
the corresponding flux from 90% to 0% in decrements of 10% of its WT (optimal) flux.
As a result, 10 different single mutants per nonessential gene and nine different single
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mutants per essential gene (the 0% flux mutants in these genes represent lethal deletion
for which epistasis cannot be calculated) were simulated. We computed the fitness of
the single mutants and double mutants with any possible pairwise allele combination of
different genes. These data were used to infer the epistatic relationships among genes.
In total, over 40 million simulations were conducted. To investigate the dynamics of
epistasis among genes, we calculated the percentage of shared epistatic interaction part-
ners between any two mutants within the same gene. Two mutant alleles are defined to
share an epistatic interaction partner (a mutant from another gene) if they both epistat-
ically interact with this mutant and the signs of epistasis are the same. The percentage
of shared epistatic interaction partners between two mutants is calculated as the number
of their shared epistatic interaction partners divided by the sum of their total epistatic
interaction partners. As shown in Figure 2.2.1A, our results indicate that the percentage
of shared epistatic interaction partners between two mutants of the same gene decreases
as the flux difference between them increases. Two mutants of the same genes could
have as low as only ≈ 20% overlap between their epistatic interaction partners, indicat-
ing that the epistatic profile of a gene is largely dependent on the mutant types used. Our
results also show that the average number of epistatic interaction partners per gene do
not affect this conclusion (Figure A.1). Interestingly, there are cases where the sign of
epistasis between two genes can even change under varying mutant types (an example
is in Figure A.2, and all pairs with reversed sign of epistasis are listed in Dataset S1).
However, such events are rare (≈ 1.2% of all gene pairs that show epistatic interactions).
Furthermore, we repeated the above FBA analysis for another species, Escherichia coli,
and the results confirmed the above trend (Figure A.3).
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Figure 2.1: Epistatic relations between genes are allele specific. (A) FBA simulation
results for the distribution of the percentage of shared epistatic interaction partners be-
tween two mutant alleles within the same gene. Solid and broken lines represent mean
and 95% confidence intervals, respectively. (B) The cumulative distribution for the per-
centage of shared epistatic interaction partners between two mutant alleles within the
same gene based on real experimental data. Two broken lines represent 10% and 20%
of shared epistatic profiling, respectively.
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In a recently released high-throughput experiment that measured genome-wide
epistatic relations among genes in S. cerevisiae [79], there were 43 mutant pairs hav-
ing two different mutant alleles of the same gene (Dataset S2), each of which were
experimentally crossed with 3,885 array gene deletion mutants to explore their epistatic
relations in the genome. In total, over 200,000 double mutants were experimentally
constructed. This dataset provides the most comprehensive experimental source for
investigating the epistatic landscape of different mutant alleles in the same gene. Fig-
ure 2.2.1B shows the empirical cumulative distribution for the percentage of shared in-
teraction partners between mutant pairs within the same gene. Our results indicate that
more than 50% of mutant pairs within the same gene have less than 10% overlap of their
epistatic interaction partners, and ≈ 90% mutant pairs have less than 20% overlap (Fig-
ure 2.2.1B). As shown in Dataset S2, the functions of genes used in the experiments are
very diverse, and not restricted to metabolic functions as genes in the FBA model. Nev-
ertheless, the result from experimental studies confirms our FBA modeling prediction
that different mutant alleles of the same gene can have very distinct epistatic interaction
partners in the genome. In addition, the conclusions are robust under various epistasis
thresholds (Figure A.1).
2.2.2 Sign of Epistasis for Individual Genes Depends on Mutation
Severity.
The relative prevalence of positive vs. negative epistasis is of tremendous importance for
understanding many evolutionary processes [76, 77, 78]. In the following we addressed
this issue for different alleles of the same gene. Based on the above high-throughput
experimental dataset, we calculated the percentage of negative epistasis for each mutant,
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defined as the number of negative epistatic partners for this mutant divided by the overall
number of its epistatic partners. We then compared the percentage of negative epistasis
between different mutant alleles of the same gene in the experiment. Among 43 mutant
pairs in the study, 35 mutant pairs have significantly different fitnesses between two
mutants of the same gene. As shown in Figure 2.2.2A left, 21 mutant pairs (60%) show
that alleles with more severe defects have a higher chance than the other allele in the
same gene to develop negative epistasis in the genome.
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Figure 2.2: Mutant alleles in the same gene with more severe defects tend to have a
higher percentage of negative epistasis in yeast. (A) The two matrices represent all mu-
tant pairs identified in real experimental data (left) and FBA simulation (right) (fitness
difference |∆ f | ≥ 0.01; epistasis threshold | | ≥ 0.01). Each cell represents one mutant
pair within the same gene. The color bar to the right represents the normalized percent-
age of negative epistasis for the mutant allele with more severe defects (percentage of
negative epistasis for the mutant allele with more severe defects divided by the sum of
percentage of negative epistasis for two mutant alleles). Red and yellow colors repre-
sent that mutant allele with more severe defects in the same gene has higher and lower
percentage of negative epistasis than the other allele, respectively. (B) Distribution for
the number of mutant pairs among randomly selected 35 pairs where mutants with more
severe defects have higher percentage of negative epistasis. The arrow represents the
observed number for the mutant allele pairs within the same genes. (C) The percentage
of mutant pairs in which the mutant allele with more severe defects in the same gene has
a higher percentage of negative epistasis under various fitness difference and epistasis
thresholds during FBA simulations.
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To see if this result could be caused by a systematic trend in the high-throughput
experiments, we randomly selected 35 pairs of mutants from distinct genes that have the
same fitness level for single-deletion mutant and fitness difference between two mutants
as the above 35 pairs of mutants within the same genes, and compared their relative
prevalence of negative epistasis. The permutation was repeated 100,000 times, and the
result is depicted in Figure 2.2.2B. Among all repeats of randomly selected 35 mutant
pairs, only a small percentage (4.1%) have 21 or more mutant pairs where the mutant
with more severe defects has a higher chance than the other mutant to develop negative
epistasis in the genome, indicating that our observation for different mutant alleles of the
same gene is not likely caused by the overall pattern in the high-throughput experiments.
Using results from the above FBA simulation, we also confirmed the same pattern
that between mutant alleles of the same gene, the mutant allele with more severe defect
is more likely than the other allele to develop negative epistasis in the genome (Fig-
ure 2.2.2A, right). Indeed, an even higher percentage of mutant allele pairs in the FBA
simulation (≈ 70%) than in real experiments (60%) support this conclusion. To avoid
possible bias from the definition of epistasis and fitness differences between mutant al-
leles in the FBA simulation, we repeated the calculations based on multiple criteria and
our conclusion remains the same (Figure 2.2.2C).
Our observation is surprising given that previous results based on virus models or
gene network simulations proposed a totally opposite pattern at the genome level, i.e.,
mutations with larger mutational defects are more likely to develop positive epistasis
[104, 105, 106, 107, 108]. We further used the FBA simulations to explore the dynamics
of epistasis for various mutant alleles of the same gene in different species. High-quality
genome-wide metabolic networks in three bacteria (Escherichia coli [109], Salmonella
typhimurium [110], and Helicobacter pylori [111]), one archaea (Methanosarcina bark-
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eri [112]), and another single-cell eukaryote (Plasmodium falciparum [113]) were used
in our simulation. As shown in Figure 2.3, when two mutant alleles of the same gene
are compared, in 22%, 17%, 32%, and 19% of cases for E. coli, S. typhimurium, H. py-
lori, and M. barkeri, respectively, mutant alleles with more severe defects display higher
percentages of negative epistasis than the other allele, indicating that more deleterious
mutant alleles in the same gene indeed tend to develop positive epistasis in these species.
However, these numbers are significantly smaller than that of yeast and another eukary-
otic organism, P. falciparum (52%). The conclusion is robust under various epistasis
thresholds (Figure A.5).
2.2.3 Self-Purging Mechanism for Deleterious Mutations at the
Population Level
Our above results indicate that between two random mutant alleles of the same gene,
the chance for the allele with more severe mutational consequence to develop a higher
percentage of negative epistasis than the other allele is 50-70% in eukaryotic organisms,
but only 20-30% in bacteria and archaea. In other words, mutant alleles with more se-
vere defects in the same gene might have a higher chance to develop negative epistasis
in eukaryotic organisms than in bacteria and archaea. We constructed a simple popula-
tion genetic model as in Figure 2.2.3A to address the evolutionary significance of this
observation. The genetic system has two genes: a query gene A, which contains three
different alleles (AS: mutants with severe defects; AD: mutants with weak defects; AWT:
WT), and a gene X, which has two different alleles (mutant, XM, and WT, XWT). We
simulated the ratio of allele frequency between the severe and the weak mutant alleles
in gene A under different probabilities of having negative epistasis between these two
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Figure 2.3: Mutant alleles with more severe defects tend to have a higher percentage
of negative epistasis in eukaryotes than bacteria and archaea. The y axis shows the per-
centage of mutant pairs in which mutant alleles with more severe defects in the same
gene have a higher percentage of negative epistasis than the other allele. FBA simula-
tions were conducted for three bacterial species (E. coli, S. typhimurium, and H. pylori),
one archaea species (M. barkeri), and two single-cell eukaryote species (P. falciparum
and S. cerevisiae). The mean and SEs were based on results from 40 epistasis threshold
values ranging from 0.01 to 0.05.
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alleles and the mutant allele in the gene X.
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Figure 2.4: Increased efficiency of purging deleterious mutations in eukaryotic organ-
isms. (A) The population genetics model for allele frequency changes from generation
to generation. In the figure, ρ and ω represent allele frequency and fitness, respectively.
A and X are genes with different alleles, and  is the epistasis term between mutant types
of different genes. (B) The ratio of the severe to the weak alleles of the A gene in the
50th, 100th, 150th, 200th, 250th, and 300th generations. Colors represent the ratio as
indicated at the bottom. The diagonal line in each panel represents the situation where
the severe and the weak mutant alleles have the same probability of having negative
epistasis in the genome. It is noteworthy to point out that in each panel the ratio of
the severe to the weak alleles decreases, indicating increased efficiency of purging the
severe mutant allele, from the upper right (region I, the weak mutant has more negative
epistasis) to the bottom left (region II, the severe mutant has more negative epistasis)
part of the panel. The arrows A and B are discussed in the text.
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Our results in Figure 2.2.3B depict the simulation results. The six panels in the fig-
ure represent the ratio of AS to AD alleles in the 50th, 100th, 150th, 200th, 250th, and
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300th generations, respectively. Our simulations indicate that if the percentage of neg-
ative epistasis for the severe mutant is kept as a constant, as the percentage of negative
epistasis for the weak mutation increases (as shown by the arrow A), the ratio of the
severe to the weak allele frequency would increase. However, this ratio would decrease,
indicating a faster removal of the severe mutants from the population, in another direc-
tion (as shown by the arrow B), i.e., the percentage of negative epistasis for the weak
mutant is kept as a constant, but the percentage of negative epistasis for the severe mu-
tant increases. Therefore, the distribution for the sign of epistasis among different alleles
of the same gene observed in this study might represent an efficient way for eukaryotic
organisms to purge deleterious mutations from populations.
2.3 Discussion
Our study represents a genome-wide theoretical survey for the dynamics of global
epistatic effects under various mutant alleles of the same gene. We show that the epistatic
profiling of a gene at the genome level is largely dependent on mutant types involved.
Our results indicate that previous conclusions inferring epistatic relations among genes
based on only one mutant type per gene can be greatly improved by using multiple
mutant alleles. More importantly, our study shows that mutant alleles with severe de-
fects have a higher chance to develop negative epistasis in eukaryotic organisms than
in bacteria and archaea. It has been speculated that eukaryotic organisms might have
more negative epistasis due to their increased complexity over prokaryotic organisms
[114, 115]. Even if this hypothesis is true, however, our results for different mutant
alleles of the same gene cannot be directly inferred from this complexity argument.
Even though the mechanism underlying our observation remains to be determined,
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we argue that such distributions for negative epistasis among different alleles of the same
genes have significant evolutionary consequences, as shown in our population genetics
simulations (Figure 2.2.3). The origin and maintenance of sexual reproduction remains
one of the central issues in evolutionary biology. Population genetics models have been
proposed to explore the impact of epistasis on the maintenance of sexual reproduction
[116, 117, 118, 119]. The mutational deterministic hypothesis posits that sex enhances
the ability of natural selection to purge deleterious mutations by bringing them together
into single genome through recombination [116]. This explanation requires the preva-
lence of negative epistasis at the genome level. Here we found that the mutations with
larger deleterious defects within the same gene have a higher chance to develop negative
epistasis in eukaryotic organisms than bacteria and archaea. The model we proposed in
Figure 2.2.3, which is based on the population genetics theory from Kondrashov [116],
indicates that such distribution of negative epistasis among different alleles of the same
gene in eukaryotic organisms might lead to more efficient purging of deleterious mu-
tations from populations, thus providing a previously unappreciated evolutionary ad-
vantage for sexual reproduction. We emphasize that these findings do not necessarily
provide sufficient evidence to explain the cause for the emergence of sexual reproduction
during evolution.
Although we found several unique characteristics regarding the global epistatic land-
scape of different mutant alleles in the same gene, three caveats need to be addressed.
First, the FBA modeling used in this study, which has been successfully applied to var-
ious research problems [34, 93, 94, 95, 96, 97], includes only metabolic genes in the
simulation. However, results from our analysis on the experimentally defined epistatic
relations among ≈ 0.2 million double mutants comprising ≈ 4,000 S. cerevisiae genes,
which nearly represent all functional categories in the budding yeast, confirmed our
major FBA modeling predictions.
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Second, even though FBA is one of the most comprehensive computational tools
for simulating epistatic interactions among genes, there are still many aspects that can
be improved to aid in capturing the full set of empirical genetic interactions [53]. For
example, rules for transcriptional regulation and physical interactions can be integrated
into the current FBA framework to improve its accuracy [120]. In addition, mapping
between individual alleles and metabolic flux reduction is a complex process and diffi-
cult to measure experimentally [121]. It is noteworthy that in our simulations we have
uniformly evaluated fitness consequence based on the percentage of WT flux attainable
in a specific background. Depending on the regulation dynamics of individual genes,
such uniform sampling may be unlikely to correspond to random sampling of mutant
alleles. For instance, a mutation that limits the availability of a ligand that activates an
enzyme following a Hill equation with early saturation may have a very high frequency
of neutral or mildly deleterious mutations compared with a similar enzyme with late
saturation. Nevertheless, uniform sampling in our study is still useful in illustrating the
main evolutionary ideas presented here, which all have to do with relative severity of
mutations rather than their absolute fitness.
Third, measuring the presence of epistasis is subject to a choice of threshold. Does
the flux smoothly influence epistasis, or can epistasis abruptly change or become zero?
We have seen evidence of both trends in our simulations. Though there are many differ-
ent trends in the magnitude of epistasis that we are currently investigating, we present
two cases to explore this issue (Figures A.6 and A.7 and Datasets S3 and S4). How-
ever, based on Figure A.1 and A.5, we have confirmed that our major results are robust
to a variety of epistasis thresholds. As a result, although the choice of thresholds is a
common problem for research on epistasis, we are still confident that our conclusion
is unlikely to be significantly influenced by this factor. With these limitations in mind,
our observations identified several important features for the epistasis among genes, and
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call on future experimental and theoretical efforts to revisit genetics and evolutionary
theories that can integrate epistatic dynamics among genes in biological systems.
2.4 Methods
2.4.1 Experimental Dataset
The experimental data were extracted from a global survey for the epistatic interactions
among genes in S. cerevisiae [79]. In this original SGA study, the authors screened 1,712
S. cerevisiae query gene mutants against 3,885 array gene mutants to generate a total of
more than 5 million gene mutant pairs spanning all biological processes. In each gene
mutant pair, the epistasis value is calculated based on the equation  = Wxy −WxWy, in
which Wxy is the fitness of an organism with two mutations in genes X and Y, and Wx or
Wy refers to the fitness of the organism with mutation only at gene X or Y, respectively.
In addition, a statistical confidence measure (p-value) was assigned to each interaction
based on the observed variation of each double mutant across four experimental repli-
cates and estimates of the background error distributions for the corresponding query
and array mutants. Finally, a defined confidence threshold (| | ≥ 0.01, P < 0.05) was
applied to generate epistatic interactions [79].
2.4.2 Flux Balance Analysis
FBA frames the stoichiometric equations that describe the biological reactions of a sys-
tem as the following matrix equations, which is possible because stoichiometric equa-
tions are linear [8, 91, 92].
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maximize cT v
subject to Sv = dxdt = 0
vlb  v  vub
(2.1)
The vector of concentration change over time ( dxdt ) is found by multiplying the sto-
ichiometric matrix S by a flux vector v. S has columns corresponding to each reaction
in the system, and rows corresponding to metabolites. Typically, one or more enzymes
correspond to each reaction, which allows us to see how a genetic perturbation, such
as a knockout, may affect the system. The vector v consists of reaction fluxes and is
subject to upper and lower bounds vub = (u1, u2 . . . , un)T and vlb = (l1, l2 . . . , ln)T . If we
want to simulate the knockout or knockdown of an enzyme, the fluxes corresponding to
that enzyme can be constrained to be zero or lower than WT, respectively. It is assumed
that the change in concentration over time is at steady state, therefore dxdt = 0 in the FBA
simulation [8].
The linear objective is written in terms of the vi with weight coefficients ci. Modified
versions of COBRA and COBRA2 scripts, popular FBA software packages written for
MATLAB, were used to implement our simulation framework [92]. The method for
calculating a realistic WT flux for a given environment and organism model is taken
from Smallbone and Simeonidis 8. This method, termed geometric FBA, attempts to
choose a flux vector that is close to the average of all optimal flux vectors. The geometric
FBA solution is also a minimal L1-norm solution, which has been previously heralded
as a good choice because it minimizes the total amount of flux needed to achieve the
objective, based on the fact that cells would avoid having much unnecessary flux and
wasted energy [8]. A minimal L1-norm solution is advantageous in this study because
restricting fluxes for mutants based on unnecessarily large WT fluxes may not constrain
the system. Finally, the minimal L1-norm solution avoids the problem of having futile
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cycles, which are thermodynamically infeasible [8].
Mutations of genes are simulated by the use of gene-reaction mapping and flux con-
straints. Enzymes may be involved in multiple reactions (i.e., pleiotropy). Although we
often have Boolean rules describing the relationship between genes in an enzyme com-
plex, it is currently extremely difficult to ascertain the exact contribution of each enzyme
to each reaction [121]. Choosing the simplest unbiased approach, we used gene-reaction
mapping and uniformly constrained the flux through each reaction associated to the gene
being mutated. With one notable exception [34], most research relating to simulation of
mutations with FBA has focused on null mutants [23, 93, 94, 95, 96, 97, 98]. Our simu-
lation approach, though simplifying the actual dynamics that result in decreased fluxes
in vivo, allows us to see behavior that was not previously possible. To be consistent, we
used the same equation and threshold (| | ≥ 0.01) to calculate epistasis for FBA results
as we did for the experimental data.
2.4.3 Population Genetics Model
A flowchart in Figure A.8 provides more illustration of the simulation procedure. We
constructed a genetic system with a query gene A, which contains three different alle-
les (AS: severe mutant; AD: weakly deleterious mutants; and AWT: WT) and a gene X
that has two different alleles (XM: mutant and XWT: WT). The table in Figure 2.2.3A
explains how genotype frequencies could be calculated from generation T to generation
T + 1 under natural selection. In the figure, ρ and ω represent allele frequency and fit-
ness, respectively. The average fitness in generation T could be calculated [122]. We
simulated the ratio of allele frequency for the severe (AS) to the weak (AD) mutant alle-
les of the A gene under all possible combinations of the percentages of negative epistasis
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for these two alleles, as shown on the x and y axis of Figure 2.2.3B. For each possible
combination in each generation (a specific location on each panel of Figure 2.2.3B),
the following two-step procedure was repeated 1,000 times. First, the epistatic relations
(negative, positive, and no epistasis) between the mutant alleles of the genes A and X
were randomly determined as the following: either A allele is assumed to have 10%
possibility of having epistasis (either positive or negative) with the allele XM [79]; when
A and X alleles do have epistasis, the likelihoods for the epistasis being negative (and
the remaining epistases are positive) are assigned independently for AS and AD alleles
according to their location on Figure 2.2.3B. Second, the fitness of each genotype was
calculated, which was then used to infer the genotype frequencies in the next generation
according to Figure 2.2.3A. The average genotype frequencies among 1,000 random-
izations were then recorded for simulations in the next generation. The ratio of allele
frequency for the severe to the weak mutant alleles of the A gene in each generation was
calculated based on genotype frequencies in that generation.
To make the simulation simple, the initial allele frequencies for the severe, weak,
and WT alleles of the A gene were assumed to be equal (one-third), and the initial
allele frequencies for the mutant and WT of the X gene were also assumed to be equal
(one-half). The fitness was assumed to be 1, 0.99, and 0.98 for the WT, weak, and
severe mutant alleles of gene A, respectively, and 1 and 0.99 for the WT and the mutant
alleles of gene X, respectively. The positive and negative epistasis values between A
and X gene mutants were assumed to be 0.01 and 0.01, respectively. A variety of fitness
differences between the severe and weak alleles and epistasis values have also been used
in the simulations, and the trend remains the same.
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CHAPTER 3
DYNAMIC EPISTASIS UNDER VARYING ENVIRONMENTAL
PERTURBATIONS
Epistasis describes the phenomenon that mutations at different loci do not have inde-
pendent effects with regard to certain phenotypes. Understanding the global epistatic
landscape is vital for many genetic and evolutionary theories. Current knowledge for
epistatic dynamics under multiple conditions is limited by the technological difficulties
in experimentally screening epistatic relations among genes. We explored this issue by
applying flux balance analysis to simulate epistatic landscapes under various environ-
mental perturbations. Specifically, we looked at gene-gene epistatic interactions, where
the mutations were assumed to occur in different genes. We predicted that epistasis tends
to become more positive from glucose-abundant to nutrient-limiting conditions, indicat-
ing that selection might be less effective in removing deleterious mutations in the latter.
We also observed a stable core of epistatic interactions in all tested conditions, as well
as many epistatic interactions unique to each condition. Interestingly, genes in the stable
epistatic interaction network are directly linked to most other genes whereas genes with
condition-specific epistasis form a scale-free network. Furthermore, genes with stable
epistasis tend to have similar evolutionary rates, whereas this co-evolving relationship
does not hold for genes with condition-specific epistasis. Our findings provide a novel
genome-wide picture about epistatic dynamics under environmental perturbations.
3.1 Author Summary
Epistasis, often referred to as genetic interactions, occur when mutational effects of
genes depend on each other. Aside from often times complicating the way in which the
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phenotype of an organism relates to its genotype, epistatic interactions (or epistases) are
essential to several important theories in biology, especially in evolution. Due to the
difficulty in experimentally assessing epistasis across an entire genome, we employed
mathematical modeling of the metabolic network of bakers yeast to comprehensively
simulate genetic interactions for virtually all known metabolic genes in the organism.
We performed comprehensive simulations in 17 different environments, which differ by
their nutrients. We characterized a trend that occurs in genetic interactions when yeast
is transferred from a glucose-abundant environment to other environments. We also
found that both the set of genetic interactions present in all conditions and the set of
interactions present in a single environment are fairly large sets with highly different
connectivity. Furthermore, the set present in all conditions tends to consist of gene pairs
with similar evolutionary rates.
3.2 Introduction
Epistasis refers to the phenomenon wherein mutations of two genes can modify each
others phenotypic outcomes. It can be positive (alleviating), or negative (aggravating),
when a combination of deleterious mutations shows a fitness value that is higher, or
lower, than expectation, respectively. For example, a mutation that hampers a pathway’s
function may allow for other mutations in the same pathway without a fitness conse-
quence, resulting in positive epistasis. Conversely, genes or pathways with redundant
functions can give rise to negative epistasis. It is well established that epistasis is im-
portant for the evolution of sex [107, 117, 123], speciation [124], mutational load [125],
ploidy [126], genetic architecture of growth traits [127], genetic drift [128], genomic
complexity [115], and drug resistance [129]. As biological systems in nature have to
face multiple genetic and environmental perturbations, understanding the global land-
36
scape and dynamics of epistasis under these perturbations remains an important issue in
the evolutionary field. In an earlier study, we addressed genome-wide epistasis dynam-
ics under various genetic perturbations [9]. In this study, we will investigate the impact
of environmental perturbations on global epistasis dynamics.
How epistatic interactions among genes change in different environmental con-
ditions has been intensively studied in various model organisms, including E. coli
[130, 131, 132], S. cerevisiae [133, 134, 135], C. elegans [136, 137] and D.
melanogaster [138, 139, 140]. The results of these studies, however, are very controver-
sial. While some studies observed increasing positive epistasis under harsh conditions
[131, 135, 138], others have opposite findings [132, 133, 134, 136, 137, 139, 140, 141].
Even within the same species, different experimental studies might have conflicting con-
clusions (e.g. Kishony and Leibler 131, Cooper et al. 132). One possible reason for the
above controversy could have originated from the fact that most studies only looked at
the epistasis dynamics based on a small number of genes, where the properties cannot
be generalized to the entire organism.
The main obstacle to exploring global epistatic dynamics under a variety of environ-
ments is the difficulty of applying high-throughput experimental platforms. To explore
epistasis on a genomic scale, a number of technologies have been developed to sys-
tematically map genetic interaction networks, such as synthetic genetic array (SGA)
[79, 80], diploid-based synthetic lethality analysis with microarrays (dSLAM) [81, 82],
synthetic dosage-suppression and lethality screen [83, 84, 85] and epistatic miniarray
profiles (EMAP) [86, 87, 88]. A key issue for all these experimental studies is that
these epistatic networks have been constructed only under normal laboratory conditions.
However, cells are constantly bombarded by various external environmental stresses.
Epistasis dynamics under these perturbations cannot be predicted based on normal lab-
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oratory conditions. Few studies have constructed epistatic networks under multiple en-
vironmental perturbations. A recent study that has only constructed epistatic networks
for a group of genes with specific functions under one normal and one harsh condition
already requires a large amount of effort [142]. Consequently, genome-scale epistasis
landscapes under a variety of environmental perturbations remain largely uncharacter-
ized.
Here we explored this issue by using Flux Balance Analysis (FBA) to simulate epis-
tasis dynamics among genes under multiple environmental perturbations. FBA involves
optimization of an objective function, commonly growth maximization in microbes,
subject to the reactions and constraints of a metabolic network, which can provide re-
liable predictions [8, 22, 24, 92, 98, 101]. Using this platform, a previous study has
investigated synthetic lethal interactions (one type of negative epistasis) under multiple
environmental perturbations and showed the plasticity of epistatic interactions in the
metabolic networks [95]. Here we examined both positive and negative epistasis using
FBA, and were able to show that at the genome scale epistatic interactions tend to be-
come more positive in nutrient-limiting conditions relative to abundant-glucose media.
In addition, while a large proportion of epistatic interactions can be rewired dynami-
cally under varying environments, there is a core of epistatic interactions that are stable
across all tested environments. We also discovered different network and evolutionary




3.3.1 FBA modeling and simulated growth conditions
We applied the yeast S. cerevisiae metabolic reconstruction iMM904 [91] to examine the
dynamics of epistasis under various environmental perturbations. The reconstruction
has 904 metabolic genes that are associated with 1,412 metabolic reactions. We con-
ducted FBA simulations under an abundant-glucose condition and 16 nutrient-limiting
conditions with the following environmental perturbations. In 15 of these perturbations,
the carbon source (abundant glucose) was replaced by one of the following: acetalde-
hyde, acetate, adenosine 3’,5’-bisphosphate, adenosyl methionine, adenosine, alanine,
allantoin, arginine, ethanol, glutamate, glutamine, glycerol, low glucose, trehalose, and
xanthosine, respectively. These conditions represent a wide variety of nutrient and en-
ergy sources: nucleosides, amino acids, sugars, alcohols, etc. Additionally, we looked
at abundant glucose under limited phosphorus availability.
To ensure that all these environmental conditions have the same growth rates in
the following analyses, we restricted the carbon source or phosphorous uptake levels
for each of the 16 environmental perturbations such that only 20% of the high-glucose
growth rate was attained. This was chosen because it has been shown that metabolism
was directly linked to growth and similar growth rates often induced similar metabolic
pathways [143]. It is therefore important to use a fixed growth rate among different
conditions to control for the relationship between growth rates and the overall metabolic
activity so as not to induce a growth-rate specific effect. The 20% high-glucose level
was chosen because some media types do not support high growth rates, regardless
of the abundance of the nutrient source. In order to estimate epistasis between genes,
we created a mutation for each gene in each condition that restricted the flux to be
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50% of the wild-type flux found by geometric FBA for all reactions associated with
the mutant gene [9]. Epistatic relations between any two genes were calculated under
each condition. We also tested our core findings allowing maximum growth in each
condition (Table S1) and the general trends in our results remained similar, as described
in the following.
3.3.2 More positive differential epistases from rich media to
nutrient-limiting conditions
To directly address how the sign and magnitude of epistases change under nutrient-
limiting conditions, we calculated differential epistasis (d), which is defined as the
epistatic changes from abundant-glucose media to the nutrient-limiting condition for
each gene pair in each growth condition. A gene pair with positive (or negative) differ-
ential interaction under an environmental perturbation is defined as these two genes hav-
ing increasing (or decreasing) epistasis values from the abundant-glucose media to that
condition. Figure 3.3.2A depicts the distribution of differential epistases in two growth
conditions (ethanol and glycerol) as an example. Only genes with |d | ≥ 0.01 in at least
one of the two conditions are included in this figure. As quantified in Table S2, there
are 6.1% and 5.5% of total gene pairs with |d| ≥ 0.01 from abundant-glucose media to
ethanol and glycerol growth conditions, respectively. Among them, a large number of
gene pairs even change their sign of epistasis (Table S2). Simulations in other conditions
show similar effects (Table S2), indicating that epistatic relationships among genes can
be very dynamic between abundant-glucose media and nutrient-limiting conditions.
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Figure 3.1: More positive differential epistases under environmental perturbations. (A)
Heat maps describe the global dynamics of differential epistasis from abundant-glucose
medium to ethanol (left panel) and glycerol (right panel) conditions. Only gene pairs
with |d | ≥ 0.01 in either condition are included in the figure. Different colors represent
differential epistasis values as indicated by the color bar at the bottom. The differential
epistasis values are assigned to be 0.1 (or -0.1) in the heat-maps when it is greater than
0.1 (or less than -0.1). It is noteworthy to point out that the epistasis patterns are indeed
very different between the two conditions (Figure 3.2A). (B) Percentage of positive and
negative differential epistases under ethanol and glycerol conditions. (C) Ratio of pos-
itive to negative differential epistases in each simulated condition. The result from a
high-throughput experiment is also shown. The letters A-P represent acetaldehyde, ac-
etate, adenosine 3’,5’-bisphosphate, adenosyl methionine, adenosine, alanine, allantoin,




We further investigated the sign of differential epistasis from abundant-glucose to
nutrient-limiting conditions. As shown in Figure 3.3.2A, we observed more yellow dots
(positive differential epistasis) than blue dots (negative differential epistasis) in both
panels. Indeed, as quantified in Figure 3.3.2B, 72% and 57% of differential epistases
are positive in ethanol and glycerol conditions, respectively. We further explored all
16 nutrient-limiting conditions and the results are shown in Figure 3.3.2C. In most of
our simulated conditions (13/16), there are significantly more positive differential epis-
tases than negative differential epistases (Binomial test, P < 10-5 for each of the 13
conditions), indicating that epistasis tends to become more positive in nutrient-limiting
conditions. This conclusion does not depend on the criteria we used to define differential
epistasis (Figure B.1).
A recent high-throughput experiment measured epistatic relations between ≈ 80,000
gene pairs with and without perturbation by a DNA-damaging agent (methyl methane-
sulfonate, MMS). The study represents the most comprehensive experimental study so
far to explore epistatic dynamics from a rich medium to a harsh condition [142]. Inter-
estingly, the authors also found more positive differential epistases than negative differ-
ential epistases, which is consistent with our general observation (Figure 3.3.2C). We
further allowed maximum growth in each condition and the general trends in our results
remained similar (Figure B.1).
We found that differential epistasis had functional importance after performing both
Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) en-
richment analyses to compare genes with positive and negative differential epistases
through the glucose-abundant to ethanol transition. We chose the ethanol condition as
an example because it is one of the most widely used conditions for the bakers yeast.
Interestingly, we observed that 38 GO terms and 8 KEGG pathways are enriched for
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positive differential epistasis, while 18 GO terms and 1 KEGG pathways are enriched
for negative differential epistasis (Table S3). More importantly, we found positive and
negative differential epistases uniquely contribute to different aspects of ethanol and
energy metabolism. For example, positive differential epistasis is enriched in mono-
hydric alcohol metabolic processes, oxidoreductase activity acting on aldehyde group
donors, the TCA cycle, and pyruvate metabolism, while negative differential epistasis is
enriched in ethanol metabolic processes and various amino acid terms and pathways, in-
dicating the functional importance of differential epistasis (Table S3). This is consistent
with experimental results that show differential epistatic interactions, rather than static
epistatic interactions, are functionally related to the response of interest [142].
Several system properties were found to correlate with the ratio of the number of
positive to negative differential epistases (Table S4). A strong correlation exists between
the number of essential genes in a given condition and the ratio of positive to negative
differential epistasis on transition from high glucose to that condition (ρ = 0.9056, P
= 1.3905e-006), which was a better predictor than the number of non-zero fluxes in
the wild-type vector for that environment (ρ = 0.7131, P = 0.0019). An even stronger
predictor for positive differential epistasis was the mean relative fitness of single mutants
in the new environment (ρ = −0.9941, P = 6.4340e-015); this anticorrelation suggests
that a propensity for a lower single mutant fitness can cause a shift towards positive
epistasis.
3.3.3 Dynamic epistasis between nutrient-limiting conditions
Figure 3.3.2 explored the epistasis dynamics from abundant-glucose media to nutrient-
limiting conditions. As biological systems in nature constantly face changing envi-
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ronmental perturbations, it is interesting to investigate the epistasis dynamics among
nutrient-limiting conditions. To achieve this aim, we first explored the epistatic rela-
tionship between the same gene pairs in the two environmental perturbations based on
growth in ethanol and glycerol. Figure 3.2A lists the number of gene pairs that have
various epistatic relationships. It is noteworthy to point out that, consistent with previ-
ous published results there are significantly more positive epistases between genes than
negative ones in either condition [34].
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Figure 3.2: Epistasis dynamics between environmental perturbations. (A) Number of
gene pairs with various epistatic relationships between ethanol and glycerol growth con-
ditions. (B) The distribution for the percentages of gene pairs with similar epistasis re-
lation between any 2 of 16 conditions. The frequency is derived from the 120 pairs of
environmental conditions simulated in this study.
If two genes have the same sign of epistasis and | | ≥ 0.01 in both conditions, they
are defined as having similar epistatic relationship in these two conditions. To quantify
epistatic dynamics between ethanol and glycerol growth conditions, we defined the per-
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centage of gene pairs with similar epistatic relations to be the number of gene pairs with
similar epistasis relations shared in these two conditions (overlap) divided by the num-
ber of gene pairs with epistasis in either condition (union). Our results show that 79%
of gene pairs have similar epistasis relations between these two conditions. Figure 3.2B
shows the distribution for the percentages of gene pairs with similar epistasis relations
between any 2 of 16 conditions, demonstrating a variable degree of epistatic similarity
between any two conditions. This conclusion still holds when we used different criteria
to define epistatic relationships between genes (Figure B.3).
To understand the global distribution of all epistatic relations, we considered 16
conditions together and calculated the fraction of epistatic interactions existing in 1,
2, 3, . . . , 15, and 16 conditions, respectively. As shown in Figure 3.3.3A, we found
that there is a U frequency distribution for the number of growth conditions in which a
specific epistatic interaction is observed. This means that approximately 52% of these
interactions are either condition-specific (24%; termed dynamic) or predicted to exist
in all conditions (28%; termed stable), and ≈ 48% is intermediate (exists in multiple
but not all 16 conditions). An analogous result was obtained previously, but only for
synthetic lethal interactions [95]. We also changed the growth assumption and allowed
maximum growth in each condition and reanalyzed the global distribution of all epistatic
relations. The U frequency distribution for the number of growth conditions in which
a specific epistatic interaction is observed remained similar (Figure B.4). Based on the
result in Figure 3.3.3A, we further calculated the ratio of these three types of epistatic
relations in each of the 16 environmental perturbations. As shown in Figure 3.3.3B, we
found that in each environment, ≈ 40-60% of epistatic interactions are stable ones and
that each specific environmental condition also has many private epistases among genes.
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Figure 3.3: The global distribution of epistatic relations under simulated conditions. (A)
Distribution for the number of conditions in which each epistatic interaction exists. Note
that ≈ 28% of epistatic relations are extremely stable (the very right bar) and ≈ 24% are
extremely dynamic (the very left bar). (B) Fraction of three types of epistatic relations
in each of the 16 environmental perturbations, as indicated by the color bar to the right.
The numbers in the brackets represent the number of conditions in which each epistatic
interaction exists, as indicated in (A). The letters A-P represent the simulated conditions
as indicated in Figure 1.
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3.3.4 Different network properties for stable and dynamic epistasis
Analysis on network properties can reveal various organization principles (e.g. fre-
quency of occurrence, centrality) for epistasis networks [79, 80] and therefore provide
valuable information to further distinguish stable and dynamic epistasis. To achieve
this aim, we compared networks formed by extremely stable and extremely dynamic
epistasis among genes and asked whether they have distinct network properties. The
degree distributions for both types of epistasis are shown in Figure 3.4A. Interestingly,
extremely stable epistatic interactions form an exponential network architecture, which
is homogeneous, meaning that most nodes have a very similar number of links (Fig-
ure 3.4A, left panel). In contrast, the extremely dynamic epistatic interactions give rise
to a scale-free network topology, which is heterogeneous, meaning that the majority of
nodes have few links but a small number of hubs have a large number of links (Fig-
ure 3.4A, right panel).
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Figure 3.4: Network properties for the extremely stable and extremely dynamic
epistatic interactions. (A) Degree distribution for genes in two epistatic interaction net-
works. The networks have nodes that correspond to genes and edges that correspond to
epistatic interactions. (B) Three network parameters (the definition of which are shown
in Methods) for two epistatic interaction networks.
In addition, we calculated three network parameters to compare these two types of
epistatic interactions. We found that the network formed by extremely stable epistases
has a smaller shortest path length, a larger clustering coefficient and larger closeness
than the network formed by extremely dynamic epistases (Figure 3.4B). These results
are consistent with the scenario that genes with extremely stable epistasis are directly
linked to most other genes and form an exponential network topology, while genes with
extremely dynamic epistasis form a scale-free network. Our results also show that the
network induced by intermediate epistases have intermediate values of these parameters
compared to that of extremely stable and extremely dynamic epistasis networks (Tables
S5 and S6).
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3.3.5 Co-evolution of genes with epistatic interaction
Gene pairs with epistasis identified in real experiments usually show similar evolution-
ary rates. To investigate whether two genes with predicted epistasis also tend to co-
evolve, we calculated the evolutionary rate differences between two genes with epistasis
from FBA modeling (Figure 3.3.5A). Evolutionary rates (dN/dS) based on orthologous
gene sets from four yeast species of the genus Saccharomyces were downloaded from a
commonly used reference dataset [144]. Simulations based on the same number of gene
pairs with FBA-predicted epistasis were conducted to estimate the evolutionary rate dif-
ferences for any two randomly selected genes. As shown in Figure 3.3.5A, the gene
pairs with FBA-predicted epistatic interactions tend to have more similar evolutionary
rates than random expectation (P < 10-4).
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Figure 3.5: Co-evolution between genes with epistasis. (A) Average evolutionary
rate differences between gene pairs with FBA-predicted epistasis (green), extremely
dynamic epistasis (blue) and extremely stable epistasis (red) are highlighted by three
arrows, respectively. The random simulations with the same number of gene pairs as
each of the three groups were repeated 10,000 times and the frequency distributions are
shown (marked by the same colors as the corresponding arrows, respectively). (B) The
evolutionary rates for genes that are involved in extremely stable and extremely dynamic
epistasis, respectively. The error bars represent standard errors.
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In Figure 3.4 we observed unique network properties for extremely stable and ex-
tremely dynamic epistatic interactions. We further investigate the co-evolution between
genes with these two types of epistatic relationships. As shown in Figure 3.3.5A, genes
with extremely stable epistasis tend to co-evolve (P < 10-4), while the difference be-
tween genes with extremely dynamic epistasis and random expectation becomes much
smaller (P = 0.06). The evolutionary rate difference between gene pairs with extremely
stable and extremely dynamic epistasis is also significant (t-test, P = 8e-6). This differ-
ence is not caused by genes that are involved in extremely stable or extremely dynamic
epistasis, because these two groups of genes do not have significantly different evolu-
tionary rates (t-test, P = 0.796, Figure 3.3.5B).
3.4 Discussion
3.4.1 Natural selection in nutrient-limiting conditions
Whether a genetic mutation has a fitness consequence depends on other sites, a phe-
nomenon called epistasis (see Lehner 145 for a recent review on molecular mecha-
nisms). Positive epistasis alleviates the total harm when multiple deleterious mutations
combine together and thus reduces the effectiveness of natural selection in removing
these deleterious mutations, whereas negative epistasis plays the opposite role by in-
creasing the efficiency of purging deleterious mutations by natural selection. Results
from this study present an initial glimpse over environment-induced epistasis dynamics
at the genome scale. Using differential epistasis from abundant-glucose to nutrient-
limiting conditions, our results show that epistasis between specific genes can become
more positive or more negative in nutrient-limiting conditions, which is consistent with
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previous findings in small scale studies [130, 131, 132, 133, 134, 135, 136, 137, 138,
139, 140, 141]. However, we showed that, at the genome scale, epistasis is more positive
in nutrient-limiting conditions. Interestingly, our simulation results are consistent with a
recent genome-wide study between laboratory and harsh growth conditions [142]. How
epistasis affects selection in harsh conditions has been controversial [146]. Our results
provide the genome-wide evidence arguing that selection might be less effective in re-
moving deleterious mutations in harsh conditions, which could be one of the underlying
reasons for a recent observation that stimulation of a stress response can reduce mutation
penetrance in Caenorhabditis elegans [147].
3.4.2 Network properties and evolutionary patterns for stable and
dynamic epistasis
Our results indicate that epistasis could be extremely stable or dynamic among various
environmental perturbations, which is consistent with a previous FBA study investigat-
ing synthetic lethal relations among non-essential genes [95]. The inclusion of essential
genes in our study allows for investigation on many important metabolic pathways that
were not previously analyzed. Nevertheless, the distribution of epistasis among multiple
environments (Figure 3.3.3A) remains largely unchanged from the previous study [95]
even when essential genes are included.
We also found that stable and dynamic epistatic relationships show totally different
network properties and evolutionary patterns, which might provide new biological and
evolutionary insights. The gene pairs with stable epistases tend to co-evolve with each
other. In addition, from the biological pathway perspective, the smaller shortest path
length and larger closeness values in the stable epistasis network both imply that genes
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with stable epistases tend to be functionally associated with a large number of neighbors
to form a condensed functional network, different from genes in the dynamic epistasis
network that are loosely connected. Furthermore, the large clustering coefficient in the
stable epistasis network also supports the idea that genes with stable epistasis interac-
tions form a network core in the whole epistasis network. Combined with observations
in Figure 3.3.5, this core module of epistasis in the metabolic network might represent
stable functional associations between genes that are essential for important biological
functions and evolutionary conserved even under different environmental perturbations.
The lack of co-evolution pattern and scale-free network properties for the dynamic epis-
tasis network, however, might represent unstable functional associations between genes,
which may only be responsible for unique functions under specific conditions.
3.4.3 Implications and significance for exploring stable and dy-
namic epistasis
Our prediction about stable and dynamic epistasis could have important functional appli-
cations. A recent study showed that the synthetic lethal (negative epistasis) relationship
between fumarate hydratase and haem oxygenase can be employed successfully to iden-
tify an in vitro drug target in hereditary leiomyomatosis and renal-cell cancer (HLRCC)
cells [62]. Exploring both dynamic and stable epistasis could be useful in this con-
text; stable epistatic interactions may be important for drug target detection in cancer or
other pathogens, whereas it may sometimes be necessary to exploit dynamic epistatic
relationships, possibly induced by treatment with an external perturbation.
Furthermore, rational evolutionary design techniques such as OptKnock [148] and
OptGene [149] attempt to find which knockouts will enable a reaction of interest to
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be coupled with growth (i.e. have positive epistasis with growth-associated genes in
a specific environment). However, these techniques do not take into account epistasis
dynamics across different environments. In this study, we have found that epistatic
relations can be highly dynamic under various environmental perturbations, which raises
the possibility to improve these techniques by considering epistasis dynamics in future
studies. Research on using compensatory perturbations to reach desired network states
is ongoing [150].
3.4.4 Caveats and future directions
Though we show several novel insights into how varying environments can influence
epistasis, several caveats should be addressed. First, the FBA modeling used in this
study, which was proven to have great predictive power and has been successfully em-
ployed in addressing numerous research problems [8, 24, 98], only includes metabolic
genes. Second, even though FBA offers the most comprehensive simulation method for
studying epistasis, there are many improvements that can be made in order to capture
the empirically observed set of epistatic interactions [53]. For example, integrating tran-
scriptional regulation and physical interactions into this framework could improve the
current methods in predicting epistasis and other evolutionary processes [120]. Related
to this point, FBA as used herein only considers the steady state and does not take into
account any dynamics or initial conditions, and would necessarily miss any epistatic
interactions that are due to dynamics in the system, such as changing concentrations;
dynamic FBA (which is part of rFBA) might be a solution, but would likely require
about a minimum of two orders of magnitude increase in computation time [20, 53].
Recent work on new objective functions targeting metabolite turnover rather than flux
per se has also proven successful in recovering many epistases that were previously not
58
found with FBA [151].
Third, in order to understand the impact of environmental perturbations on epis-
tasis, we used a reductive approach and only considered one mutation type per gene to
simulate the global epistatic landscape in 16 environments. There are countless environ-
ments in nature. Furthermore, different mutations in the same gene and the interactions
between genes and environment can likely have an even more complex impact on the
epistasis dynamics. While it would be ideal to simulate a larger variety of environmental
conditions for multiple mutations of the same gene, the computational cost is a limiting
factor. Our previous study showed that different mutants of the same gene could have
very dynamic epistatic interaction partners in a single environment [9]. In this study,
we chose to use one mutation per gene as we are focusing on addressing how different
environments could affect gene epistasis dynamics. Nevertheless, in order to see how
sensitive our results were, we performed the analysis for our core results by simulating
16 environments using different growth assumption, where the organisms are allowed to
have unrestricted uptake of the limiting nutrient to obtain the maximum growth in that
condition. We found the major trends in our results are largely unchanged (Figures B.1
and B.1; Table S1).
Keeping these issues in mind, our analysis uncovered several prominent features of
epistatic interactions under a variety of environmental perturbations, and call on future
effort to confirm these simulation results using high-throughput experimental platforms.
More importantly, the enrichment of stable and dynamic epistasis provides a new per-
spective to understand how biological systems may rewire epistasis in nature.
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3.5 Methods
Scripts for generating and analyzing the data can be found in the source code
repository located at https://github.com/bbarker/COBRAscripts/. Scripts
and documentation specific to this paper are located in the subdirectory
MyProjects/EnvironmentalEpistasisFBA.
3.5.1 Flux Balance Analysis
Flux Balance Analysis attempts to tackle issues inherent in other methods of metabolic
modeling, such as the need to measure a large number of parameters, slow speed of
simulation, and dependence on initial conditions [22, 152]. Other than needing a fairly
complete understanding of the reactions present in an organism, the only measurements
required to perform a genome-scale metabolic simulation are those for determining
biomass constitution or a gene expression profile [24, 91]. Strictly speaking, FBA is a
particular type of constraint based modeling (CBM). Constraint based modeling frames
the stoichiometry that describe the reactions present in an organism as a matrix equation
with indeterminates (reaction fluxes) subject to constraints [8, 91]. The optimization
problem is described as follows:
maximize cT v
subject to Sv = dxdt = 0
vlb  v  vub
(3.1)
S is a matrix, in which rows and columns correspond to cellular metabolites and
reactions in the reconstructed network respectively. v is the reaction flux with upper and
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lower bounds vub and vlb respectively. Multiplying the stoichiometric matrix S by the
flux vector v equals the concentration change over time ( dxdt ). At steady state, the flux
through each reaction is given by Sv = 0. Further details on the underlying methods can
be found in the literature [8, 9, 34].
The fluxes of mutations employed in this analysis were restricted to be 50% of the
wild-type fluxes found for growth rate maximization by geometric FBA [34]. To find
new conditions with a specified carbon source or other limiting nutrient that achieves
20% of the high-glucose growth rate, we can solve a linear program for the minimiza-
tion of the limiting nutrient uptake while requiring the growth rate to be equal to 20%
of the abundant-glucose growth-rate. For maximum growth rate conditions (Table S1,
Figures B.1 and B.4), we allowed unrestricted uptake of the limiting nutrient to obtain
the maximum growth in that condition, up to the point where it would reach the high-
glucose growth rate. Mutations affecting protein complexes and pleiotropic genes are
handled by uniform restriction across enzymes as described before [9].
3.5.2 Definition of epistasis
In each gene mutant pair, the epistasis value is calculated based on the equation:  =
Wxy −WxWy, in which Wxy is the fitness of an organism with two mutations in genes X
and Y, whereas Wx or Wy refers to the fitness of the organism with mutation only at gene
X or Y respectively. Each fitness listed previously is calculated relative to the wild-type
fitness. Absolute fitness values are determined by the value of the biomass maximization
objective present in the model. Finally, a confidence threshold (| | ≥ 0.01) was applied
to generate epistatic interactions [9, 34, 79]. We also conducted analyses based on a
different threshold for epistasis and the general conclusions still hold in our analysis
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(Figures B.1 and B.3).
3.5.3 Evolutionary rates and network parameters
Evolutionary rates of S. cerevisiae genes were downloaded from supplementary mate-
rials of Wall et al. 144, in which orthologs were defined by four complete genomes of
Saccharomyces species (Saccharomyces cerevisiae, Saccharomyces paradoxus, Saccha-
romyces mikatae and Saccharomyces bayanus) and evolutionary rates at synonymous
and nonsynonymous sites were calculated based on a four-way yeast species alignment
for S. cerevisiae genes by PAML. For the distributions in 3.3.5A, we randomly sampled
gene pairs with the same number of gene pairs as in three epistasis networks (epistasis
in all 16 conditions, extremely stable epistasis, and extremely dynamic epistasis, respec-
tively), and calculated the average evolutionary rate differences between random gene
pairs in each of these three sample sets. The simulations were repeated 10,000 times for
each of the three groups, which are color coded to correspond to the epistasis networks
of the same size.
Network parameters such as the shortest path length, clustering coefficient and close-
ness were calculated using the computer software Pajek, downloaded from: http:
//vlado.fmf.uni-lj.si/pub/networks/pajek. The shortest path length between
two genes in a network reflects the overall network interconnectedness; the smaller the
average shortest path length is, the higher chance that genes in this network could in-
teract with the other genes. The clustering coefficient of a network is a measurement of
the degree to which nodes in a network tend to cluster together; the larger the average
clustering coefficient is, the more closely the genes are connected, forming modules.
The closeness of a network measures the centrality of nodes within a network; nodes
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that occur on shortest paths with other nodes have higher closeness than those that do
not [153].
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CHAPTER 4
A ROBUST AND EFFICIENT METHOD FOR ESTIMATING ENZYME
COMPLEX ABUNDANCE AND METABOLIC FLUX FROM EXPRESSION
DATA
A major theme in constraint-based modeling is unifying experimental data, such
as biochemical information about the reactions that can occur in a system or the com-
position and localization of enzyme complexes, with high-throughput data including
expression data, metabolomics, or DNA sequencing. The desired result is to increase
predictive capability and improve our understanding of metabolism. The approach typ-
ically employed when only gene (or protein) intensities are available is the creation
of tissue-specific models, which reduces the available reactions in an organism model,
and does not provide an objective function for the estimation of fluxes. We develop
a method, flux assignment with LAD (least absolute deviation) convex objectives and
normalization (FALCON), that employs metabolic network reconstructions along with
expression data to estimate fluxes. In order to use such a method, accurate measures of
enzyme complex abundance are needed, so we first present an algorithm that addresses
quantification of complex abundance. Our extensions to prior techniques include the
capability to work with large models and significantly improved run-time performance
even for smaller models, an improved analysis of enzyme complex formation, the ability
to handle large enzyme complex rules that may incorporate multiple isoforms, and either
maintained or significantly improved correlation with experimentally measured fluxes.
FALCON has been implemented in MATLAB and ATS, and can be downloaded from:
https://github.com/bbarker/FALCON. ATS is not required to compile the soft-
ware, as intermediate C source code is available. FALCON requires use of the COBRA
Toolbox, also implemented in MATLAB.
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4.1 Introduction
FBA (flux balance analysis) is the oldest, simplest, and perhaps most widely used linear
constraint-based metabolic modeling approach [2, 154]. FBA has become extremely
popular, in part, due to its simplicity in calculating reasonably accurate microbial fluxes
or growth rates (e.g. Schuetz et al. 7, Fong and Palsson 18); for many microbes, a simple
synthetic environment where all chemical species are known suffices to allow prolifera-
tion, giving fairly complete constraints on model inputs. Additionally, it has been found
that their biological objectives can be largely expressed as linear objectives of fluxes,
such as maximization of biomass [7]. Neither of these assumptions necessarily hold for
mammalian cells growing in vitro or in vivo, and in particular the environment is far
more complex for mammalian cell cultures, which have to undergo gradual metabolic
adaptation via titration to grow on synthetic media [155]. Recently, there have been
many efforts to incorporate both absolute and differential expression data into metabolic
models [156]. The minimization of metabolic adjustment (MoMA; Segre` et al. 157) al-
gorithm is the simplest metabolic flux fitting algorithm, and it can be extended in order
to allow the use of absolute expression data for the estimation of flux [1], which is the
approach taken in this study.
The MoMA method is framed as a constrained least-squares optimization problem,
is typically employed to calculate the flux vector of an in silico organism after a mutation
by minimizing the distance between the wild-type flux and the mutant flux. The biolog-
ical intuition is that the organism has not had time to adapt to the restricted metabolic
capacity and will maintain a similar flux to the wild-type (WT) except where the per-
turbations due to the mutation dictate necessary alterations in fluxes [24]. Suppose a
is the WT flux vector obtained by an optimization procedure such as FBA, empirical
measurements, or a combination of these. For an undetermined flux vector v in a model
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(vi − ai)2 (4.1)
subject to the stoichiometric constraints Sv = 0 where v = (v1, . . . , vN)T and S is
the stoichiometric matrix (rows correspond to metabolites, columns to reactions, and
entries to stoichiometric coefficients). Constant bounds on fluxes are often present, such
as substrate uptake limits, or experimental Vmax estimates, so we write these as the con-
straints vlb  v  vub. The objective may be equivalently expressed in the canonical
quadratic programming (QP) vector form as min. 12v
T v − aT v. This assumes that each
ai is measured, but it is also possible and sometimes even more useful to employ this
objective when only a subset of the ai are measured (if ai is not measured for some i,
then we omit (vi − ai)2 from the objective). In metabolomics, for instance, it is always
the case in experiments with labeled isotope tracers that only a relatively small subset of
all fluxes are able to be estimated with metabolic flux analysis (MFA; Shestov et al. 2).
Combining MoMA with MFA provides a technique to potentially estimate other fluxes
in the network.
A variant of MoMA exists that minimizes the absolute value of the difference be-
tween ai and vi for all known ai. To our knowledge, the following linear program is the







subject to Sv = 0
vlb  v  vub
∀i : −di ≤ vi − ai ≤ di
di ≥ 0
(4.2)
The di are just the distances from a priori fluxes to their corresponding fitted fluxes.
Linear MoMA has the advantage that it is not biased towards penalizing large magnitude
fluxes or under-penalizing fluxes that are less than one [24, 158]. Additionally, linear
programs are often amenable to more alterations that maintain convexity than a quadratic
program [158].
We wish to apply MoMA to expression data rather than flux data, but there are two
primary problems that must be tackled. First, we must quantify enzyme complex abun-
dance as accurately as possible given the gene expression data. Although there is not
a one-to-one correspondence between reactions and enzyme complexes, the correspon-
dence is much closer than that between individual genes and metabolic reactions. In the
first part of this work, we employ an algorithm that can account for enzyme complex
formation and thus quantify enzyme complex abundance. Second, we must fit real-
valued variables (fluxes) to non-negative data (expression), which is challenging to do
efficiently. To accomplish this, we build on the original MoMA objective, which must
be altered in several ways (also discussed in Lee et al. 1, which lays the groundwork
for the current method). We develop automatic scaling of expression values so that they
are comparable to flux units obtained in the optimization routine. This can be an ad-
vantage over the prior method as it no longer requires the manual choice of a flux and
complex abundance pair with ratio that is assumed to be representative of every such
pair in the system. Related to this, we also implement the sharing of enzyme com-
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plex abundance between the reactions that the complex catalyzes, rather than assuming
there is no competition between reactions catalyzed by the same complex. Reaction
direction assignment enables comparison of fluxes and expression by changing fluxes
to non-negative values. We show that batch assignment, rather than serial assignment
[1] of reaction direction can greatly improve time efficiency. Finally, we employ several
sensitivity analyses and performance benchmarks so that users of the FALCON method
and related methods may have a better understanding of what to expect in practice.
4.2 Methods
Most genome-scale models have attached Boolean (sans negation) gene rules to aid in
determining whether or not a gene deletion will completely disable a reaction. These are
typically called GPR (gene-protein-reaction) rules and are a requirement for FALCON;
their validity, like the stoichiometric matrix, is important for generating accurate predic-
tions. Also important are the assumptions and limitations for the process of mapping
expression data to complexes so that a scaled enzyme complex abundance (hereafter re-
ferred to as complex abundance) can be estimated. We address these in the next section
and have attached a flow chart to illustrate the overall process of mapping expression
of individual genes to enzyme complexes within the greater context of flux estimation
(Figure 4.1). We employ an algorithm for this step—finding the minimum disjunction—
for estimating complex abundance as efficiently and as accurately as possible given the
assumptions (Section C.2).
Consideration of constraint availability, such as assumed reaction directions and nu-
trient availability, is crucial in this type of analysis. In order to work with two sets
of constraints with significantly different sizes in yeast, we wrote the MATLAB func-
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tion removeEnzymeIrrevs to find all enzymatic reactions in a model that are anno-
tated as reversible but are constrained to operate in one direction only. The script then
changes the bounds to allow flux in both directions. The function useYN5irrevs copies
the irreversible annotations found in Yeast 5.21 [1] to a newer yeast model, but could
in principle be used for any two models; by default, this script is coded to first call
removeEnzymeIrrevs on both models before copying irreversible annotations. Ap-
plication of these scripts removes 853 constraints in Yeast 5.21 and 1,723 constraints
in Yeast 7. Despite the significant relaxation in constraints, since nutrient uptake con-
straints are unaffected, FBA only predicts a 1.28% increase in growth rate in the mini-
mally constrained Yeast 7 model. However, in FALCON, we are no longer optimizing a
sink reaction like biomass, and this relaxation in internal constraints proves to be more
important. Constraint sets for Human Recon 2 are described in Figure C.4.
4.2.1 Estimating enzyme complex abundance
Given the diversity and availability of genome-scale expression datasets, either as mi-
croarray or more recently RNA-Seq, it could be useful to gauge the number of enzyme
complexes present in a cell. A recent study found that only 11% of annotated Drosophila
protein complexes have subunits that are co-expressed [159], so it cannot be assumed
that any given protein subunit level represents the actual complex abundance. We for-
malize a model for enzyme complex formation based on GPR rules that are frequently
available in genome-scale annotations.
The original expression to complex abundance mapping procedure [1] performed
a direct evaluation of GPR rule expression values—replacing gene names with their











flux bounds (vlb, vub)
Flux fitting (FALCON)
Reactions:
fluxes (v : µ, σ)
Figure 4.1: Flowchart illustrating the two algorithms used in this paper. The process
of estimating enzyme complex abundance is displayed in detail, whereas the flux-fitting
algorithm (FALCON) is illustrated as a single step for simplicity. First, for each gene in
the model with available expression data, the mean and (if available) standard deviation
or some other measure of uncertainty are read in. Gene rules (also called GPR rules) are
also read in for each enzymatic reaction. The reaction rules are parsed and the minimum
disjunction algorithm is applied, making use of the gene’s mean expression. Next, the
estimated and unitless enzyme complex abundance and variance are output for each
enzymatic reaction. Finally, flux fitting with FALCON (Algorithm 1) can be applied,
and requires the model’s stoichiometry and flux bounds. The final output has the option
of being a deterministically estimated flux, or a mean and standard deviation of fluxes if
alternative optima are explored.
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Boolean expression of the GPR rule in any way. Below we illustrate a problem that
can occur with this mapping where some genes’ expression levels may be counted more
than once.
The ri are different reaction rules and the ei are the corresponding estimated complex
abundance levels. Lower case letters are shorthand for the expression level of the corre-
sponding gene ID in uppercase; for example, a = E (A), where E (A) is the expression
of gene A.
r1 := [A and B] or [A and C] → e1 = min(a, b) + min(a, c)
r2 := [A and (B or C)] → e2 = min(a, b + c)
(4.3)
Supposing A is the minimum, then if we just evaluate r1 directly (a rule in disjunctive
normal form, or DNF), A will be counted twice. Rules with sub-expressions in DNF are
frequently encountered in practice, but directly evaluating them can lead to erroneous
quantification.
Another possibility is partitioning expression among multiple occurrences of a gene
in a rule. For instance, in r1 above, we could evaluate it as e1 = min( a2 , b) + min(
a
2 , c)
to account for the repeated use of a. However, other potential issues aside, we can see
that this can cause problems rather quickly. For instance, suppose b = a and c = 0; then
min(a,b + c) = b = a appears to be correct, not min( a2 , b) + min(
a
2 , c) =
a
2 + 0. From
this example, we can see that conversion to conjunctive normal form (CNF; Russell and
Norvig 160), as in r2 appears to be a promising prerequisite for evaluation.
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4.2.2 The min-disjunction algorithm estimates enzyme complex
abundance
In Section C.2, we show that converting a rule to CNF is a sound method to aid in
the estimation of enzyme complex abundance. The minimum disjunction algorithm is
essentially just the standard CNF conversion algorithm [160], with the implementation
caveat that a gene that is in disjunction with itself should be reduced to a literal. We’ve
found that this makes the CNF conversion algorithm tractable for all rules and prevents
double counting of gene expression. Conversion to CNF and selection of the minimum
disjunction also removes redundant genes from the complex (e.g. holoenzymes; see
Assumption 8). Biologically, selecting the minimum disjunction effectively finds the
rate-limiting component of enzyme-complex formation. After conversion to CNF, the
minimum disjunction algorithm substitutes gene-expression values as described in Lee
et al. 1 and evaluates the resulting arithmetic expression. Another new feature of our
approach is the handling of missing gene data. If expression is not measured for a
gene in a GPR rule, the rule is modified so that the missing gene is no longer part of
the Boolean expression. For instance, if data is not measured for gene B in [A and (B
or C)] then the rule would become [A and C]. This prevents penalization of the rule’s
expression value in the case that the missing gene was part of a conjunction, and it also
assumes there was no additional expression from the missing gene if it is in a disjunction.
Although conversion to CNF may be intractable for some expressions [160], we
tested our implementation of the algorithm on three of the most well-curated models
which contain some of the most complex GPR rules available. These models are for E.
coli [161], yeast [162], and human [63]. In all cases, the rules were converted to CNF in
less than half a second, which is far less than the typical flux fitting running time from
Algorithm 1.
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Using the minimum disjunction method results in several differences from direct
substitution and evaluation in yeast GPR rules. When data completely covers the genes
in the model (e.g. Lee et al. 1), complex abundance tends to have few differences in
yeast regardless of the evaluation method (25 rules; 1.08% of all rules for Yeast 7). This
number goes up significantly in Human Recon 2 [63] due to more complex GPR rues
(935 rules; 22% of all rules). For the human model, we could not find any data set
that covered every gene, so instead random expression data roughly matching a power
law was used to generate this statistic. If we use proteomics data for yeast and human
models, the algorithmic variation in how missing gene data is handled causes some
additional increase in differences [163, 164]. For proteomics, in the Yeast 7 model
205 rules (8.87% of all rules) differed, and in Human Recon 2, 1002 rules (23.57% of
all rules) differed. We can see that for yeast, the changes in flux attributed to enzyme
abundance evaluation can be relatively small for data with 100% gene coverage, but can
be significant in Human (Figure C.1).
4.3 The FALCON algorithm
Prior work that served as an inspiration for this method used Flux Variability Analysis
(FVA) to determine reaction direction [1]. Briefly, this involves two FBA simulations
per reaction catalyzed by an enzyme, and as the algorithm is iterative, this global proce-
dure may be run several times before converging to a flux vector. We removed FVA to
mitigate some of the cost, and instead assign flux direction in batch; while it is possible
that the objective value may decrease using this approach, this is not an issue since the
objective function increases to include more irreversible fluxes at each iteration, and the
objective value of a function with more fluxes should supersede the importance of one
with fewer fluxes.
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One major advance in our method is the consideration of enzyme complexes shar-
ing multiple reactions, which we call reaction groups. This is done by partitioning an
enzyme complex’s abundance across its reactions by including all reactions associated
to the complex in the same constraint. Both minimally and highly constrained mod-
els (Section 4.4.2) show some fluxes with significant differences depending on the use
of group information, particularly in the minimally constrained model (Figure 4.2). We
now discuss the algorithm in detail, including several other important features, including
automatic scaling of expression.
To make working with irreversible fluxes simpler, we convert the model to an irre-
versible model, where each reversible flux v j in the original model is split into a forward
and a backward reaction that take strictly positive values: v j, f and v j,b. We also account
for enzyme complexes catalyzing multiple reactions by including all reactions with iden-
tical GPR rules in the same residual constraint; indexed sets of reactions are denoted Ri
and their corresponding estimated enzyme abundance is ei. Figure 4.2 shows the dif-
ference in Algorithm 1 when we do not use reaction group information. The standard
deviation of enzyme abundance, σi, is an optional weighting of uncertainty in biological
or technical replicates.
We employ a normalization variable n in the problem’s objective and flux-fitting
constraints to find the most agreeable scaling of expression data. The linear fractional
program shown below can be converted to a linear program by the Charnes-Cooper
transformation [158]. To avoid the need for fixing any specific flux, which may in-
troduce bias, we introduce the bound
∑
j | ∃i s.t. j∈Ri
∣∣∣v j∣∣∣ ≥ VΣlb. This guarantees that the
optimization problem will yield a non-zero flux vector. As an example of how this
can be beneficial, this means we do not need to measure any fluxes or assume a flux
is fixed to achieve good results; though this does not downplay the value of obtaining
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Figure 4.2: Comparison of setting FALCON to use no reaction group information
(x-axis) versus with group information (y-axis; default FALCON setting) for both the
highly constrained Yeast 7 model (a) and the minimally constrained Yeast 7 model (b).
Error bars with length equal to one standard deviation are shown for both approaches as
a result of alternative solutions in FALCON.
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experimentally-based constraints on flux when available (Figure C.2).
The actual value of VΣlb is not very important due to the scaling introduced by n, and
we include a conservatively small value that should work with any reasonable model.
However, for numeric reasons, it may be best if a user chooses to specify a value appro-
priate for the model. Similarly, if any fluxes are known or assumed to be non-zero, this
constraint becomes unnecessary. To keep track of how many reactions are irreversible
in the current and prior iteration, we use the variables rxnsirrev and rxnsirrev,prior. The
algorithm terminates when no reactions are constrained to be exclusively forward or
backward after an iteration.
Algorithm 1 and the method in Lee et al. 1 are both non-deterministic. In the first
case, Algorithm 1 solves an LP during each iteration, and subsequent iterations depend
on the LP solution, so that alternative optima may affect the outcome. In the latter case,
alternative optima of individual LPs is not an issue, but the order in which reactions
assigned to be irreversible can lead to alternative solutions. However, we found that
the variation due to this stochasticity is typically relatively minor, particularly in cases
where the model is more heavily constrained (Figs. C.1 and C.2).
4.4 Results and Discussion
4.4.1 Performance benchmarks
Using the same yeast exometabolic and expression data employed for benchmarking
in the antecedent study [1] that included an updated version of the Yeast 5 model [165]
and the latest yeast model [162], we find that our algorithm has significant improvements
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Algorithm 1 FALCON
INPUT: {Ri : i an index for a unique enzyme complex where
Ri = { j : complex i catalyzes reaction j}}
INPUT: enzyme abundances (mean: ei, standard deviation: σi)
INPUT: model (S matrix, vlb, vub)
umin ← min j {V j,max : V j,max > 0} where V j,max = max
(∣∣∣vlb, j∣∣∣ , ∣∣∣vub, j∣∣∣).
VΣlb ← umin |{ j : ∃i s.t. j ∈ Ri}|
rxnsirrev ← number of reactions ( j) such that either vub, j > 0 or vlb, j < 0, but not both.
for all i do












while rxnsirrev > rxnsirrev,prior do
rxnsirrev,prior ← rxnsirrev







j | ∃i s.t. j∈Ri
∣∣∣v j∣∣∣ ≥ VΣlb∀i : −di ≤ ∑ j∈Ri(v j, f + v j,b) − nei ≤ di where v j = v j, f − v j,b




j | v j, f + v j,b > 0, v j, f , v j,b
}
do
Constrain the smaller of v j, f and v j,b to be 0.





Table 4.1: Performance of FALCON and other CBM methods for predicting yeast ex-
ometabolic fluxes in two growth conditions with highly (HC) and minimally (MC) con-
strained models (a) and associated timing analysis (b). For Lee et al. and FALCON
methods, the mean time for a single run of the method is listed; all other methods did not
have any stochasticity employed. Values are shown in two significant figures. Method
descriptions can be found in Lee et al. 1.
(a) Max. µ Model Experimental Standard FBA Fitted FBA GIMME iMAT Lee et al. FALCON
75 % Yeast 5 MC 1 0.66 0.66 NaN 0.57 0.64 1
75 % Yeast 7 MC 1 0.66 0.66 0.68 0.66 0.66 0.98
75 % Yeast 5 HC 1 0.73 0.78 0.75 0.66 0.98 0.99
Pearson’s r 75 % Yeast 7 HC 1 0.70 0.70 0.80 0.66 0.98 0.99
85 % Yeast 7 MC 1 0.62 0.62 0.65 0.62 0.62 0.97
85 % Yeast 5 HC 1 0.88 0.89 0.9 0.81 0.99 0.99
85 % Yeast 7 HC 1 0.67 0.67 0.87 0.62 0.98 0.98
(b) Max. µ Model Experimental Standard FBA Fitted FBA GIMME iMAT Lee et al. FALCON
75 % Yeast 5 MC 0 0.9 470 0.81 50 110 1.8
75 % Yeast 7 MC 0 1.9 3,100 2.1 12,000 600 5.6
75 % Yeast 5 HC 0 0.12 110 0.18 1.4 15 0.27
Time (s) 75 % Yeast 7 HC 0 0.72 940 1.7 240 670 5.5
85 % Yeast 7 MC 0 2.3 3,100 3.8 14,000 610 4.6
85 % Yeast 5 HC 0 0.12 110 0.18 2.5 15 0.22
85 % Yeast 7 HC 0 0.70 110 2.5 100 530 5.9
in time efficiency while maintaining correlation with experimental fluxes, and is much
faster than any similarly performing method (Table 4.1; Figure C.2). Timing for the
human model also improved in FALCON; in a model with medium constraints and
exometabolic directionality constraints, FALCON completed on average in 3.6 m and
the method from Lee et al. 1 in 1.04 h. Furthermore, when we remove many bounds
constraining the direction of enzymatic reactions that aren’t explicitly annotated as being
irreversible in prior work [1], we find that our formulation of the approach seems to be
more robust than other methods.
We see that the predictive ability of the algorithm does not appear to be an artifact;
when FALCON is run on permuted expression data, it doesn’t do as well as the actual
expression vector (Figure 4.3). The full-sized flux vectors estimated from permuted
expression as a whole also does not correlate well with the flux vector estimated from the
actual expression data, but we notice that the difference is visibly larger in the minimally
constrained model compared to the highly constrained model (Figure C.3). Rigidity
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in the highly constrained model appears to keep most permutations from achieving an
extremely low Pearson correlation, likely due to forcing fluxes through the same major
pathways, but a rank-based correlation still shows strong differences.
4.4.2 Sensitivity to expression noise
To understand the sensitivity of flux to expression, we multiply noise from multivariate
log-normal distributions with the expression vector and see the effect on the estimated
fluxes. For instance, correlation between two types of proteomics data yields a Pearson’s
r = 0.7 [164], corresponding to an expected σ ≈ 1.4 and expected r ≈ 0.4 for flux in our
most highly constrained human model (Figure C.4). We find that enzymatic reaction di-
rectionality constraints influence the sensitivity of the model to expression perturbation
(Figure 4.4.2). It is important to note that mere presence of the constraints does not help
us determine the correct experimental fluxes when other classes of methods (e.g. FBA;
Table 4.1) are used. Additionally, it is possible to obtain good predictions even without
a heavily constrained model (Table 4.1).
With Human Recon 2, additional constraint sets supply some benefit, but even the
most extreme constraint set does not compare to what is available in Yeast 7, which is
also inherently constrained by the fact that yeast models will be smaller than compara-
ble human models (Figure C.4). For mammalian models, more sophisticated means of
constraint, such as enzyme crowding constraints [60], or using FALCON in conjunction
with tissue specific modeling tools, may prove highly beneficial.
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Figure 4.3: Kernel-smoothed PDFs of correlation between experimental fluxes and
fluxes estimated from FALCON when all gene expression data points are permuted.
Arrows mark the correlation when FALCON is run on the unpermuted expression data.
Random correlations tend to be much more positive in the highly constrained model
(a) than in the minimally constrained model (b). 5,000 permutation replicates were
performed in all cases.
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Figure 4.4: Correlation of perturbed enzyme abundance vectors and flux vectors with
the associated unperturbed vector for the Yeast 7 model. The interval median correla-
tion is shown in green. Noise sampled from a multivariate log-normal distribution with
parameters µ = 1 and σ (x-axis) is multiplicatively applied to the enzyme abundance
vector, and the y-axis shows the Pearson correlation between the two vectors (a). Simi-
lar plots show correlation between flux vectors estimated with FALCON using the same
perturbed and unperturbed expression vectors (b-c).
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4.4.3 Flux estimates provides information beyond enzyme complex
abundance
It is not an unreasonable hypothesis that fluxes would correlate well with their associated
complex abundances. Indeed, the general principle needed for fitting fluxes to enzyme
complex abundances is to assume the values would be correlated in the absence of other
constraints (e.g. branch points that arise from the stoichiometry). More specifically, it
should be the case that flux is proportional to enzyme complex abundance given ample
availability of substrate, and that this proportionality constant does not vary too much
between reactions. There are undoubtedly many exceptions to this rule, but it seems
as though there may be some underlying evolutionary principles for it to work in this
parsimonious fashion, as has been partly verified [166].
Aside from the obvious benefits of constraint-based methods also estimating fluxes
for non-enzymatic reactions, and assigning a direction for reversible enzymatic reac-
tions, we see that in general, our method does not predict a strong correlation between
complex abundance and flux (Figure C.5). Recently it has been shown that many fluxes
are not under direct control of their associated enzyme expression level [167], which
gives experimental support to the idea that a network-based approach, such as that pre-
sented in this paper, may be useful in understanding how fluxes may be constrained by
expression data. Chubukov et al. 167 also note that enzymes may be overexpressed in
some cases, either for robustness or because of noise in transcriptional regulation. This
will not usually be a problem in FALCON, unless entire pathways are overexpressed,
which would be unusual as it would represent a seemingly large energetic inefficiency.
The present work doesn’t attempt to use empirically obtained kinetic parameters to
estimate Vmax, but this approach does not seem as promising in light of experimental
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evidence that many reactions in central carbon metabolism tend to operate well below
Vmax [166]. Still, a better understanding of these phenomena may make it possible to
improve flux estimation methods such as the one presented here, or more traditional
forms of MFA [2] by incorporating enzyme complexation and kinetic information.
4.4.4 Increasing roles for GPR rules and complex abundance esti-
mates
Still, complex abundance may have uses aside from being a first step in FALCON. The
method presented here for complex abundance estimation can be used as a stand-alone
method, as long as GPR rules from a metabolic reconstruction are present. For instance,
it may not always be desirable to directly compute a flux. As an example, the relative
abundance of enzyme complexes present in secretions from various biological tissues,
such as milk or pancreatic secretions, may still be of interest even without any intracel-
lular flux data. Perhaps more importantly, this approach to estimating relative complex
levels can be employed with regulatory models such as PROM [31] or other regulatory
network models that can estimate individual gene expression levels at time t + 1 given
the state of the model at a time t.
GPR rules and stoichiometry may be inaccurate or incomplete in any given model.
In fact, for the foreseeable future, this is a given. By using the GPR and not just the
stoichiometry to estimate flux, it is possible that future work could make use of this
framework to debug not just stoichiometry as some methods currently do (e.g. Reed
et al. 168) , but also GPR rules. Hope for improved GPR rule annotation may come
from many different avenues of current research. For instance, algorithms exist for
reconstructing biological process information from large-scale datasets, and could be
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tuned to aid in the annotation of GPR rules [169]. Flexible metabolic reconstruction
pipelines such as GLOBUS may also be extended to incorporate GPR rules into their
output, and in so doing, extend this type of modeling to many non-model organisms
[170]. Another limitation that relates to lack of biological information is that we always
assume a one-to-one copy number for each gene in a complex. Once more information
on enzyme complex structure and reaction mechanism becomes available, an extension
to the current method could make use of this information. Even at the current level of
structure, we think it is evident that GPR rules should undergo some form of standard-
ization; Boolean rules without negation may not always capture the author’s intent for
more complex purposes like flux fitting.
4.5 Conclusion
We have formalized and improved an existing method for estimating flux from expres-
sion data, as well as listing detailed assumptions in Table C.1 that may prove useful in
future work. Although we show that expression does not correlate well with flux, we
are still essentially trying to fit fluxes to expression levels. The number of constraints
present in metabolic models (even the minimally constrained models) prevents a good
correlation between the two. However, as with all constraint-based models, constraints
are only part of the problem in any largely underdetermined system. We show that gene
expression can prove to be a valuable basis for forming an objective, as opposed to meth-
ods that only use expression to further constrain the model by creating tissue-specific or
condition-specific models [29, 30].
For better curated models, the approach described immediately finds use for under-
standing metabolism, as well as being a scaffold to find problems for existing GPR rules,
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and more broadly the GPR formalism itself. The present results and avenues for future
improvement show that there is much promise for using expression to estimate fluxes,
and that it can already be a useful tool for performing flux estimation and analysis.
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CHAPTER 5
EPISTATIC LANDSCAPES ARISING FROM ADAPTIVE MUTATIONS
Existing literature has only dealt with the simulation of strictly deleterious mutants
rather than beneficial mutants in the constraint-based modeling literature, which is
chiefly due to existing studies optimizing the fitness function, which leaves no room for
improvement. In this study, we develop a constraint-based approach that can simulate
beneficial, neutral, and deleterious mutations. We show that this simulation technique
can be useful for understanding adaptive trajectories, and we develop a software library
for the analysis of evolutionary paths. Our mechanistic model can reproduce the dis-
tribution of epistases between beneficial mutations that was observed in a data set and
a population genetic model fit to the same data set, showing that our model behaves
appropriately in this conext and may be a useful tool for further evolutionary analyses.
Finally, in experimental data sets and in our simulations, slightly beneficial mutations
are much more likely to have positive (synergistic) epistasis with other beneficial muta-




Biologists have long wondered the extent to which evolution occurs due to nearly neutral
and slightly deleterious mutations, or adaptive mutations, or more complex situations
involving these types of mutations as well as their epistatic interactions [171, 172].
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The occurrence of beneficial mutations and how they affect adaptation is currently
an area of active interest in evolutionary biology [173, 174]. Although much focus in the
past has been placed on deleterious mutations because of their prevalence in nature and
disease, it is ultimately beneficial mutations that are responsible for adaptive evolution.
Since beneficial mutations are relatively rare, and since combining multiple mutants
in the lab is increasingly difficult for the more mutations that are to be combined, an in
silico analysis can shed light on what may be expected in adaptive evolution.
5.1.2 The need for a new modeling framework
Clearly, using FBA with the growth objective alone is not enough–we only ever get
the optimum for our fitness objective. A way to circumvent this issue is to associate a
feature of the system (e.g. flux into biomass) as the fitness while optimizing some other
objective. This latter mechanism is not generally used as most models tend to be rather
under-constrained as is. However, as we’ve seen, the FALCON method (Chapter 4) and
other fitting methods like MoMA provide a way to use high-throughput data to introduce
many additional constraints to the system.
Having a systems tool that can work with models of particular organisms will not
only add another tool in the computational evolution and population genetics arsenal,
but also in applied fields such as evolutionary engineering of microbial engineering, and




5.2.1 Weighted MoMA-FBA objectives
Minimization of metabolic adjustment (MoMA), along with Flux Balance Analysis
(FBA), has proven successful in simulating growth rates and predicting in silico fluxes.
Here we discuss a weighted objective approach that combines both objectives.
The typical MoMA problem is framed as a least-squares optimization problem and is
typically employed to calculate the flux vector of an in silico organism after a mutation
[23]. The biological intuition is that the organism has not had time to adapt to the
restricted metabolic capacity and will maintain a similar flux to the wild-type (WT). If
a is the WT flux vector obtained by an optimization procedure, such as min-norm FBA






subject to the stoichiometric constraints Sv = 0 where S is the stoichiometric matrix
and v = (v1, . . . , vN)T is the undetermined flux vector. Additional constant bounds on
fluxes are often present, such as substrate uptake limits, so we write vlb  v  vub. The










vT v − aT v.
When we try the standard MoMA procedure in a new environment, several things
become clear. For instance, switching the energy and carbon source from glucose to
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ethanol will result in zero growth because the biomass is relatively small compared to
other fluxes numerically. This is easily fixed by adding a weight to the biomass, though
there are also certain numerical issues related to this with at least some solvers (e.g.
MOSEK) that require an inverse weight on all other fluxes.
To accommodate these weights, let w be a positive scalar weight, and let f (w) and
g(w) be two scalar weight functions such that f (w) > 0 and g(w) > 0 for all w ≥ 1. We
also assume f (w) is monotonically increasing and g(w) is monotonically decreasing.
While g(w) is employed to achieve the inverse weighting mentioned above, f (w) is used
to achieve gradual regularization as w increases. Biologically, regularization is impor-
tant as it allows efficiency in enzyme synthesis to be modeled, which is typically done








Index b corresponds to the growth or biomass pseudo-reaction. In the simulations
below, g(w) = 1√w . For some simulations we haven’t yet used a nonzero f (w), but an
example we have used is f (w) = log (log w+1)C where C is a scaling constant.
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f (w) + g(w) 0 · · · 0
0 . . . 0
...
... 0 f (w) + g(w) 0
0 · · · 0 0

.
For convenience, informally denote this objective function as M(w, d1, . . . , dm)
where the optional di represent possible mutations to the model.
The difference in smoothness between weighted quadratic MoMA and linear MoMA
can be illustrated by considering the growth rate to be a function of the weight placed on
the biomass objective (Figure 5.1). An advantage of quadratic MoMA is that it simulates
a continuous range of fitnesses potentially matching any required fitness level exactly.
Quadratic programming does not admit alternative optima either, if the objective is con-
vex, as in MoMA. However, these benefits are not necessarily always biologically rele-
vant; discrete mutations may give a discrete jump in fitness. There is no obvious reason
why having a unique optima would be biologically preferred; in fact, when compared to
simple objectives like MoMA or FBA, most biological systems appear to operate sub-
optimally [7]. Weighted linear MoMA can model these discrete transitions in flux state,
and often this is reflected in discrete jumps in fitness, as seen above.
In the above figure, the difference in fitness between weighted quadratic MoMA
and linear MoMA can be seen. An advantage of quadratic MoMA is that it simulates
a continuous range of fitnesses, potentially matching any required fitness level exactly.
However, this is not necessarily always biologically relevant; in reality, discrete muta-
tions may give a discrete jump in fitness. Weighted linear MoMA models these discrete
transitions in flux state, and often this is reflected in discrete jumps in fitness, as seen
above.
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Figure 5.1: Weight on the biomass component of an objective (x-axis) influences the
growth rate, where the other objective component is a MoMA objective that tries to
minimize the flux difference with an ancestral environment.
Weighted MoMA predicts expression states
Using tiling array data for s288c in YPD and YPE conditions from Xu et al. [175], we
compare the number of genes expected to have a two-fold or greater change in expres-
sion from YPD to YPE to the fluxes mapped to genes also having greater than two-
fold change in the same environmental transition. The x-axis represents the weight on
growth. The number of genes having more than two-fold flux and expression change in
the model and and in the experiment are shown in blue. The red and red dotted lines
represent the random expectation and 95% CI for expression agreement for a random
expression vector with the genes belonging to the model and experimental dataset. The
random expression vector has the same number of two-fold up-regulated and two-fold
down-regulated genes as the real relative expression vector.
Interestingly, the weight and corresponding fitness that agrees most with the experi-
mental predictions is sub-optimal in both the quadratic and linear cases, suggesting that
the s288c strain was not fully adapted to the YPE environment when the expression was
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Figure 5.2: Number of yeast genes that are at least two-fold up-regulated or down-
regulated when going from YPD to YPE media with matching predictions from
weighted MoMA (blue line) and the associated 95% confidence interval (red dotted
line) around the prediction to random chance (red line).
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weighted linear MoMA: glucose to ethanol
geometric FBA: Glucose
Figure 5.3: The number of active reactions (reactions with non-zero flux) plotted
against the weight on the biomass component of a weighted linear MoMA objective
(blue). An flux that maximizes biomass production that is centered among alternative
optima is shown for comparison (red dotted line).
assayed. To compare directly with geometric FBA (a minimal L1-norm solution), we
found that geometric FBA had 123 concurring genes whereas weighted linear MoMA
had 124; similarly, a minimal L2-norm FBA solution in Ethanol had 162 agreeing so-
lutions and weighted quadratic MoMA had 165, showing that weighted MoMA can do
at least as good as the gold standards for de novo FBA solutions in predicting accurate
fluxes.
Simulated adaptation induces complexity in sub-optimal solutions
Previous work explored the complexity of optimal and sub-optimal flux vectors, find-
ing that generally the sub-optimal solutions have more active fluxes than the optimal
solutions [176]. We found a similar trend with weighted MoMA where, once growth
is non-zero, the initial flux state has more active reactions than in the ancestral envi-
ronment (glucose; red dashed line) or than in the more adapted stages in the current
(ethanol) environment (Figure 5.3).
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5.2.2 Adaptive mutations with objective weights
Aside from the problem of separating the fitness function from the optimization ob-
jective function, there is the issue of combining traditional flux restriction mutations,
which are known as hard constraints, which may result in an unsolvable system —
an almost certainly undesirable effect of this mutation modeling formalism. Instead, it
would be better if mutations could be modeled as soft constraints. Concretely, whereas
hard constraints are enacted in the actual constraints of the optimization problem, soft
constraints merely change the objective. This means that multiple soft constraints com-
bined together under some mutational model would be compatible in the sense that they
wouldn’t unexpectedly result in an unsolvable system. When performing growth opti-
mization in FBA, normally only the biomass pseudo-reaction has a non-zero (positive)
entry. Nonzero values for any other entry could only decrease the flux. In weighted
MoMA or FALCON, nonzero coefficients for any enzymatic reaction could prove po-
tentially beneficial, as they may push the system in a direction that is more in line with
growth optimization and less in line with MoMA or the FALCON flux-fitting objective.
FALCON and weighted MoMA provide two possible avenues for soft constraints:
expression level and expression variation. However, it is not clear yet what expression
variation really means, so further investigation is necessary. Furthermore, using a hard
constraint model for mutants, as opposed to a soft constraint like weights on fluxes, ap-
pears to reduce the amount of non-trivial interactions: in the hard-constraint method one
highly beneficial mutation may exactly subsume the mutation of a less beneficial mu-
tant by forcing flux through the reaction; this happens to a certain extent in the weighted
model as well, but not nearly as frequently.
An example for both the quadratic and linear cases exemplifies the difference in
smoothness obtained from using either a linear or quadratic objective for weighted
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MoMA with objective weights (mutations) on a particular reaction (Figure D.1).
5.2.3 Adaptive trajectories and evolutionary path analysis
Phenotypes involving a small number of mutations have had their adaptive paths ana-
lyzed systematically ([173, 174, 177, 178]; four or five mutations). In Weinreich et al.
[174], all mutations occur on a single enzyme, and even in such a localized case, sign
epistasis, which gives rise to evolutionary traps, occurs for the majority of mutational
paths. In the present study, we used less severe grounds for deciding if an evolutionary
path is a likely dead-end, but even so, we can see that (Figure 5.2.3; Section D.2.1).
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Figure 5.4: An examination of simulated evolutionary dead-ends. Randomly selecting
10 beneficial mutations from over 150 total beneficial mutations in a yeast model will
have a varying number of mutations that are present in the combinatorial mutant with
the highest fitness The percent of paths that reach the optimal mutant by avoid traps
tends to decrease as more mutations are considered (5.5a), or viewed another way, the




In a genome-scale metabolic model, we observe that while the majority of paths
are not likely to have a problem, once eight or nine genes are involved, the average
number of paths to reach the optimum without experiencing a trap are only 65%. This
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demonstrates that the presence of traps are heterogeneous, just as in the single-enzyme
experiment of Weinreich et al. [174], suggesting that the order of mutations often matter
to a very significant degree in evolution.
The fact that many unobstructed evolutionary paths are observed at the genome-scale
suggests that evolution is, in general, not very predictable (Figure 5.2.3). However, if we
consider that neutral mutations are unlikely to fix in a population, the number of viable
paths would greatly decrease (Section D.2.1). Interestingly, in every experimental case
(Table D.1), only a single fitness peak appears to be present [174, 179]. When we
consider simulations from genome-scale models instead of isolated pathways or single
protein, we still observe the single fitness optima for five mutation sets, but once we
consider eight mutations, every set of eight or more mutations presents with multiple
local optima. This suggests that evolution becomes not only less predictable when we
look at evolution of larger systems or evolution at a large time scale, but also less likely
to reach the global optimal fitness.
Software for evolutionary path analysis
Storing all evolutionary paths in memory or disk can become intractable. For instance,
even 10 mutations has 10! ≈ 3.6 million possible paths, but only 210 = 1, 024 mutant
combinations. Due to this difficulty, we have created software to allow the dynamic
exploration and analyses of these paths.
The C programs for dynamically performing analyses on text files containing fitness
data for all combinations of n mutations can be found online, and additional information
and and examples related to usage is available (Section D.2.1).
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Table 5.1: Pairwise epistasis values (calculated multiplicatively) from two experimental
systems.
(a) Khan et al. [178]
fitness t s g r
1.145 t
1.108 s -0.060
1.030 g -0.027 -0.014
1.015 r -0.056 -0.004 0.005
1.003 p 0.049 0.078 0.045 0.007
(b) Chou et al. [173]
fitness gshA GB fgh
1.509 gshA
1.166 GB -0.120
1.142 fgh -0.100 -0.012
1.096 pntAB -0.040 0.021 0.029
Small beneficial mutants exhibit positive epistasis
Prior studies using metabolic models have shown that deleterious mutations tend to
exhibit negative epistasis for stronger mutations and positive epistasis for weaker muta-
tions ([9, 34]; Figure D.2). The reason for positive epistasis being prevalent for delete-
rious mutations is that most of them occur in essential pathways, and one mutation will
buffer against the effects of a second mutation ([9]). Somewhat surprisingly, we also
see that predictions for epistasis involving weakly beneficial mutations also tend to have
positive epistasis (Figure 5.6; Section 5.4.1). This trend is verified for two experiments
involving multiple genes (as in our simulation) where fitnesses are readily calculated
([173, 178]; Table 5.1).
The trend for increasing negative epistasis as mutations become increasingly benefi-
cial (also termed diminishing returns epistasis; [173]) can be easily understood in most
contexts, including metabolism, due to the fact that in any given environment there must
be a physiological maximum value for most phenotypes, including growth rate of a cell
or individual organism. Thus, if one mutant is extremely beneficial, it proportionally
limits the effect another beneficial mutant might have when combined together. Such
decreasing marginal benefits are not the only reason we may tend to see small mutants
with positive epistasis; Fisher’s geometric model implies that increasing complexity will
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decrease the likelihood that any given mutation will be beneficial, and increasingly so
for mutations with more extreme changes in the phenotypic space [180]. Since a muta-
tion that exhibits positive epistasis with many other mutations is just a way of saying the
mutation is likely to be beneficial on many genetic backgrounds, the effect observed by
Orr [180] extends beyond absolute fitness values and into the epistatic landscape. Fur-
thermore, in our metabolic models (as in most biological systems), fluxes do not operate
in isolation; a mutation in a gene expression level or reaction constraint will affect other
reaction fluxes in the system, and can be classified as pluripotent. If it is an essential
reaction, many fluxes are likely to be affected, thus exhibiting a complex phenotype and
a high degree of pluripotency. Large pluripotent mutations would then be expected to
have a larger total length in Fisher’s geometric model, and be less likely to be beneficial
or have positive epistasis. This is exactly what we see in metabolic models with dele-
terious mutations, which tends to exhibit positive epistasis for smaller mutations and
negative epistasis for more extreme mutations (Figure D.2; [9, 34]).
This trend in epistasis can also be captured by our constraint-based modeling frame-
work for beneficial mutations. After in silico screening for beneficial mutations (Sec-
tion 5.4.2), we can examine trends in pairwise epistasis as a function of the single mu-
tant fitnesses Figure 5.6. A fairly distinct border appears to be present between the
region that has some positive epistasis and no positive epistasis. By considering that
an epistatic cutoff (call it c) is employed, we may use the multiplicative epistatic rela-
tionship Wxy − WxWy > c, which yields the reciprocal function Wy < Wxy−cWx for fixed
Wxy, bounding the region in which positive epistasis, as defined by the threshold c, can
occur. Since Wxy is not a constant, there may be some variation in the actual trend from
a true reciprocal function.
The distribution of epistases arising from beneficial mutations is highly similar to
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(a) mean epistasis
(b) percent of positive epistasis
Figure 5.6: The mean epistasis (5.6a) and percentage (5.6b) of positive epistasis for
epistases such that | | ≥ 0.01.
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Figure 5.7: Distribution of epistases arising in a yeast model from beneficial mutations
sampled according to EVA.
that found in natural biological systems that are also described by population genetic
models (Figure 5.7; [181]). Interestingly, the small-scale data from Martin et al. [181]
is from an RNA virus (VSV), whereas our stoichiometric models are not designed for
modeling viruses. Nonetheless, the trend remains similar, suggesting that this is a trend
that extends across completely different types of models as well as from the fitness
of complex life forms and simple non-living viruses. This excellent fit requires that an
appropriate distribution of fitnesses is sampled according to extreme value theory (EVA;
Section 5.4.2; [172, 182]).
5.3 Discussion
We have developed a data-driven modeling framework in the constraint-based metabolic
modeling family that allows the exploration of combinatorial epistases and reproduces
trends seen from studies in the forefront of evolutionary research [173, 178, 181]. Con-
temporaneous, theoretical insights in to how a general class of mechanistic models,
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encompassing those used in this study, give rise to traditional population genetic mod-
els such as Fisher’s geometric model [183]. The methodologies described in this paper
should have applications in diverse fields due to their reliance on mechanistic models
available for many organisms [184].
The questions are often difficult or impossible to assess experimentally due to limited
resources. In genome-scale models, to our knowledge, only microbial epistasis has so
far been studied for all enzymes (often referred to as genome-scale in this context). This
is due to several factors.
One issue is that these computations can still take a significant amount of time, and
the increase in model size of Human Recon 2 over Yeast can cause even a relatively
simple FBA run to go up by an order of magnitude. This problem is compounded
by the increase in the number of genes in the human model, since computing epista-
sis consumes space and time as O(n2) where n is the number of genes in the model.
More important than this issue, which might be overcome with enough computational
resources, is the issue of an objective function. It has been shown numerous times that
FBA with a biomass objective can be a reasonable approximation to what a microbe is
trying to achieve metabolically [7, 20, 185]. While Recon 2 is equipped with a “gen-
eralized biomass reaction”, it is not clear what the meaning of this is, and it certainly
seems to greatly overestimate the metabolism even of fast-growing cancer cells [186].
We propose FALCON as a potential method to get around this issue for non-microbial
models.
Another advantage of FALCON is that it allows one to directly probe mutations that
are represented as gene expression perturbations. A decreased level of gene expression
may also be metabolically equivalent to the effect of a missense mutation, for example.
This allows a different sampling strategy than before; for instance, we could observe
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how uniform expression restriction compares to uniform flux restriction [9]. Assuming
an accurate model of enzyme-complex expression measurement, the former should be
the more realistic model.
A limitation is that we have only considered metabolic genes and their effect on
steady-state metabolism. While in principle a similar method could be applied to whole
cell models [68, 187], the computation time would not be feasible to the screening for
beneficial mutations, nor of exploring them combinatorially, as the time needed for a
single mutant takes at least a day even in the smallest bacterial model [68]. Future
insights into improving the efficiency of whole cell models, or making a compromise on
which systems are simulated (e.g. rFBA, [53]), may improve these efforts.
5.4 Methods
5.4.1 Beneficial mutation simulation for pairwise epistasis
In order to generate a realistic WT flux, we use experimental expression data to fit a
flux vector ([1, 188]). Because even FALCON can take one or two orders of magnitude
longer than MoMA (or linear MoMA), we use linear MoMA to estimate the flux vectors
for single and double mutants. Since our fitness is just flux through the biomass pseudo-
reaction, which is a complicated sink, it never seems to carry a flux in practice when
expression-flux fitting techniques are used. Therefore, we used experimentally deter-
mined growth rates as a constraint in the flux fitting step for calculation of the WT flux
vector (strain S96 in YPE (3% ethanol): µ = 0.1249, YPD (2% glucose): µ = 0.4621,
strain BY in YPEG: µ = 0.21). Though this approach was only used for pairwise epis-
tasis in the current study, it would also be appropriate for combinatorial epistasis (we
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simply used FBA to generate wild-type adapted flux vectors for our combinatorial epis-
tasis simulations).
5.4.2 Mutation screening and sampling
To more closely follow existing theory in population genetics we performed Gaussian
sampling centered at the WT phenotype [182]. For each reaction, we sampled flux re-
strictions where the WT flux (FWT ) was at the mean of the Gaussian distribution. Since
there is some uncertainty in the underlying distribution of mutational effects that would
best reflect nature, we used several different distributions and employed the FVA to
bound the distribution [37]. For example, for the 99.9% Gaussian sampling (Figures 5.7
and 5.8), for each reaction, we sampled fluxes from a truncated normal distribution be-
tween the FVA minimum (Fmin) and FVA maximum (Fmax) where the underlying normal
distribution would have 99.9% of its density in FWT ±max (|FWT − Fmin| , |FWT − Fmin|).
This sampling technique (in particular the symmetric bounds about FWT ) was chosen in
order to approximate how sampling mutations from Fisher’s geometric model results in
a beneficial mutation distribution distribution conforming to extreme value distributions
[182, 189]. Only beneficial mutants were kept for the present analysis.
A truncated normal sampling strategy drawing 99.9% of mutations within the larger
FVA bound will be less likely to sample extremely divergent fluxes than a sampling
strategy drawing 50% of mutations within the larger FVA bound since the tails of the
latter distribution will be placed further away from the WT. We find it is preferable to
sample a high percentage of mutations that are closer to the WT in order to generate ben-
eficial mutations distribution conforming to extreme value theory, since otherwise the
mutation sampling in our metabolic model begins to approximate a uniform distribution
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Figure 5.8: Distribution of beneficial mutations arising in a yeast YPE model sampled
according to EVA (truncated normal sampling with 99.9% mutations occurring within
the larger FVA bound).
(Figure D.3). It can be seen that epistasis distributions resulting from EVA-conforming
fitness distributions result in a skew toward near-zero epistasis and positive epistasis as
we tend to sample more mutants near the WT (Figure 5.7).
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SUPPORTING INFORMATION FOR DYNAMIC EPISTASIS FOR
DIFFERENT ALLELES OF THE SAME GENE
A.1 Supporting Figures
Figure A.1: The conclusion in Fig. 1 is not dependent on the average number of
epistatic interaction partners per gene. (A) The distribution of average number of
epistatic interaction partners per gene. For each gene with epistasis, its average number
of epistatic interaction partners was calculated among all mutant alleles of this gene. (B-
D) A similar conclusion to that of Fig. 1 can be obtained when we only use genes with
fewer than 500 (B), 500-2,000 (C), and more than 2,000 (D) average epistatic interaction
partners. The same methods in Fig. 1 were used here to generate B-D.
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Figure A.2: A complex epistatic landscape exhibits a transition from large positive to
large negative epistasis values, along with a region of zero epistasis. Epistasis is viewed
as a function of the CTP1 and ARO3 genes flux restriction. The color corresponds to the
z-axis (epistasis), with red being more positive, green being near zero, and blue being
more negative.
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Figure A.3: Percentage of shared epistatic interacting partners based on flux differences
between two mutant alleles of the same gene. The analysis procedure is the same as Fig.
1A, but instead of using the S. cerevisiae model, here we repeated the analysis using the
E. coli model (38).
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Figure A.4: The conclusion that epistatic relations between genes are allele-specific is
robust to various epistasis thresholds. Left 5 panels: The FBA simulation results for
the distribution of the percentage of shared epistatic interaction partners between two
mutant alleles within the same gene. Solid and broken lines represent mean and 95%
confidence intervals, respectively. Right 5 panels: The cumulative distribution for the
percentage of shared epistatic interaction partners between two mutant alleles within the
same gene based on real experimental data. Both experimental and simulated results are
robust under various epistasis thresholds.
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Figure A.5: The conclusion in Fig. 3, for which mutant alleles with more severe defects
tend to have a higher percentage of negative epistasis in eukaryotes than bacteria and
archaea, is robust under various epistasis and fitness difference thresholds. The same
methods to generate Fig. 2C for S. cerevisiae are used here for the other five species.
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Figure A.6: An epistatic landscape exhibits smooth change in epistasis as a function of
the flux restriction for the genes HXT13 and ADE1. The color corresponds to the z-axis
(epistasis), with red being more positive, and green being near zero. See dataset S3 for
simulated data. HXT13 is a hexose transporter and ADE1 is required for de novo purine
biosynthesis. The epistasis surface for HXT13 and ADE1 is quite smooth, which is a
fairly common pattern and we may infer that epistasis, at least in metabolism, is often
dependent on thresholds.
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Figure A.7: An epistatic landscape exhibits a sharp transition to zero epistasis, primar-
ily as a consequence of the THR4 flux restriction. The color corresponds to the z-axis
(epistasis), with red being more positive, and green being near zero. See dataset S4
for simulated data. Epistasis is examined between threonine synthase gene THR4 and
COX1 (subunit 1 of cytochrome c oxidase). Both genes are associated with mutually
exclusive reactions. As shown in the figure, there are regions where the epistasis is ef-
fectively zero (on the order of 10-5) where the THR4 single mutant growth rate has only
changed very slightly, effectively allowing the mutations to act independently. Once the
THR4 mutant becomes more severe, the effects are no longer independent.
115
Figure A.8: A flow chart to illustrate the simulation process that generates Fig. 4B. This
procedure included 5 steps as indicated in the 5 blue boxes, and we have repeated step
2 to step 5 in the simulation to produce all possible allele combinations, as highlighted
in the red box.
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A.2 Supporting Data
Supporting datasets S1-S4 are available online (DOI: 10.1073/pnas.1121507109).
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Figure B.1: More positive differential epistases under environmental perturbations for
different thresholds of differential epistasis (|d | ≥ 0.001, A) and (|d | ≥ 0.05, B). Ra-
tio of positive to negative differential epistases in each simulated condition are shown.
The letters A-P represent acetaldehyde, acetate, adenosine 3’,5’-bisphosphate, adeno-
syl methionine, adenosine, alanine, allantoin, arginine, ethanol, glutamate, glutamine,
glycerol, low glucose, phosphate, trehalose, and xanthosine, respectively.
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Figure B.2: Analogous to Figure 3.3.2B-C, but using a maximum growth rate for each
condition, where the maximum is constrained to be no higher than the high-glucose
growth rate. (A) Percentage of positive and negative differential epistases under ethanol
and glycerol conditions. (B) Ratio of positive to negative differential epistases in each
simulated condition. The result from a high-throughput experiment is also shown. The
letters A-P represent acetaldehyde, acetate, adenosine 3’,5’-bisphosphate, adenosyl me-
thionine, adenosine, alanine, allantoin, arginine, ethanol, glutamate, glutamine, glyc-
erol, low glucose, phosphate, trehalose, and xanthosine, respectively. Note that in (B),
low glucose has the same growth rate as high-glucose, but has different epistatic inter-




Figure B.3: Epistasis dynamics between environmental perturbations under different
epistasis definition. (A) Number of gene pairs with various epistatic relationships
between ethanol and glycerol growth conditions under a lower (| | ≥ 0.001) and a
higher (| | ≥ 0.05) epistasis threshold. (B) The distribution for the percentages of
gene pairs with similar epistasis relations between any 2 of 16 conditions under a lower
(| | ≥ 0.001) and a higher (| | ≥ 0.05) epistasis threshold.
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Figure B.4: Analogous to Figure 3.3.3A, but using a maximum growth rate for each
condition, where the maximum is constrained to be no higher than the high-glucose
growth rate. Distribution for the number of conditions in which each epistatic interaction
exists. Note that ≈ 26% of epistatic relations are extremely stable (the very right bar)
and ≈ 19% are extremely dynamic (the very left bar).
B.2 Supporting Tables
Tables S1-S6 are available online at https://app.box.com/s/x1bx3bntyzlpbh3ciuwq.
B.2.1 Table Legends
Table S1. Wild-type growth rates used in the maximal growth rate simulations used for
Figures B.1 and B.4.
Table S2. Condition-specific epistases and sign-epistases prevalence in the iMM904
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yeast model.
Table S3. GO term enrichment analysis results for differential epistasis in transition to
ethanol.
Table S4. Properties of simulated systems that correlate with the ratio of positive to
negative differential epistases.
Table S5. List of epistatic interactions for the extremely stable, dynamic, and interme-
diate epistasis networks.






























































































Figure C.1: Comparison of fluxes when FALCON is run with enzyme abundance cal-
culated by direct evaluation (x-axis) and the minimum disjunction algorithm (y-axis);
error bars with length equal to one standard deviation are shown for both approaches as
a result of alternative solutions in FALCON. Yeast was evaluated with default (highly)
constrained (a) and minimally constrained (b) models, and no strong difference be-
tween direct evaluation or or the minimum disjunction method is observed in either
case. However, for human models with a highly constrained reaction set (RPMI media,
CORE-sign, and enzymatic direction) (c) and default constraints (d), we see there is a
large amount of variation between the two evaluation techniques. In the human cases,
two outliers were not shown that correspond to a single large flux cycle (‘release of B12
by simple diffusion’ and ‘transport of Adenosylcobalamin into the intestine’).
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Figure C.2: Shown are flux predictions using a number of methods and four different
models (Yeast 5 MC and Yeast 7 MC are minimally constrained Yeast 5 and Yeast 7;
Yeast 5 HC and Yeast 7 HC are highly constrained Yeast 5 and Yeast 7). Error bars
are shown for the Lee et al. method and for FALCON, where one side of the error bar
corresponds to a standard deviation. Note that there can be no variation for glucose in the
former case since glucose flux is fixed as part of the method. FALCON performs very
well for large fluxes (a-c), and is also the best performer in general for the next largest
flux, glycerol (d). It also has sporadic success for smaller fluxes, but all methods seem
to have trouble with the smallest fluxes (e.g. e). Note that fluxes are drawn in log scale
(specifically a flux v is drawn as sgn (v) log10 (1 + v)). Similar results are obtainable for
the 85% maximum growth condition.
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Figure C.3: Kernel-smoothed PDFs are drawn for correlations between the entire flux
vector estimated by FALCON on permuted and unpermuted data. Stability and corre-
lation are effected by constraints, as there are differences between the minimally con-
strained (b, d) and highly constrained (a, c) Yeast 7 models. 5,000 permutation repli-
cates were performed in all cases.
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Figure C.4: These figures are generated in the same way as those in Figure 4.4.2,
but for Human Recon 2 instead of Yeast 7. We used several different constraint sets
based on experimental media and exometabolic flux data in the NCI-60 cell lines [3].
These constraints were applied cumulatively, and are listed in the order of most con-
strained (b) to least constrained (f). Included are default Recon 2 constraints (f),
RPMI media constraints (e; function constrainCoReMinMaxSign; 556 constraints),
exometabolic fluxes with a common sign across all cell lines and replicates (d; func-
tion constrainCoReMinMaxSign; 567 cumulative constraints), enzymatic reaction di-
rectionality constraints from a linear MoMA fitting on the exometabolic flux data that
agree across all NCI-60 cell lines (c; constrainImputedInternal; 593 cumulative
constraints), and the same again considering all reactions instead of only enzymatic re-
actions (b; 618 cumulative constraints).
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Figure C.5: Pearson correlation between FALCON flux magnitudes, prerequisite en-
zyme complex estimates (from minDisj), and various simpler gene expression estimates
based on the list of genes associated to each reaction. For yeast (a), the upper and lower
triangles are the 75% and 85% maximum growth conditions, respectively, and human is
done similarly with the K562 and MDA-MB-231 cell lines (b). As for expression esti-
mates, the sum of expression and enzyme complex estimate levels are generally the least
correlated with other expression estimates. As expected, the enzyme complex estimates
are the most correlated with the FALCON fluxes, as they are used in the algorithm.
However, it is important to note that they are not very similar, exemplifying the affect
the network constraints play when determining flux. Interestingly, enzyme complex
abundance is found to correlate very highly with the maximum expression level for the
complex; this can be attributed to many genes having relatively simple complexes that
are isozymes, where one major isozyme is typically highly expressed.
C.2 Assumptions for enzyme complex formation
In order to quantify enzyme complex formation (sometimes called enzyme complex-
ation), the notion of an enzyme complex should be formalized. A protein complex
typically refers to two or more physically associated polypeptide chains, which is some-
times called a quaternary structure. Since we are not exclusively dealing with multi-
protein complexes, we refer to an enzyme complex as being one or more polypeptide
chains that act together to carry out metabolic catalysis.
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Assumption 1. A fundamental assumption that we need in order to guarantee an ac-
curate estimate of (unitless) enzyme complex abundance are the availability of accurate
measurements of their component subunits. Unfortunately, this is currently not possi-
ble, and we almost always must make do with mRNA measurements, which may even
have some degree of inaccuracy in measuring the mRNA abundance. What has been
seen is that Spearman’s ρ = 0.6 for correlation between RNA-Seq and protein intensity
in datasets from HeLa cells [190]. This implies that much can likely still be gleamed
from analyzing RNA-Seq data, but, an appropriate degree of caution must be used in
interpreting results based on RNA-Seq data. By incorporating more information, such
as metabolic constraints, we hope to obviate some of the error in estimating protein
intensity from RNA-Seq data.
Assumption 2. We also include the notion of isozymes–different proteins that cat-
alyze the same reaction–in our notion of enzyme complex. Isozymes may arise by
having one or more differing protein isoforms, and even though these isoforms may not
be present in the same complex at the same moment, we consider them to be part of the
enzyme complex since one could be substituted for the other.
As an example for assumptions described so far, take the F1 subcomplex of ATP
Synthase (Figure C.6), which is composed of seven protein subunits (distinguished by
color, left). On the right-hand side we see different isoforms depicted as different colors.
Error in expression data aside, instead of considering the abundances with multiplicity
and dividing their expression values by their multiplicity, it may be easier to simply note
that the axle peptide (shown in red in the center of the complex) only has one copy in the
complex, so its expression should be an overall good estimation of the F1 subcomplex
abundance. This reasoning will be useful later in considering why GPR rules may be
largely adequate for estimating the abundance of most enzyme complexes.
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Figure C.6: Illustration of the F1 part of the ATP Synthase complex (PDB ID 1E79;
Gibbons et al. 4, Bernstein et al. 5, Gezelter et al. 6). This illustration demonstrates both
how an enzyme complex may be constituted by multiple subunits (left), and how some
of those subunits may be products of the same gene and have differing stoichiometries
within the complex (right).
Assumption 3. The modeling of enzyme complex abundance can be tackled by using
nested sets of subcomplexes; each enzyme complex consists of multiple subcomplexes,
unless it is only a single protein or family of protein isozymes. These subcomplexes are
required for the enzyme complex to function (AND relationships), and can be thought of
as the division of the complex in to distinct units that each have some necessary function
for the complex, with the exception that we do not keep track of the multiplicity of
subcomplexes within a complex since this information is, in the current state of affairs,
not always known. However, there may be alternative versions of each functional set
(given by OR relationships). Eventually, this nested embedding terminates with a single
protein or set of peptide isoforms (e.g. isozymes). In the case of ATP Synthase, one
of its functional sets is represented by the F1 subcomplex. The F1 subcomplex itself
can be viewed as having two immediate subcomplexes: the single γ (axle) subunit and
three identical subcomplexes each made of an α and β subunit. Each αβ pair works
together to bind ADP and catalyze the reaction [191]. The αβ subcomplex itself then
has two subcomplexes composed of just an α subunit on the one hand and the β subunit
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on the other. It is obvious that one of these base-level functional subcomplexes (in this
example, either γ or αβ) will be in most limited supply, and that it will best represent
the overall enzyme complex abundance (discounting the issues of multiplicity for αβ,
see Assumption 4).
The hierarchical structure just described, when written out in Boolean, will give a
rule in CNF (conjunctive normal form), or more specifically (owing to the lack of nega-
tions), clausal normal form, where a clause is a disjunction of literals (genes). This is
because all relations are ANDs (conjunctions), except possibly at the inner-most sub-
complexes that have alternative isoforms, which are expressed as ORs (disjunctions).
Since GPR rules alone only specify the requirements for enzyme complex formation,
we will see that not all forms of Boolean rules are equally useful in evaluating the en-
zyme complex abundance, but we have established the assumptions in Table C.1 and
an alternative and logically equivalent rule [160] under which we can estimate enzyme
complex copy number.
There is no guarantee that a GPR rule has been written down with this hierarchi-
cal structure in mind, though it is likely the case much of the time as it is a natural
way to model complexes. However, any GPR rule can be interpreted in the context of
this hierarchical view due to the existence of a logically equivalent CNF rule for any
non-CNF rule, and it is obvious that logical equivalence is all that is required to check
for enzyme complex formation when exact isoform stoichiometry is unknown. As an
example, we consider another common formulation for GPR rules, and a way to think
about enzyme structure—disjunctive normal form (DNF). A DNF rule is a disjunctive
list of conjunctions of peptide isoforms, where each conjunction is some variation of
the enzyme complex due to substituting in different isoforms for some of the required
subunits. A rule with a more complicated structure and compatible isoforms across sub-
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Table C.1: A list of assumptions about how Gene-Protein-Reaction rules can describe
enzyme complex stoichiometry.
Table C.1. Assumptions in GPR-based Enzyme Complex Formation
1. Expression values are highly correlated with the copy numbers of their
corresponding peptide isoforms.
2. Protein isoforms contributing to isozymes are considered part of the same
enzyme complex.
3. Any enzyme complex can be described as a hierarchical subset of (possi-
bly redundant) subcomplexes; redundant subcomplexes, as elaborated in
(4), are not currently modeled.
4. Assume one copy of peptide per complex; exact isoform stoichiometry is
not considered.
5. With the exception of complexes having identical rules (i.e. the same
complex listed for different reactions), each copy of a peptide is available
for all complexes in the model.
6. There is only one active site per enzyme complex.
7. We assume that different pathways have similar flux sensitivities with
respect to their enzyme abundances.
8. If a particular subcomplex can be catalyzed by A and it can also be cat-
alyzed by A and B (e.g. B acts as a regulatory unit, as in holoenzymes),
this just simplifies to A once expression values are substituted in. Sim-
ilarly, allosteric regulation is not modeled. Relatedly, there are no NOT
operations in GPR rules (just ANDs and ORs).
9. Enzyme complexes form without the assistance of protein chaperones
and formation is not coupled to other reactions.
10. Post-translational modifications do not affect complex formation.
11. Rate of formation and degradation of complexes doesn’t play a role, since
we assume steady-state.
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complexes may be written more succinctly in CNF, whereas a rule with only very few
alternatives derived from isoform variants may be represented clearly with DNF. In rare
cases, it is possible that a GPR rule is written in neither DNF or CNF, perhaps because
neither of these two alternatives above are strictly the case, and some other rule is more
succinct.
Assumptions 4, 5 and 6. One active site per enzyme complex implies a single com-
plex can only catalyze one reaction at a time. Multimeric complexes with one active site
per identical subunit would be considered as one enzyme complex per subunit in this
model. Note that it is possible for an enzyme complex to catalyze different reactions. In
fact, some transporter complexes can transfer many different metabolites across a lipid
bilayer—up to 294 distinct reactions in the reversible model for solute carrier family 7
(Gene ID 9057). Another example is the ligation or hydrolysis of nucleotide, fatty acid,
or peptide chains, where chains of different length may all be substrates or products of
the same enzyme complex. While we do not explicitly consider these in in the mini-
mum disjunction algorithm, these redundancies are taken into account subsequently in
Algorithm 1.
What is currently not considered in our process is that some peptide isoforms may
find use in completely different complexes, and in some cases, individual peptides may
have multiple active sites; in the first case, we assume an unrealistic case of superpo-
sition where the isoform can simultaneously function in more than one complex. The
primary reason we have not tackled this problem is because exact subunit stoichiome-
try of most enzyme complexes is not accurately known, but an increasing abundance of
data on BRENDA [192] gives some hope to this problem. A recent E. coli metabolic
model incorporating the metabolism of all known gene products [187] also includes pu-
tative enzyme complex stoichiometry in GPR rules. For the second point, there are a
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few enzymes where a single polypeptide may have multiple active sites (e.g. fatty acid
synthase), and this is not currently taken into account in our model.
Assumption 8. We do not make any special assumptions requiring symmetry of an
isoform within a complex. For instance, the example in assumption 8 shows how you
might have one subcomponent composed of a single isoform, and another subcompo-
nent composed of that gene in addition to another isoform. In this case, it is simply
reduced to being the first gene only that is required, since clearly the second is strictly
optional. That isn’t to say that the second gene may not have some metabolic effect, such
as (potentially) aiding in structural ability or altering the catalytic rate, but it should
have no bearing on the formation of a functional catalytic complex. Holoenzymes—
enzymes with metabolic cofactors or protein subunits that have a regulatory function for
the complex—would likely be the only situation where this type of rule might need to
be considered in more detail. But in the absence of detailed kinetic information, this
consideration (much like allosteric regulation) is not useful.
No additional algorithmic considerations are needed, as this is a by-product of the
conversion to CNF. For instance, take the following example where the second conjunc-
tion has the redundant gene g3:
(g1 ∧ g2) ∨ (g1 ∧ g2 ∧ g3)
Distributing during the process of conversion to CNF results in:
g1 ∧ (g1 ∨ g2) ∧ (g1 ∨ g3) ∧ (g2 ∨ g1) ∧ g2 ∧ (g2 ∨ g3)
Because every disjunction with more than one literal is in conjunction with another
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disjunction with only one of its literals, the disjunction with fewer literals will be the
minimum of the two once evaluated. This applies to both of the singleton disjunctions
g1 and g2, so all other disjunctions will effectively be ignored (it is up to the implementer
whether the redundant sub-expressions are removed before evaluation):
g1 ∧XXXXX(g1 ∨ g2)∧XXXXX(g1 ∨ g3)∧XXXXX(g2 ∨ g1)∧g2XXXXX∧(g2 ∨ g3) = (g1 ∧ g2)
Assumption 7. Another important biochemical assumption is that reactions should
operate in a regime where they are sensitive to changes in the overall enzyme level in
the pathways that they belong in [166, 167]. This is perhaps the most important issue to
be explored further for methods like this, since if it is not true, some other adjustment
factor would be needed to make the method realistic. For instance, if all reactions in
a pathway are operating far below Vmax, but it is not the case in another pathway, the
current method does not have information on this, and will try to put more flux through
the first pathway than should be the case.
Assumptions 9, 10 and 11. Due to the quickness, stability, and energetic favora-
bility of enzyme complex formation, the absence of chaperones or coupled metabolic
reactions required for complex formation may be reasonable assumptions, but further
research is warranted [68]. Additionally, as in metabolism, we assume a steady state for
complex formation, so that rate laws regarding complex formation aren’t needed. How-
ever, further research may be warranted to investigate the use of a penalty for complex
levels based on mass action and protein-docking information. Requisite to this would be
addressing assumption 4. It would be surprising (but not impossible) if such a penalty
were very large due to the cost this would imply for many of the large and important
enzyme complexes present in all organisms [193]. A more serious consideration may
be that information on post-translational modification is not currently considered. Post-
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translational modification is highly context-specific and the relevant data is not as cheap
to get as expression data, so it may be some time before it can be integrated into the
modeling framework.
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Table C.2: Running times (in seconds, ± standard deviation) for FALCON using various
algorithms implemented in the Gurobi package. For yeast models, 1,000 replicates were
performed, and for the human model, 100 replicates were performed.
Model Primal-Simplex Dual-Simplex Barrier
Yeast 5.21 (2,061 reactions) 7.841 ± 1.697 7.611 ± 1.267 10.859 ± 2.788
Yeast 7.0 (3,498 reactions) 51.863 ± 22.731 65.317 ± 12.771 242.137 ± 57.129
Human 2.03 (7,440 reactions) 159.077 ± 24.903 152.297 ± 39.783 366.166 ± 92.321
C.3 Benchmarking of solvers
We have exclusively used the Gurobi solver [194] for this work, which is a highly com-
petitive solver that employs by default a parallel strategy to solving problems: a different
algorithm is run simultaneously, and as soon as one algorithm finished the others termi-
nate. Of course, if there is a clear choice of algorithm for a particular problem class, this
should be used in production settings to avoid wasted CPU time and memory. In order
to address this, we benchmarked the three non-parallel solver methods in Gurobi (since
parallel solvers simply use multiple methods simultaneously). The exception to this rule
is the Barrier method, which can use multiple threads, but in practice for our models ap-
pears to use no more than about 6 full CPU cores simultaneously for our models. Our
results for Yeast 5 and Yeast 7 with minimal directionality constraints [1, 162, 165] and
Human Recon 2 [63] are shown in Table C.2).
We found that in Yeast 7 with the primal-simplex solver, there is a chance the solver
will fail to find a feasible solution. We verified that this is a numeric issue in Gurobi and
can be fixed by setting the Gurobi parameter MarkowitzTol to a larger value (which
decreases time-efficiency but limits the numerical error in the simplex algorithm). In
practice, failure for the algorithm to converge at an advanced iteration is rare and is
not always a major problem (since the previous flux estimate by the advanced iteration
should already be quite good), but it is certainly undesirable; a warning message will be
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Table C.3: Running time per FALCON iteration (in seconds, ± standard deviation)
using various algorithms implemented in the Gurobi package. For yeast models, 1,000
replicates were performed, and for the human model, 100 replicates were performed.
Model Primal-Simplex Dual-Simplex Barrier
Yeast 5.21 (2,061 reactions) 0.721 ± 0.023 0.652 ± 0.040 1.100 ± 0.112
Yeast 7.0 (3,498 reactions) 2.725 ± 0.298 2.469 ± 0.289 11.309 ± 1.589
Human 2.03 (7,440 reactions) 6.422 ± 0.484 5.233 ± 0.661 15.782 ± 3.209
printed by falcon if this occurs, at which point parameter settings can be investigated.
In the future, we plan to improve falcon so that parameters will be adjusted as needed
during progression of the algorithm after finding a good test suite of models and data.
For now, we use the dual-simplex solver, for which we have always had good results.
Because the number of iterations depends non-trivially on the model and the expres-
sion data, it may be more helpful to look at the average time per iteration in the above
examples (Table C.3).
Given the above rare trouble with primal simplex solver the universal best perfor-
mance enjoyed by the dual-simplex method (Tables C.2 and C.3), we would advise the
dual-simplex algorithms, all else being equal. The dual-simplex method is also recom-
mended for memory-efficiency by Gurobi documentation, but we did not observe any
differences in memory for different solver methods.
All timing analyses were performed on a system with four 8-core AMD Opteron™
6136 processors operating at 2.4 GHz. Figure C.2, Table 4.1, and Tables C.2 and C.3
used a single unperturbed expression file per species (S. cerevisiae and H. sapiens; see
timingAnalysis.m for details). Values were averaged across 32 replicates. Note that
the iMAT method is formulated as a mixed integer program [30], and was able to use
additional parallelization of the solver [194] whereas other methods only used a single
core (our system had 32 cores and iMAT with Gurobi would use all of them). Tables C.2
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and C.3 used multivariate log-normal noise multiplied by the original expression vector
to introduce more variance in the calculations; the human models were tested with 100
replicates and the yeast models with 500 replicates.
C.4 Generation of figures and tables
All non-trivial figures can be generated using MATLAB scripts found in the
analysis/figures subdirectory of the FALCON installation. In particular, fig-
ures should be generated through the master script makeMethodFigures.m by call-
ing makeMethodFigures(figName) where figName has a name corresponding to
the desired figure. In some cases, some MATLAB .mat files will need to be gen-
erated by other scripts first; see the plotting scripts or the subsections below for de-
tails. An example is to make the scatter plots showing the difference between run-
ning falcon with enzyme abundances determined by direct evaluation or the mini-
mum disjunction algorithm; all three scatter plots are generated with the command
makeMethodFigures('fluxCmpScatter'). Note that, as written, this requires a
graphical MATLAB session.
Comparison of the effects of the employed enzyme complexation methods were eval-
uated using compareEnzymeExpression.m and compareFluxByRGroup.m. Compar-
ison of reaction groups was performed in compareFluxByRGroup.m.
C.4.1 Timing analyses
All timing analyses were performed on a system with four 8-core AMD Opteron™ 6136
processors operating at 2.4 GHz. Figure C.2 and Table 4.1 used unperturbed expression
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data; see yeastResults.m for details). Values for the FALCON method were averaged
across 32 replicates, while values for the Lee et al. 1 method were averaged across
8 replicates. Human timing analyses were performed using methodTimer.m with 8
replicates.
C.4.2 Data sources
Enzyme complexation comparisons were performed on proteomics data from Gholami
et al. 164 (Human; 786-O cell line) and Picotti et al. 163 (yeast; BY strain), and on
RNA-Seq data from Lee et al. 1 (yeast; 75% max µ condition).
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APPENDIX D




Figure D.1: The same reaction is used in both figures, and in both instances, a slightly
negative weight on the reaction appears to be most beneficial (compare to 0, which
represents the wild-type). Weight on a (linear or quadratic, respectively) regularization
objective component is shown on the y-axis, which is often a helpful constant both
biologically and for removing invalid flux cycles [7, 8].
144
Figure D.2: Flux restriction increases the percentage of negative epistatic interactions.
Data taken from Xu et al. [9].
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(a) 50% Gaussian sampling












Figure D.3: Example distributions of beneficial mutations for the yeast YPE example
when sampling 50% of flux mutations within the larger FVA bound using a truncated




D.2.1 Evolutionary path analysis
The repository housing the project is currently located at: https://github.com/
bbarker/COBRAscripts. The C code which is used for the analysis may be found
in the MyProjects/AdaptiveMuts/TreeTraversal subdirectory.
The power-set of mutations can be ordered in the natural binary order. For instance,
four mutations can be ordered from 0000 (wild-type) to 1111 (all mutations present) ,
where a ’0’ denotes the absence of the given mutation and a ’1’ denotes its presence. An
example of the four mutation case can be given in one line of a text file as follows:
0.013743, 0.024794, 0.020672, 0.023515, 0.019147, 0.02291, 0, 0, 0.017884,
0.024196, 0.016066, 0.023515, 0.015166, 0.02291, 0, 0
The first fitness in the list, which corresponds to the wild-type, is the divisor in the
following output from printPaths1, showing all 4! paths that may arise from the above
mutants.
*** Replicate 0 ***
0 4 3 2 1
1.000000 1.301317 1.103544 0.000000 0.000000
0 4 3 1 2
1.000000 1.301317 1.103544 1.667030 0.000000
0 4 2 3 1
1.000000 1.301317 1.169032 0.000000 0.000000
1printpaths has the same usage as trapFind; see page 150
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0 4 2 1 3
1.000000 1.301317 1.169032 1.711053 0.000000
0 4 1 3 2
1.000000 1.301317 1.760605 1.667030 0.000000
0 4 1 2 3
1.000000 1.301317 1.760605 1.711053 0.000000
0 3 4 2 1
1.000000 1.393218 1.103544 0.000000 0.000000
0 3 4 1 2
1.000000 1.393218 1.103544 1.667030 0.000000
0 3 2 4 1
1.000000 1.393218 0.000000 0.000000 0.000000
0 3 2 1 4
1.000000 1.393218 0.000000 0.000000 0.000000
0 3 1 4 2
1.000000 1.393218 1.667030 1.667030 0.000000
0 3 1 2 4
1.000000 1.393218 1.667030 0.000000 0.000000
0 2 4 3 1
1.000000 1.504184 1.169032 0.000000 0.000000
0 2 4 1 3
1.000000 1.504184 1.169032 1.711053 0.000000
0 2 3 4 1
1.000000 1.504184 0.000000 0.000000 0.000000
0 2 3 1 4
1.000000 1.504184 0.000000 0.000000 0.000000
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0 2 1 4 3
1.000000 1.504184 1.711053 1.711053 0.000000
0 2 1 3 4
1.000000 1.504184 1.711053 0.000000 0.000000
0 1 4 3 2
1.000000 1.804118 1.760605 1.667030 0.000000
0 1 4 2 3
1.000000 1.804118 1.760605 1.711053 0.000000
0 1 3 4 2
1.000000 1.804118 1.667030 1.667030 0.000000
0 1 3 2 4
1.000000 1.804118 1.667030 0.000000 0.000000
0 1 2 4 3
1.000000 1.804118 1.711053 1.711053 0.000000
0 1 2 3 4
1.000000 1.804118 1.711053 0.000000 0.000000
’Replicate 0’ merely denotes that this output was due to the first example power set
of mutants in a file, since randomBeneficialPsets.m or randomAdaptivePsets.m
can be used to generate multiple sets of mutants. The primary difference between the two
scripts is that the former uses hard constraint changes as mutations, whereas the latter
uses weights (which is the version used in the present study). In an experimental setting,
it is much more likely that we would only have one replicate, which is exactly why
experimental settings are unlikely to be useful for showing trends in adaptive evolution.
Each line of fitnesses is preceded by a corresponding line which lists which mutation was
added at that point in the evolutionary path (0 to n where n is the number of mutations, so
n = 4 in this example). It may be desirable to map these mutations back to the reactions
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Table D.1: Example output of trapFind applied to experimental datasets. The input
files may be found in this project’s TreeTraversal/Experiments subdirectory.
study mutations reached optima trap: fitness decrease trap: local maxima
Weinreich et al. [174] 5 96 18 0
Khan et al. [178] 5 108 7 0
Chou et al. [173] 4 24 0 0
they are associated with in the model. This output from the above scripts is stored in
files with the suffix rxnlist.csv.
The trapFind program can be used to find how many paths have traps (local fitness
optima or fitness decreases) that prevent adaptation from reaching the global fitness
maximum among all combinations of mutations in the set.
This program takes as its first argument a file containing comma-delimited lists of
mutant fitnesses described above, followed by the number of individual mutations as the
second argument, and the number of replicates (lines in the file) as the third argument:
trapFind [number of mutants] [number of replicates]
The output is contained in [original file prefix] trapAnalysis.csv. The
contents of the file are comma-separated lists (one per mutation set) that have the follow-
ing information: number of mutations, number of paths that reach the optimum, number
paths terminated due to a decrease in fitness, and the number of paths terminated due to
local maxima. As a further example, the output for three experimental datasets has been
listed (Table D.1).
Note that some paths that become trapped may have themselves branched into other
paths, so the tally for the last three columns does not necessarily reach n!. If we consider
that neutral mutations are unlikely to become fixed in a population [174], only 18 of 120
paths are evolutionarily inaccessible, instead of the 96 encountered in this analysis.
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D.2.2 Pairwise adaptive mutations
The function we used to generate the pairwise epistasis data is randomEpistasisSampler
found in MyProjects/AdaptiveMuts. This function relies on another function in the
same directory for generating a pool of single mutants, randomSingleBeneMuts.
151
BIBLIOGRAPHY
[1] Dave Lee, Kieran Smallbone, Warwick B Dunn, Ettore Murabito, Catherine L Winder, Douglas B Kell, Pedro Mendes, and Neil Swain-
ston. Improving metabolic flux predictions using absolute gene expression data. BMC Syst. Biol., 6(1):73, January 2012. ISSN 1752-
0509. doi: 10.1186/1752-0509-6-73. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3477026&tool=
pmcentrez&rendertype=abstract.
[2] Alexander A Shestov, Brandon Barker, Zhenglong Gu, and Jason W Locasale. Computational approaches for understanding energy
metabolism. Wiley Interdiscip. Rev. Syst. Biol. Med., 5(6):733–750, July 2013. ISSN 1939-005X. doi: 10.1002/wsbm.1238. URL
http://dx.doi.org/10.1002/wsbm.1238.
[3] Mohit Jain, Roland Nilsson, Sonia Sharma, Nikhil Madhusudhan, Toshimori Kitami, Amanda L Souza, Ran Kafri, Marc W Kirschner,
Clary B Clish, and Vamsi K Mootha. Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation. Science
(80-. )., 336(6084):1040–1044, May 2012. doi: 10.1126/science.1218595. URL http://www.sciencemag.org/content/336/6084/
1040.abstract.
[4] Clyde Gibbons, Martin G Montgomery, Andrew G W Leslie, and John E Walker. The structure of the central stalk in bovine F1-ATPase at
2.4 A resolution. Nat Struct Mol Biol, 7(11):1055–1061, November 2000. ISSN 1072-8368. URL http://dx.doi.org/10.1038/80981.
[5] Frances C Bernstein, Thomas F Koetzle, Graheme J B Williams, Edgar F Meyer Jr., Michael D Brice, John R Rodgers, Olga Kennard,
Takehiko Shimanouchi, and Mitsuo Tasumi. The protein data bank: A computer-based archival file for macromolecular structures. Arch.
Biochem. Biophys., 185(2):584–591, January 1978. ISSN 0003-9861. doi: http://dx.doi.org/10.1016/0003-9861(78)90204-7. URL http:
//www.sciencedirect.com/science/article/pii/0003986178902047.
[6] Dan Gezelter, Bradley A Smith, and Egon Willighagen. Jmol: an open-source Java viewer for chemical structures in 3D, 2013. URL
http://www.jmol.org/.
[7] R. Schuetz, N. Zamboni, M. Zampieri, M. Heinemann, and U. Sauer. Multidimensional Optimality of Microbial Metabolism. Science (80-.
)., 336(6081):601–604, May 2012. ISSN 0036-8075. doi: 10.1126/science.1216882. URL http://www.sciencemag.org/cgi/doi/
10.1126/science.1216882.
[8] Kieran Smallbone and Evangelos Simeonidis. Flux balance analysis: a geometric perspective. J. Theor. Biol., 258(2):311–5, 2009. ISSN
1095-8541. doi: 10.1016/j.jtbi.2009.01.027. URL http://www.ncbi.nlm.nih.gov/pubmed/19490860.
152
[9] Lin Xu, Brandon Barker, and Zhenglong Gu. Dynamic epistasis for different alleles of the same gene. Proc. Natl. Acad. Sci. U. S. A., June
2012. ISSN 1091-6490. doi: 10.1073/pnas.1121507109. URL http://www.ncbi.nlm.nih.gov/pubmed/22689976.
[10] Howard M Shapiro. Studies in the Structure of the Bacterial Economy: An Input-Output Model of Escherichia Coli. PhD thesis, Harvard
University, 1961.
[11] Howard M Shapiro. Input-Output Models of Biological Systems: Formulation and Applicability. Comput. Biomed. Res., 2:430–445, 1969.
[12] C Van De Panne and F Rahnamat. The First Algorithm for Linear Programming : An Analysis of Kantorovich ’ s Method. Econ. Plan., 19
(2):76–91, 1985.
[13] M.R. Watson. Metabolic maps for the Apple II. Biochem. Soc. Trans., 12:1093–1094, 1984.
[14] J M Savinell and Bernhard Ø Palsson. Network analysis of intermediary metabolism using linear optimization. I. Development of math-
ematical formalism. J. Theor. Biol., 154(4):421–54, March 1992. ISSN 0022-5193. URL http://www.ncbi.nlm.nih.gov/pubmed/
1593896.
[15] Joanne M Savinell, Bernhard Ø Palsson, and Ann Arbor. Network Analysis of Intermediary Metabolism using Linear Optimization . II .
Interpretation of Hybridoma Cell Metabolism The uses of linear optimization theory to calculate and interpret fluxes in metabolic. Cell
Metab., pages 455–473, 1992.
[16] J S Edwards and Bernhard Ø Palsson. The Escherichia coli MG1655 in silico metabolic genotype: its definition, characteristics, and
capabilities. Proc. Natl. Acad. Sci. U. S. A., 97(10):5528–33, May 2000. ISSN 0027-8424. URL http://www.pubmedcentral.nih.
gov/articlerender.fcgi?artid=25862&tool=pmcentrez&rendertype=abstract.
[17] Iman Famili, Jochen Forster, Jens Nielsen, and Bernhard Ø Palsson. Saccharomyces cerevisiae phenotypes can be predicted by using
constraint-based analysis of a genome-scale reconstructed metabolic network. Proc. Natl. Acad. Sci. U. S. A., 100(23):13134–9, November
2003. ISSN 0027-8424. doi: 10.1073/pnas.2235812100. URL http://www.ncbi.nlm.nih.gov/pubmed/14578455.
[18] Stephen S Fong and Bernhard Ø Palsson. Metabolic gene-deletion strains of Escherichia coli evolve to computationally predicted growth
phenotypes. Nat. Genet., 36(10):1056–8, October 2004. ISSN 1061-4036. doi: 10.1038/ng1432. URL http://www.ncbi.nlm.nih.
gov/pubmed/15448692.
153
[19] Ronan M T Fleming, C M Maes, M a Saunders, Y Ye, and Bernhard Ø Palsson. A variational principle for computing nonequilibrium
fluxes and potentials in genome-scale biochemical networks. J. Theor. Biol., 292:71–7, January 2012. ISSN 1095-8541. doi: 10.1016/j.
jtbi.2011.09.029. URL http://www.ncbi.nlm.nih.gov/pubmed/21983269.
[20] A Varma and Bernhard Ø Palsson. Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion
in wild-type Escherichia coli W3110. Appl. Environ. Microbiol., 60(10):3724–31, October 1994. ISSN 0099-2240. URL http://www.
pubmedcentral.nih.gov/articlerender.fcgi?artid=201879&tool=pmcentrez&rendertype=abstract.
[21] M M Zavlanos and A A Julius. Robust flux balance analysis of metabolic networks. In Am. Control Conf. (ACC), 2011, pages 2915–2920,
June 2011. doi: 10.1109/ACC.2011.5991248.
[22] Jeffrey D Orth, Ines Thiele, and Bernhard Ø Palsson. What is flux balance analysis? Nat. Biotechnol., 28(3):245–8, March 2010. ISSN
1546-1696. doi: 10.1038/nbt.1614. URL http://www.ncbi.nlm.nih.gov/pubmed/20212490.
[23] Daniel Segre`, Dennis Vitkup, and George M Church. Analysis of optimality in natural and perturbed metabolic networks. Proc. Natl. Acad.
Sci. U. S. A., 99(23):15112–7, November 2002. ISSN 0027-8424. doi: 10.1073/pnas.232349399. URL http://www.pubmedcentral.
nih.gov/articlerender.fcgi?artid=137552&tool=pmcentrez&rendertype=abstract.
[24] Tomer Shlomi, Omer Berkman, and Eytan Ruppin. Regulatory on/off minimization of metabolic flux. Proc. Natl. Acad. Sci., 102(21):
7695–7700, 2005.
[25] Jan Schellenberger, Nathan E Lewis, and Bernhard Ø Palsson. Elimination of thermodynamically infeasible loops in steady-state metabolic
models. Biophys. J., 100(3):544–53, February 2011. ISSN 1542-0086. doi: 10.1016/j.bpj.2010.12.3707. URL http://www.ncbi.nlm.
nih.gov/pubmed/21281568.
[26] D Beard, S Liang, and H Qian. Energy Balance for Analysis of Complex Metabolic Networks. Biophys. J., 83(1):79–86, July 2002. ISSN
00063495. doi: 10.1016/S0006-3495(02)75150-3. URL http://linkinghub.elsevier.com/retrieve/pii/S0006349502751503.
[27] Christopher S Henry, Linda J Broadbelt, and Vassily Hatzimanikatis. Thermodynamics-based metabolic flux analysis. Biophys. J., 92
(5):1792–805, March 2007. ISSN 1542-0086. doi: 10.1529/biophysj.106.093138. URL http://www.pubmedcentral.nih.gov/
articlerender.fcgi?artid=1796839&tool=pmcentrez&rendertype=abstract.
154
[28] Yuliang Wang, James a Eddy, and Nathan D Price. Reconstruction of genome-scale metabolic models for 126 human tissues using
mCADRE. BMC Syst. Biol., 6:153, January 2012. ISSN 1752-0509. doi: 10.1186/1752-0509-6-153. URL http://www.ncbi.nlm.
nih.gov/pubmed/23234303.
[29] Scott A Becker and Bernhard Ø Palsson. Context-specific metabolic networks are consistent with experiments. PLoS Comput. Biol., 4(5):1–
10, May 2008. ISSN 1553-7358. doi: 10.1371/journal.pcbi.1000082. URL http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=2366062&tool=pmcentrez&rendertype=abstract.
[30] Tomer Shlomi, Moran N Cabili, Markus J Herrgård, Bernhard Ø Palsson, and Eytan Ruppin. Network-based prediction of human tissue-
specific metabolism. Nat. Biotechnol., 26(9):1003–10, September 2008. ISSN 1546-1696. doi: 10.1038/nbt.1487. URL http://www.
ncbi.nlm.nih.gov/pubmed/18711341.
[31] Sriram Chandrasekaran and Nathan D Price. Probabilistic integrative modeling of genome-scale metabolic and regulatory networks
in Escherichia coli and Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A., 107(41):17845–50, October 2010. ISSN 1091-
6490. doi: 10.1073/pnas.1005139107. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2955152&tool=
pmcentrez&rendertype=abstract.
[32] Marcin Imielinski and Calin Belta. Deep epistasis in human metabolism. Chaos, 20(2):026104, June 2010. ISSN 1089-7682. doi: 10.1063/
1.3456056. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2909311&tool=pmcentrez&rendertype=
abstract.
[33] Marcin Imielinski and Calin Belta. Exploiting the pathway structure of metabolism to reveal high-order epistasis. BMC Syst. Biol., 2:40,
January 2008. ISSN 1752-0509. doi: 10.1186/1752-0509-2-40. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=2390508&tool=pmcentrez&rendertype=abstract.
[34] Xionglei He, Wenfeng Qian, Zhi Wang, Ying Li, and Jianzhi Zhang. Prevalent positive epistasis in Escherichia coli and Saccharomyces
cerevisiae metabolic networks. Nat. Genet., 42(3):272–6, 2010. ISSN 1546-1718. doi: 10.1038/ng.524. URL http://www.ncbi.nlm.
nih.gov/pubmed/20101242.
[35] Christopher S Henry, Matthew D Jankowski, Linda J Broadbelt, and Vassily Hatzimanikatis. Genome-scale thermodynamic analysis of
Escherichia coli metabolism. Biophys. J., 90(4):1453–61, February 2006. ISSN 0006-3495. doi: 10.1529/biophysj.105.071720. URL
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1367295&tool=pmcentrez&rendertype=abstract.
155
[36] Anne Ku¨mmel, Sven Panke, and Matthias Heinemann. Putative regulatory sites unraveled by network-embedded thermodynamic analysis
of metabolome data. Mol. Syst. Biol., 2:2006.0034, January 2006. ISSN 1744-4292. doi: 10.1038/msb4100074. URL http://www.
pubmedcentral.nih.gov/articlerender.fcgi?artid=1681506&tool=pmcentrez&rendertype=abstract.
[37] Arne C Mu¨ller and Alexander Bockmayr. Fast thermodynamically constrained flux variability analysis. Bioinformatics, pages 1–7, February
2013. ISSN 1367-4811. doi: 10.1093/bioinformatics/btt059. URL http://www.ncbi.nlm.nih.gov/pubmed/23390138.
[38] H S Haraldsdo´ttir, Ines Thiele, and Ronan M T Fleming. Quantitative assignment of reaction directionality in a multicompartmental
human metabolic reconstruction. Biophys. J., 102(8):1703–11, April 2012. ISSN 1542-0086. doi: 10.1016/j.bpj.2012.02.032. URL
http://www.ncbi.nlm.nih.gov/pubmed/22768925.
[39] Daniele De Martino, Matteo Figliuzzi, Andrea De Martino, and Enzo Marinari. A scalable algorithm to explore the Gibbs energy landscape
of genome-scale metabolic networks. PLoS Comput. Biol., 8(6):e1002562, January 2012. ISSN 1553-7358. doi: 10.1371/journal.pcbi.
1002562. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3380848&tool=pmcentrez&rendertype=
abstract.
[40] Prabhasa Ravikirthi, Patrick F Suthers, and Costas D Maranas. Construction of an E. Coli genome-scale atom mapping model for MFA
calculations. Biotechnol. Bioeng., 108(6):1372–82, June 2011. ISSN 1097-0290. doi: 10.1002/bit.23070. URL http://www.ncbi.nlm.
nih.gov/pubmed/21328316.
[41] Patrick Warren and Janette Jones. Duality, Thermodynamics, and the Linear Programming Problem in Constraint-Based Models of
Metabolism. Phys. Rev. Lett., 99(10):108101, September 2007. ISSN 0031-9007. doi: 10.1103/PhysRevLett.99.108101. URL
http://link.aps.org/doi/10.1103/PhysRevLett.99.108101.
[42] Nathan E Lewis, Gunnar Schramm, Aarash Bordbar, Jan Schellenberger, Michael P Andersen, Jeffrey K Cheng, Nilam Patel, Alex Yee,
Randall a Lewis, Roland Eils, Rainer Ko¨nig, and Bernhard Ø Palsson. Large-scale in silico modeling of metabolic interactions between
cell types in the human brain. Nat. Biotechnol., 28(12):1279–85, December 2010. ISSN 1546-1696. doi: 10.1038/nbt.1711. URL
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3140076&tool=pmcentrez&rendertype=abstract.
[43] Neema Jamshidi and Bernhard Ø Palsson. Systems biology of the human red blood cell. Blood Cells. Mol. Dis., 36(2):239–47, 2006. ISSN
1079-9796. doi: 10.1016/j.bcmd.2006.01.006. URL http://www.ncbi.nlm.nih.gov/pubmed/16533612.
156
[44] Yuekai Sun, Ronan M T Fleming, Ines Thiele, and Michael A Saunders. Robust flux balance analysis of multiscale biochemical reaction
networks. 2012.
[45] Aarash Bordbar, Nathan E Lewis, Jan Schellenberger, Bernhard Ø Palsson, and Neema Jamshidi. Insight into human alveolar
macrophage and M. tuberculosis interactions via metabolic reconstructions. Mol. Syst. Biol., 6(422):422, October 2010. ISSN 1744-
4292. doi: 10.1038/msb.2010.68. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2990636&tool=
pmcentrez&rendertype=abstract.
[46] Niels Klitgord and Daniel Segre`. Ecosystems biology of microbial metabolism. Curr. Opin. Biotechnol., pages 541–546, May 2011. ISSN
1879-0429. doi: 10.1016/j.copbio.2011.04.018. URL http://www.ncbi.nlm.nih.gov/pubmed/21592777.
[47] Samuel M D Seaver, Christopher S Henry, and Andrew D Hanson. Frontiers in metabolic reconstruction and modeling of plant genomes.
J. Exp. Bot., 63(6):2247–58, March 2012. ISSN 1460-2431. doi: 10.1093/jxb/err371. URL http://www.ncbi.nlm.nih.gov/pubmed/
22238452.
[48] Ramy K Aziz, Scott Devoid, Terrence Disz, Robert a Edwards, Christopher S Henry, Gary J Olsen, Robert Olson, Ross Overbeek, Bruce
Parrello, Gordon D Pusch, Rick L Stevens, Veronika Vonstein, and Fangfang Xia. SEED servers: high-performance access to the SEED
genomes, annotations, and metabolic models. PLoS One, 7(10):e48053, January 2012. ISSN 1932-6203. doi: 10.1371/journal.pone.
0048053. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3480482&tool=pmcentrez&rendertype=
abstract.
[49] Christopher S Henry, Ross Overbeek, Fangfang Xia, Aaron a Best, Elizabeth Glass, Jack Gilbert, Peter Larsen, Rob Edwards, Terry Disz,
Folker Meyer, Veronika Vonstein, Matthew Dejongh, Daniela Bartels, Narayan Desai, Mark D’Souza, Scott Devoid, Kevin P Keegan,
Robert Olson, Andreas Wilke, Jared Wilkening, and Rick L Stevens. Connecting genotype to phenotype in the era of high-throughput
sequencing. Biochim. Biophys. Acta, 1810(10):967–77, October 2011. ISSN 0006-3002. doi: 10.1016/j.bbagen.2011.03.010. URL
http://www.ncbi.nlm.nih.gov/pubmed/21421023.
[50] Jose´ P Faria, Ross Overbeek, Fangfang Xia, Miguel Rocha, Isabel Rocha, and Christopher S Henry. Genome-scale bacterial transcriptional
regulatory networks: reconstruction and integrated analysis with metabolic models. Brief. Bioinform., pages 1–20, February 2013. ISSN
1477-4054. doi: 10.1093/bib/bbs071. URL http://www.ncbi.nlm.nih.gov/pubmed/23422247.
[51] Jason W Locasale. Metabolic rewiring drives resistance to targeted cancer therapy. Mol. Syst. Biol., 8(597):597, January 2012. ISSN
1744-4292. doi: 10.1038/msb.2012.30. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3421445&tool=
157
pmcentrez&rendertype=abstract.
[52] Ori Folger, Livnat Jerby, Christian Frezza, Eyal Gottlieb, Eytan Ruppin, and Tomer Shlomi. Predicting selective drug targets in cancer
through metabolic networks. Mol. Syst. Biol., 7(501):501, January 2011. ISSN 1744-4292. doi: 10.1038/msb.2011.35. URL http:
//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3159974&tool=pmcentrez&rendertype=abstract.
[53] Markus W Covert, C H Schilling, and Bernhard Ø Palsson. Regulation of gene expression in flux balance models of metabolism. J. Theor.
Biol., 213(1):73–88, 2001. ISSN 0022-5193. doi: 10.1006/jtbi.2001.2405. URL http://www.ncbi.nlm.nih.gov/pubmed/11708855.
[54] Markus J Herrgård, Baek-Seok Lee, Vasiliy Portnoy, and Bernhard Ø Palsson. Integrated analysis of regulatory and metabolic networks
reveals novel regulatory mechanisms in Saccharomyces cerevisiae. Genome Res., 16(5):627–35, 2006. ISSN 1088-9051. doi: 10.1101/gr.
4083206. URL http://www.ncbi.nlm.nih.gov/pubmed/16606697.
[55] Janis Dingel and Olgica Milenkovic. List-decoding methods for inferring polynomials in finite dynamical gene network models. Bioin-
formatics, 25(13):1686–93, July 2009. ISSN 1367-4811. doi: 10.1093/bioinformatics/btp281. URL http://www.ncbi.nlm.nih.gov/
pubmed/19401400.
[56] Elena Dimitrova, Franziska Hinkelmann, Abdul S, Reinhard Laubenbacher, Brandilyn Stigler, and Michael Stillman. Parameter estimation
for Boolean models of biological networks. Theor. Comput. Sci., 412:2816–2826, 2011.
[57] B Stigler, a Jarrah, M Stillman, and R Laubenbacher. Reverse engineering of dynamic networks. Ann. N. Y. Acad. Sci., 1115(0477):168–77,
December 2007. ISSN 0077-8923. doi: 10.1196/annals.1407.012.
[58] Abdul Salam Jarrah, Reinhard Laubenbacher, Brandilyn Stigler, and Michael Stillman. Reverse-engineering of polynomial dynamical
systems. Adv. Appl. Math., 39:477–489, 2007.
[59] Osbaldo Resendis-Antonio, Alberto Checa, and Sergio Encarnacio´n. Modeling Core Metabolism in Cancer Cells: Surveying the Topology
Underlying the Warburg Effect. PLoS One, 5(8):e12383, August 2010. ISSN 1932-6203. doi: 10.1371/journal.pone.0012383. URL
http://dx.plos.org/10.1371/journal.pone.0012383.
[60] Tomer Shlomi, Tomer Benyamini, Eyal Gottlieb, Roded Sharan, and Eytan Ruppin. Genome-scale metabolic modeling elucidates the
role of proliferative adaptation in causing the Warburg effect. PLoS Comput. Biol., 7(3):e1002018, March 2011. ISSN 1553-7358.
158
doi: 10.1371/journal.pcbi.1002018. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3053319&tool=
pmcentrez&rendertype=abstract.
[61] Alexei Vazquez and Zolta´n N Oltvai. Molecular crowding defines a common origin for the Warburg effect in proliferating cells and the
lactate threshold in muscle physiology. PLoS One, 6(4):e19538, January 2011. ISSN 1932-6203. doi: 10.1371/journal.pone.0019538.
URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3084886&tool=pmcentrez&rendertype=abstract.
[62] Christian Frezza, Liang Zheng, Ori Folger, Kartik N Rajagopalan, Elaine D MacKenzie, Livnat Jerby, Massimo Micaroni, Barbara Chane-
ton, Julie Adam, Ann Hedley, Gabriela Kalna, Ian P M Tomlinson, Patrick J Pollard, Dave G Watson, Ralph J Deberardinis, Tomer
Shlomi, Eytan Ruppin, and Eyal Gottlieb. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature,
477(7363):225–8, September 2011. ISSN 1476-4687. doi: 10.1038/nature10363. URL http://www.ncbi.nlm.nih.gov/pubmed/
21849978.
[63] Ines Thiele, Neil Swainston, Ronan M T Fleming, Andreas Hoppe, Swagatika Sahoo, Maike K Aurich, Hulda Haraldsdottir, Monica L
Mo, Ottar Rolfsson, Miranda D Stobbe, Stefan G Thorleifsson, Rasmus Agren, Christian Bo¨lling, Sergio Bordel, Arvind K Chavali, Paul
Dobson, Warwick B Dunn, Lukas Endler, David Hala, Michael Hucka, Duncan Hull, Daniel Jameson, Neema Jamshidi, Jon J Jonsson,
Nick Juty, Sarah Keating, Intawat Nookaew, Nicolas Le Nove`re, Naglis Malys, Alexander Mazein, Jason A Papin, Nathan D Price, Anatoly
Sorokin, Johannes H G M Van Beek, Dieter Weichart, Igor Goryanin, and Jens Nielsen. A community-driven global reconstruction of
human metabolism. Nat. Biotechnol., 31(March 2013):1–9, 2013. doi: 10.1038/nbt.2488.
[64] Erwin P Gianchandani, Arvind K Chavali, and Jason A Papin. The application of flux balance analysis in systems biology. 2009. doi:
10.1002/wsbm.060.
[65] Nathan E Lewis, Harish Nagarajan, and Bernhard Ø Palsson. Constraining the metabolic genotype-phenotype relationship using a
phylogeny of in silico methods. Nat. Rev. Microbiol., 10(4):291–305. ISSN 1740-1534. doi: 10.1038/nrmicro2737. URL http:
//www.ncbi.nlm.nih.gov/pubmed/22367118.
[66] Vineet Sangar, James a Eddy, Evangelos Simeonidis, and Nathan D Price. Mechanistic modeling of aberrant energy metabolism in
human disease. Front. Physiol., 3(October):404, January 2012. ISSN 1664-042X. doi: 10.3389/fphys.2012.00404. URL http:
//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3480659&tool=pmcentrez&rendertype=abstract.
[67] Joshua a Lerman, Daniel R Hyduke, Haythem Latif, Vasiliy a Portnoy, Nathan E Lewis, Jeffrey D Orth, Alexandra C Schrimpe-Rutledge,
Richard D Smith, Joshua N Adkins, Karsten Zengler, and Bernhard Ø Palsson. In silico method for modelling metabolism and gene
159
product expression at genome scale. Nat. Commun., 3(may):929, January 2012. ISSN 2041-1723. doi: 10.1038/ncomms1928. URL
http://www.ncbi.nlm.nih.gov/pubmed/22760628.
[68] Jonathan R Karr, Jayodita C Sanghvi, Derek N Macklin, Miriam V Gutschow, Jared M Jacobs, Benjamin Bolival, Nacyra Assad-Garcia,
John I Glass, and Markus W Covert. A whole-cell computational model predicts phenotype from genotype. Cell, 150(2):389–401, July
2012. ISSN 1097-4172. doi: 10.1016/j.cell.2012.05.044. URL http://www.ncbi.nlm.nih.gov/pubmed/22817898.
[69] Keren Yizhak, Tomer Benyamini, Wolfram Liebermeister, Eytan Ruppin, and Tomer Shlomi. Integrating quantitative proteomics
and metabolomics with a genome-scale metabolic network model. Bioinformatics, 26(12):i255–60, June 2010. ISSN 1367-4811.
doi: 10.1093/bioinformatics/btq183. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2881368&tool=
pmcentrez&rendertype=abstract.
[70] Markus J Herrgård, Neil Swainston, Paul Dobson, Warwick B Dunn, K Yalc¸in Arga, Mikko Arvas, Nils Blu¨thgen, Simon Borger, Roe-
land Costenoble, Matthias Heinemann, Michael Hucka, Nicolas Le Nove`re, Peter Li, Wolfram Liebermeister, Monica L Mo, Ana Paula
Oliveira, Dina Petranovic, Stephen Pettifer, Evangelos Simeonidis, Kieran Smallbone, Irena Spasic´, Dieter Weichart, Roger Brent, David S
Broomhead, Hans V Westerhoff, Betu¨l Kirdar, Merja Penttila¨, Edda Klipp, Bernhard Ø Palsson, Uwe Sauer, Stephen G Oliver, Pe-
dro Mendes, Jens Nielsen, and Douglas B Kell. A consensus yeast metabolic network reconstruction obtained from a community
approach to systems biology. Nat. Biotechnol., 26(10):1155–60, October 2008. ISSN 1546-1696. doi: 10.1038/nbt1492. URL
http://www.ncbi.nlm.nih.gov/pubmed/18846089.
[71] Jonathan R Karr, Jayodita C Sanghvi, Derek N Macklin, Abhishek Arora, and Markus W Covert. WholeCellKB: model organism databases
for comprehensive whole-cell models. Nucleic Acids Res., 41(Database issue):D787–92, January 2013. ISSN 1362-4962. doi: 10.1093/
nar/gks1108. URL http://www.ncbi.nlm.nih.gov/pubmed/23175606.
[72] http://kbase.science.energy.gov/ (Accessed March 3 2013).
[73] Stephan Pabinger, Robert Rader, Rasmus Agren, Jens Nielsen, and Zlatko Trajanoski. MEMOSys: Bioinformatics platform for genome-
scale metabolic models. BMC Syst. Biol., 5(1):20, January 2011. ISSN 1752-0509. doi: 10.1186/1752-0509-5-20. URL http://www.
pubmedcentral.nih.gov/articlerender.fcgi?artid=3045322&tool=pmcentrez&rendertype=abstract.
[74] Toma´sˇ Helikar, Bryan Kowal, Sean McClenathan, Mitchell Bruckner, Thaine Rowley, Alex Madrahimov, Ben Wicks, Manish Shrestha,
Kahani Limbu, and Jim a Rogers. The Cell Collective: toward an open and collaborative approach to systems biology. BMC Syst. Biol.,
6:96, January 2012. ISSN 1752-0509. doi: 10.1186/1752-0509-6-96. URL http://www.pubmedcentral.nih.gov/articlerender.
160
fcgi?artid=3443426&tool=pmcentrez&rendertype=abstract.
[75] Lin Xu. Dynamics of epistasis from duplicate genes to genome-wide networks. PhD thesis, Cornell University, Ann Arbor, 2012. URL
http://search.proquest.com/docview/1013994495?accountid=10267.
[76] Patrick C Phillips. Epistasis–the essential role of gene interactions in the structure and evolution of genetic systems. Nat Rev Genet, 9
(11):855–867, November 2008. ISSN 1471-0064. doi: 10.1038/nrg2452. URL http://dx.doi.org/10.1038/nrg2452http://www.
ncbi.nlm.nih.gov/pubmed/18852697.
[77] Charles Boone, Howard Bussey, and Brenda J Andrews. Exploring genetic interactions and networks with yeast. Nat. Rev. Genet., 8(6):
437–49, June 2007. ISSN 1471-0056. doi: 10.1038/nrg2085. URL http://www.ncbi.nlm.nih.gov/pubmed/17510664.
[78] Motoo Kimura and Takeo Maruyama. The mutational load with epistatic gene interactions in fitness. Genetics, 54(6):1337–1351, June
1966. ISSN 00754617. doi: 10.1002/jlac.19666940111. URL http://doi.wiley.com/10.1002/jlac.19666940111.
[79] Michael Costanzo, Anastasia Baryshnikova, Jeremy Bellay, Yungil Kim, Eric D Spear, Carolyn S Sevier, Huiming Ding, Judice L Y
Koh, Kiana Toufighi, Sara Mostafavi, Jeany Prinz, Robert P St Onge, Benjamin VanderSluis, Taras Makhnevych, Franco J Vizeacoumar,
Solmaz Alizadeh, Sondra Bahr, Renee L Brost, Yiqun Chen, Murat Cokol, Raamesh Deshpande, Zhijian Li, Zhen-Yuan Lin, Wendy Liang,
Michaela Marback, Jadine Paw, Bryan-Joseph San Luis, Ermira Shuteriqi, Amy Hin Yan Tong, Nydia van Dyk, Iain M Wallace, Joseph A
Whitney, Matthew T Weirauch, Guoqing Zhong, Hongwei Zhu, Walid A Houry, Michael Brudno, Sasan Ragibizadeh, Bala´zs Papp, Csaba
Pa´l, Frederick P Roth, Guri Giaever, Corey Nislow, Olga G Troyanskaya, Howard Bussey, Gary D Bader, Anne-Claude Gingras, Quaid D
Morris, Philip M Kim, Chris A Kaiser, Chad L Myers, Brenda J Andrews, and Charles Boone. The genetic landscape of a cell. Science, 327
(5964):425–31, 2010. ISSN 1095-9203. doi: 10.1126/science.1180823. URL http://www.ncbi.nlm.nih.gov/pubmed/20093466.
[80] Amy Hin Yan Tong, Guillaume Lesage, Gary D Bader, Huiming Ding, Hong Xu, Xiaofeng Xin, James Young, Gabriel F Berriz, Renee L
Brost, Michael Chang, YiQun Chen, Xin Cheng, Gordon Chua, Helena Friesen, Debra S Goldberg, Jennifer Haynes, Christine Humphries,
Grace He, Shamiza Hussein, Lizhu Ke, Nevan Krogan, Zhijian Li, Joshua N Levinson, Hong Lu, Patrice Me´nard, Christella Munyana,
Ainslie B Parsons, Owen Ryan, Raffi Tonikian, Tania Roberts, Anne-Marie Sdicu, Jesse Shapiro, Bilal Sheikh, Bernhard Suter, Sharyl L
Wong, Lan V Zhang, Hongwei Zhu, Christopher G Burd, Sean Munro, Chris Sander, Jasper Rine, Jack Greenblatt, Matthias Peter, Anthony
Bretscher, Graham Bell, Frederick P Roth, Grant W Brown, Brenda Andrews, Howard Bussey, and Charles Boone. Global Mapping
of the Yeast Genetic Interaction Network. Science (80-. )., 303(5659):808–813, February 2004. doi: 10.1126/science.1091317. URL
http://www.sciencemag.org/content/303/5659/808.abstract.
161
[81] Xuewen Pan, Daniel S. Yuan, Dong Xiang, Xiaoling Wang, Sharon Sookhai-Mahadeo, Joel S. Bader, Philip Hieter, Forrest Spencer,
and Jef D. Boeke. A robust toolkit for functional profiling of the yeast genome. Mol. Cell, 16:487–496, 2004. ISSN 10972765. doi:
10.1016/j.molcel.2004.09.035.
[82] Xuewen Pan, Ping Ye, Daniel S. Yuan, Xiaoling Wang, Joel S. Bader, and Jef D. Boeke. A DNA integrity network in the yeast Saccha-
romyces cerevisiae. Cell, 124:1069–1081, 2006. ISSN 00928674. doi: 10.1016/j.cell.2005.12.036.
[83] V Measday and P Hieter. Synthetic dosage lethality. In Guid. TO YEAST Genet. Mol. CELL Biol. PT B, volume 350 of METHODS IN
ENZYMOLOGY, pages 316–326. ACADEMIC PRESS INC, 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA, 2002.
[84] Vivien Measday, Kristin Baetz, Julie Guzzo, Karen Yuen, Teresa Kwok, Bilal Sheikh, Huiming Ding, Ryo Ueta, Trinh Hoac, Benjamin
Cheng, Isabelle Pot, Amy Tong, Yuko Yamaguchi-Iwai, Charles Boone, Phil Hieter, and Brenda Andrews. Systematic yeast synthetic lethal
and synthetic dosage lethal screens identify genes required for chromosome segregation. Proc. Natl. Acad. Sci. U. S. A., 102:13956–13961,
2005. ISSN 0027-8424. doi: 10.1073/pnas.0503504102.
[85] Richelle Sopko, Dongqing Huang, Nicolle Preston, Gordon Chua, Bala´zs Papp, Kimberly Kafadar, Mike Snyder, Stephen G. Oliver, Martha
Cyert, Timothy R. Hughes, Charles Boone, and Brenda Andrews. Mapping pathways and phenotypes by systematic gene overexpression.
Mol. Cell, 21:319–330, 2006. ISSN 10972765. doi: 10.1016/j.molcel.2005.12.011.
[86] Sean R Collins, Kyle M Miller, Nancy L Maas, Assen Roguev, Jeffrey Fillingham, Clement S Chu, Maya Schuldiner, Marinella Gebbia,
Judith Recht, Michael Shales, Huiming Ding, Hong Xu, Junhong Han, Kristin Ingvarsdottir, Benjamin Cheng, Brenda Andrews, Charles
Boone, Shelley L Berger, Phil Hieter, Zhiguo Zhang, Grant W Brown, C James Ingles, Andrew Emili, C David Allis, David P Toczyski,
Jonathan S Weissman, Jack F Greenblatt, and Nevan J Krogan. Functional dissection of protein complexes involved in yeast chromosome
biology using a genetic interaction map. Nature, 446:806–810, 2007. ISSN 0028-0836. doi: 10.1038/nature05649.
[87] Benoıˆt Kornmann, Erin Currie, Sean R Collins, Maya Schuldiner, Jodi Nunnari, Jonathan S Weissman, and Peter Walter. An ER-
mitochondria tethering complex revealed by a synthetic biology screen. Science, 325:477–481, 2009. ISSN 0036-8075. doi:
10.1126/science.1175088.
[88] Dorothea Fiedler, Hannes Braberg, Monika Mehta, Gal Chechik, Gerard Cagney, Paromita Mukherjee, Andrea C Silva, Michael Shales,
Sean R Collins, Sake van Wageningen, Patrick Kemmeren, Frank C P Holstege, Jonathan S Weissman, Michael-Christopher Keogh, Daphne
Koller, Kevan M Shokat, and Nevan J Krogan. Functional organization of the S. cerevisiae phosphorylation network. Cell, 136(5):952–63,
2009. ISSN 1097-4172. doi: 10.1016/j.cell.2008.12.039. URL http://www.ncbi.nlm.nih.gov/pubmed/19269370.
162
[89] Sebastian Bonhoeffer, Colombe Chappey, Neil T Parkin, Jeanette M Whitcomb, and Christos J Petropoulos. Evidence for positive epistasis
in HIV-1. Science, 306:1547–1550, 2004. ISSN 0036-8075. doi: 10.1126/science.1101786.
[90] Assen Roguev, Sourav Bandyopadhyay, Martin Zofall, Ke Zhang, Tamas Fischer, Sean R Collins, Hongjing Qu, Michael Shales, Han-
Oh Park, Jacqueline Hayles, Kwang-Lae Hoe, Dong-Uk Kim, Trey Ideker, Shiv I Grewal, Jonathan S Weissman, and Nevan J Krogan.
Conservation and rewiring of functional modules revealed by an epistasis map in fission yeast. Science, 322:405–410, 2008. ISSN 0036-
8075. doi: 10.1126/science.1162609.
[91] Monica L Mo, Bernhard Ø Palsson, and Markus J Herrgård. Connecting extracellular metabolomic measurements to intracellular flux
states in yeast. BMC Syst. Biol., 3(1):37, 2009. ISSN 1752-0509. doi: 10.1186/1752-0509-3-37. URL http://www.biomedcentral.
com/1752-0509/3/37.
[92] Scott A Becker, Adam M Feist, Monica L Mo, Gregory Hannum, Bernhard Ø Palsson, and Markus J Herrgård. Quantitative prediction
of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat. Protoc., 2(3):727–38, 2007. ISSN 1750-2799. doi:
10.1038/nprot.2007.99. URL http://www.ncbi.nlm.nih.gov/pubmed/17406635.
[93] Bala´zs Papp, Csaba Pa´l, and Laurence D Hurst. Metabolic network analysis of the causes and evolution of enzyme dispensability in yeast.
Nature, 429(6992):661–4, June 2004. ISSN 1476-4687. doi: 10.1038/nature02636. URL http://www.ncbi.nlm.nih.gov/pubmed/
15190353.
[94] Rafael U Ibarra, Jeremy S Edwards, and Bernhard Ø Palsson. Escherichia coli K-12 undergoes adaptive evolution to achieve in sil-
ico predicted optimal growth. Nature, 420(6912):186–189, November 2002. ISSN 0028-0836. URL http://dx.doi.org/10.1038/
nature01149.
[95] Richard Harrison, Bala´zs Papp, Csaba Pa´l, Stephen G Oliver, and Daniela Delneri. Plasticity of genetic interactions in metabolic networks
of yeast. Proc. Natl. Acad. Sci. U. S. A., 104(7):2307–12, February 2007. ISSN 0027-8424. doi: 10.1073/pnas.0607153104. URL
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1892960&tool=pmcentrez&rendertype=abstract.
[96] David Deutscher, Isaac Meilijson, Martin Kupiec, and Eytan Ruppin. Multiple knockout analysis of genetic robustness in the yeast
metabolic network. Nat. Genet., 38(9):993–8, September 2006. ISSN 1061-4036. doi: 10.1038/ng1856. URL http://www.ncbi.nlm.
nih.gov/pubmed/16941010.
163
[97] Daniel Segre`, Alexander Deluna, George M Church, and Roy Kishony. Modular epistasis in yeast metabolism. Nat. Genet., 37(1):77–83,
January 2005. ISSN 1061-4036. doi: 10.1038/ng1489. URL http://www.ncbi.nlm.nih.gov/pubmed/15592468.
[98] J S Edwards, R U Ibarra, and B Ø Palsson. In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental
data. Nat. Biotechnol., 19:125–130, 2001. ISSN 1087-0156. doi: 10.1038/84379.
[99] Manal AbuOun, Patrick F Suthers, Gareth I Jones, Ben R Carter, Mark P Saunders, Costas D Maranas, Martin J Woodward, and Muna F
Anjum. Genome scale reconstruction of a Salmonella metabolic model: comparison of similarity and differences with a commensal
Escherichia coli strain. J. Biol. Chem., 284:29480–29488, 2009. ISSN 0021-9258. doi: 10.1074/jbc.M109.005868.
[100] Maxime Durot, Pierre-Yves Bourguignon, and Vincent Schachter. Genome-scale models of bacterial metabolism: reconstruction and
applications. FEMS Microbiol. Rev., 33:164–190, 2009. ISSN 0168-6445. doi: 10.1111/j.1574-6976.2008.00146.x.
[101] Adam M Feist and Bernhard Ø Palsson. The growing scope of applications of genome-scale metabolic reconstructions using Escherichia
coli. Nat. Biotechnol., 26:659–667, 2008. ISSN 1087-0156. doi: 10.1038/nbt1401.
[102] Stephen S Fong, Anthony P Burgard, Christopher D Herring, Eric M Knight, Frederick R Blattner, Costas D Maranas, and Bernhard Ø
Palsson. In silico design and adaptive evolution of Escherichia coli for production of lactic acid. Biotechnol. Bioeng., 91:643–648, 2005.
ISSN 0006-3592. doi: 10.1002/bit.20542.
[103] Stephen S Fong, Andrew R Joyce, and Bernhard Ø Palsson. Parallel adaptive evolution cultures of Escherichia coli lead to convergent
growth phenotypes with different gene expression states. Genome Res., 15(10):1365–72, October 2005. ISSN 1088-9051. doi: 10.1101/gr.
3832305. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1240078&tool=pmcentrez&rendertype=
abstract.
[104] Christina L Burch and Lin Chao. Epistasis and its relationship to canalization in the RNA virus phi 6. Genetics, 167:559–567, 2004. ISSN
0016-6731. doi: 10.1534/genetics.103.021196.
[105] Lingchong You and John Yin. Dependence of epistasis on environment and mutation severity as revealed by in silico mutagenesis of phage
t7. Genetics, 160:1273–1281, 2002. ISSN 0016-6731.
[106] Rafael Sanjua´n. Quantifying antagonistic epistasis in a multifunctional RNA secondary structure of the Rous sarcoma virus. J. Gen. Virol.,
164
87:1595–1602, 2006. ISSN 0022-1317. doi: 10.1099/vir.0.81585-0.
[107] Ricardo B R Azevedo, Rolf Lohaus, Suraj Srinivasan, Kristen K Dang, and Christina L Burch. Sexual reproduction selects for robustness
and negative epistasis in artificial gene networks. Nature, 440(7080):87–90, March 2006. ISSN 1476-4687. doi: 10.1038/nature04488.
URL http://www.ncbi.nlm.nih.gov/pubmed/16511495.
[108] Rolf Lohaus, Christina L Burch, and Ricardo B R Azevedo. Genetic architecture and the evolution of sex. J. Hered., 101 Suppl:S142–57,
2010. ISSN 1465-7333. doi: 10.1093/jhered/esq013. URL http://www.ncbi.nlm.nih.gov/pubmed/20421324.
[109] Adam M Feist, Christopher S Henry, Jennifer L Reed, Markus Krummenacker, Andrew R Joyce, Peter D Karp, Linda J Broadbelt, Vassily
Hatzimanikatis, and Bernhard Ø Palsson. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for
1260 ORFs and thermodynamic information. Mol. Syst. Biol., 3(121):121, January 2007. ISSN 1744-4292. doi: 10.1038/msb4100155.
URL http://www.ncbi.nlm.nih.gov/pubmed/17593909.
[110] Ines Thiele, Daniel R Hyduke, Benjamin Steeb, Guy Fankam, Douglas K Allen, Susanna Bazzani, Pep Charusanti, Feng-Chi Chen,
Ronan M T Fleming, Chao A Hsiung, Sigrid C J De Keersmaecker, Yu-Chieh Liao, Kathleen Marchal, Monica L Mo, Emre O¨zdemir,
Anu Raghunathan, Jennifer L Reed, Sook-il Shin, Sara Sigurbjo¨rnsdo´ttir, Jonas Steinmann, Suresh Sudarsan, Neil Swainston, Inge M
Thijs, Karsten Zengler, Bernhard Ø Palsson, Joshua N Adkins, and Dirk Bumann. A community effort towards a knowledge-base and
mathematical model of the human pathogen Salmonella Typhimurium LT2. BMC Syst. Biol., 5:8, 2011. ISSN 1752-0509. doi: 10.1186/
1752-0509-5-8.
[111] Ines Thiele, Thuy D Vo, Nathan D Price, and Bernhard Ø Palsson. Expanded metabolic reconstruction of Helicobacter pylori (iIT341
GSM/GPR): an in silico genome-scale characterization of single- and double-deletion mutants. J. Bacteriol., 187:5818–5830, 2005. ISSN
0021-9193. doi: 10.1128/JB.187.16.5818-5830.2005.
[112] Adam M Feist, Johannes C M Scholten, Bernhard Ø Palsson, Fred J Brockman, and Trey Ideker. Modeling methanogenesis with a
genome-scale metabolic reconstruction of Methanosarcina barkeri. Mol. Syst. Biol., 2:2006.0004, 2006. ISSN 1744-4292. doi: 10.1038/
msb4100046.
[113] Germa´n Plata, Tzu-Lin Hsiao, Kellen L Olszewski, Manuel Llina´s, and Dennis Vitkup. Reconstruction and flux-balance analysis of the
Plasmodium falciparum metabolic network. Mol. Syst. Biol., 6:408, 2010. ISSN 1744-4292. doi: 10.1038/msb.2010.60.
165
[114] Rafael Sanjua´n and Santiago F Elena. Epistasis correlates to genomic complexity. Proc. Natl. Acad. Sci. U. S. A., 103(39):14402–5,
September 2006. ISSN 0027-8424. doi: 10.1073/pnas.0604543103. URL http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=1599975&tool=pmcentrez&rendertype=abstract.
[115] Rafael Sanjua´n and Miguel R. Nebot. A network model for the correlation between epistasis and genomic complexity. PLoS One, 3, 2008.
ISSN 19326203. doi: 10.1371/journal.pone.0002663.
[116] A S Kondrashov. Deleterious mutations and the evolution of sexual reproduction. Nature, 336:435–440, 1988. ISSN 0028-0836. doi:
10.1038/336435a0.
[117] Sarah P Otto. Unravelling the evolutionary advantage of sex: a commentary on ’Mutation-selection balance and the evolutionary ad-
vantage of sex and recombination’ by Brian Charlesworth. Genet. Res., 89(5-6):447–9, December 2007. ISSN 1469-5073. doi:
10.1017/S001667230800966X. URL http://www.ncbi.nlm.nih.gov/pubmed/18976534.
[118] J Arjan G M de Visser and Santiago F Elena. The evolution of sex: empirical insights into the roles of epistasis and drift. Nat. Rev. Genet.,
8:139–149, 2007. ISSN 1471-0056. doi: 10.1038/nrg1985.
[119] Roger D Kouyos, Olin K Silander, and Sebastian Bonhoeffer. Epistasis between deleterious mutations and the evolution of recombination.
Trends Ecol. Evol., 22(6):308–15, June 2007. ISSN 0169-5347. doi: 10.1016/j.tree.2007.02.014. URL http://www.ncbi.nlm.nih.
gov/pubmed/17337087.
[120] Bala´zs Szappanos, Ka´roly Kova´cs, Be´la Szamecz, Frantisek Honti, Michael Costanzo, Anastasia Baryshnikova, Gabriel Gelius-Dietrich,
Martin J Lercher, Ma´rk Jelasity, Chad L Myers, Brenda J Andrews, Charles Boone, Stephen G Oliver, Csaba Pa´l, and Bala´zs Papp. An
integrated approach to characterize genetic interaction networks in yeast metabolism. Nat. Genet., 43(May):656–662, May 2011. ISSN
1546-1718. doi: 10.1038/ng.846. URL http://www.ncbi.nlm.nih.gov/pubmed/21623372.
[121] Scott Banta, Murali Vemula, Tadaaki Yokoyama, Arul Jayaraman, Franc¸ois Berthiaume, and Martin L Yarmush. Contribution of gene
expression to metabolic fluxes in hypermetabolic livers induced through burn injury and cecal ligation and puncture in rats. Biotechnol.
Bioeng., 97:118–137, 2007. ISSN 1559-047X. doi: 10.1097/01253092-200603001-00230.
[122] Daniel L Hartl and Andrew G Clark. Principles of Population Genetics. Sinauer Associates, Inc., Sinauer, Sunderland, MA, 4th edition,
2007. ISBN 0878933085.
166
[123] Alexey S Kondrashov. Selection against harmful mutations in large sexual and asexual populations. Genet. Res. (Camb)., 40(03):325–332,
1982.
[124] Daven C Presgraves. Speciation Genetics: Epistasis, Conflict and the Origin of Species. Curr. Biol., 17(4):R125–R127, July 2007. doi:
10.1016/j.cub.2006.12.030. URL http://www.cell.com/current-biology/abstract/S0960-9822(06)02664-9.
[125] Thomas F Hansen and Gu¨nter P Wagner. Epistasis and the Mutation Load: A Measurement-Theoretical Approach. Genet., 158(1):477–485,
May 2001. URL http://www.genetics.org/content/158/1/477.abstract.
[126] Gabriel Musso, Michael Costanzo, ManQin Huangfu, Andrew M Smith, Jadine Paw, Bryan-Joseph San Luis, Charles Boone, Guri Giaever,
Corey Nislow, Andrew Emili, and Zhaolei Zhang. The extensive and condition-dependent nature of epistasis among whole-genome dupli-
cates in yeast. Genome Res., 18(7):1092–1099, July 2008. doi: 10.1101/gr.076174.108. URL http://genome.cshlp.org/content/
18/7/1092.abstract.
[127] Lin Xu, Huifeng Jiang, Hong Chen, and Zhenglong Gu. Genetic Architecture of Growth Traits Revealed by Global Epistatic Interactions.
Genome Biol. Evol., 3:909–914, January 2011. doi: 10.1093/gbe/evr065. URL http://gbe.oxfordjournals.org/content/3/909.
abstract.
[128] Andre´s Pe´rez-Figueroa, Armando Caballero, Aurora Garcı´a-Dorado, and Carlos Lo´pez-Fanjul. The Action of Purifying Selection, Mutation
and Drift on Fitness Epistatic Systems. Genet., 183(1):299–313, September 2009. doi: 10.1534/genetics.109.104893. URL http:
//www.genetics.org/content/183/1/299.abstract.
[129] Sandra Trindade, Ana Sousa, Karina Bivar Xavier, Francisco Dionisio, Miguel Godinho Ferreira, and Isabel Gordo. Positive Epistasis
Drives the Acquisition of Multidrug Resistance. PLoS Genet, 5(7):e1000578, July 2009. URL http://dx.doi.org/10.1371/journal.
pgen.1000578.
[130] Susanna K Remold and Richard E Lenski. Contribution of individual random mutations to genotype-by-environment interactions in
Escherichia coli. Proc. Natl. Acad. Sci., 98(20):11388–11393, September 2001. doi: 10.1073/pnas.201140198. URL http://www.pnas.
org/content/98/20/11388.abstract.
[131] Roy Kishony and Stanislas Leibler. Environmental stresses can alleviate the average deleterious effect of mutations. J. Biol., 2(2):14, 2003.
ISSN 1475-4924. URL http://jbiol.com/content/2/2/14.
167
[132] Tim F Cooper, Richard E Lenski, and Santiago F Elena. Parasites and mutational load: an experimental test of a pluralistic theory for the
evolution of sex. Proc. Biol. Sci., 272:311–317, 2005. ISSN 0962-8452. doi: 10.1098/rspb.2004.2975.
[133] Ryszard Korona. Genetic Load of the Yeast Saccharomyces cerevisiae under Diverse Environmental Conditions. Evolution (N. Y)., 53(6):
1966–1971, December 1999. ISSN 00143820. doi: 10.2307/2640455. URL http://www.jstor.org/stable/2640455.
[134] Krzysztof Szafraniec, Rhona H Borts, and Ryszard Korona. Environmental stress and mutational load in diploid strains of the yeast
Saccharomyces cerevisiae. Proc. Natl. Acad. Sci., 98(3):1107–1112, January 2001. doi: 10.1073/pnas.98.3.1107. URL http://www.
pnas.org/content/98/3/1107.abstract.
[135] Lukasz Jasnos, Katarzyna Tomala, Dorota Paczesniak, and Ryszard Korona. Interactions Between Stressful Environment and Gene Dele-
tions Alleviate the Expected Average Loss of Fitness in Yeast. Genet., 178(4):2105–2111, April 2008. doi: 10.1534/genetics.107.084533.
URL http://www.genetics.org/content/178/4/2105.abstract.
[136] Larissa L Vassilieva, Aaron M Hook, and Michael Lynch. THE FITNESS EFFECTS OF SPONTANEOUS MUTATIONS IN
CAENORHABDITIS ELEGANS. Evolution (N. Y)., 54(4):1234–1246, August 2000. ISSN 1558-5646. doi: 10.1111/j.0014-3820.
2000.tb00557.x. URL http://dx.doi.org/10.1111/j.0014-3820.2000.tb00557.x.
[137] Charles F Baer, Naomi Phillips, Dejerianne Ostrow, Aria´n Avalos, Dustin Blanton, Ashley Boggs, Thomas Keller, Laura Levy, and Edward
Mezerhane. Cumulative Effects of Spontaneous Mutations for Fitness in Caenorhabditis: Role of Genotype, Environment and Stress.
Genet., 174(3):1387–1395, November 2006. doi: 10.1534/genetics.106.061200. URL http://www.genetics.org/content/174/3/
1387.abstract.
[138] Hsiao-Pei Yang, Ana Y Tanikawa, Wayne A Van Voorhies, Joana C Silva, and Alexey S Kondrashov. Whole-Genome Effects of Ethyl
Methanesulfonate-Induced Mutation on Nine Quantitative Traits in Outbred Drosophila melanogaster. Genet., 157(3):1257–1265, March
2001. URL http://www.genetics.org/content/157/3/1257.abstract.
[139] James D Fry and Stefanie L Heinsohn. Environment Dependence of Mutational Parameters for Viability in Drosophila melanogaster.
Genet., 161(3):1155–1167, July 2002. URL http://www.genetics.org/content/161/3/1155.abstract.
[140] Alethea D Wang, Nathaniel P Sharp, Christine C Spencer, Katherine Tedman-Aucoin, and Aneil F Agrawal. Selection, Epistasis, and
ParentofOrigin Effects on Deleterious Mutations across Environments in Drosophila melanogaster. Am. Nat., 174(6):863–874, December
168
2009. ISSN 00030147. doi: 10.1086/645088. URL http://www.jstor.org/stable/10.1086/645088.
[141] Jadene A Young, Christopher P Yourth, and Aneil F Agrawal. The effect of pathogens on selection against deleterious mutations in
Drosophila melanogaster. J. Evol. Biol., 22(10):2125–2129, October 2009. ISSN 1420-9101. doi: 10.1111/j.1420-9101.2009.01830.x.
URL http://dx.doi.org/10.1111/j.1420-9101.2009.01830.x.
[142] Sourav Bandyopadhyay. Rewiring of Genetic Networks in Response to DNA Damage. Science (80-. )., 1385(2010), 2011. doi: 10.1126/
science.1195618.
[143] Agata Jakubowska and Ryszard Korona. Epistasis for Growth Rate and Total Metabolic Flux in Yeast. PLoS One, 7(3):e33132, March
2012. URL http://dx.doi.org/10.1371/journal.pone.0033132.
[144] Dennis P Wall, Aaron E Hirsh, Hunter B Fraser, Jochen Kumm, Guri Giaever, Michael B Eisen, and Marcus W Feldman. Functional
genomic analysis of the rates of protein evolution. Proc. Natl. Acad. Sci. United States Am., 102(15):5483–5488, April 2005. doi:
10.1073/pnas.0501761102. URL http://www.pnas.org/content/102/15/5483.abstract.
[145] Ben Lehner. Molecular mechanisms of epistasis within and between genes. Trends Genet., 27(8):323–331, July 2011. doi: 10.1016/j.tig.
2011.05.007. URL http://www.cell.com/trends/genetics/abstract/S0168-9525(11)00077-1.
[146] Aneil F Agrawal and Michael C Whitlock. Environmental duress and epistasis: how does stress affect the strength of selection on new
mutations? Trends Ecol. Evol., 25(8):450–8, August 2010. ISSN 0169-5347. doi: 10.1016/j.tree.2010.05.003. URL http://www.ncbi.
nlm.nih.gov/pubmed/20538366.
[147] M Olivia Casanueva, Alejandro Burga, and Ben Lehner. Fitness Trade-Offs and Environmentally Induced Mutation Buffering in Isogenic
C. elegans. Sci., 335(6064):82–85, January 2012. doi: 10.1126/science.1213491. URL http://www.sciencemag.org/content/335/
6064/82.abstract.
[148] Anthony P Burgard, Priti Pharkya, and Costas D Maranas. Optknock: A bilevel programming framework for identifying gene knockout
strategies for microbial strain optimization. Biotechnol. Bioeng., 84(6):647–657, December 2003. ISSN 1097-0290. doi: 10.1002/bit.10803.
URL http://dx.doi.org/10.1002/bit.10803.
[149] Kiran Patil, Isabel Rocha, Jochen Forster, and Jens Nielsen. Evolutionary programming as a platform for in silico metabolic engineering.
169
BMC Bioinformatics, 6(1):308, 2005. ISSN 1471-2105. URL http://www.biomedcentral.com/1471-2105/6/308.
[150] Sean P. Cornelius, William L. Kath, and Adilson E. Motter. Controlling Complex Networks with Compensatory Perturbations. May 2011.
URL http://arxiv.org/abs/1105.3726.
[151] Ana Rita Brochado, Sergej Andrejev, Costas D Maranas, and Kiran R Patil. Impact of Stoichiometry Representation on Simulation of
Genotype-Phenotype Relationships in Metabolic Networks. PLoS Comput Biol, 8(11):e1002758, November 2012. URL http://dx.
doi.org/10.1371/journal.pcbi.1002758.
[152] Jan Schellenberger, Richard Que, Ronan M T Fleming, Ines Thiele, Jeffrey D Orth, Adam M Feist, Daniel C Zielinski, Aarash Bord-
bar, Nathan E Lewis, Sorena Rahmanian, Joseph Kang, Daniel R Hyduke, and Bernhard O Palsson. Quantitative prediction of cellular
metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat. Protoc., 6(9):1290–1307, September 2011. ISSN 1754-2189.
URL http://dx.doi.org/10.1038/nprot.2011.308http://www.nature.com/nprot/journal/v6/n9/abs/nprot.2011.308.
html#supplementary-information.
[153] Albert-Laszlo Barabasi and Zoltan N Oltvai. Network biology: understanding the cell’s functional organization. Nat Rev Genet, 5(2):
101–113, February 2004. ISSN 1471-0056. URL http://dx.doi.org/10.1038/nrg1272.
[154] Nathan E Lewis, Harish Nagarajan, and Bernhard Ø Palsson. Constraining the metabolic genotype-phenotype relationship using a phy-
logeny of in silico methods. Nat. Rev. Microbiol., 10(4):291–305, April 2012. ISSN 1740-1534. doi: 10.1038/nrmicro2737. URL
http://www.ncbi.nlm.nih.gov/pubmed/22367118.
[155] Sergej Pirkmajer and Alexander V Chibalin. Serum starvation: caveat emptor. Am. J. Physiol. Cell Physiol., 301(2):C272–C279, July
2011. URL http://ajpcell.physiology.org/highwire/citation/1105/mendeley.
[156] Anna S Blazier and Jason a Papin. Integration of expression data in genome-scale metabolic network reconstructions. Front. Phys-
iol., 3(August):299, January 2012. ISSN 1664-042X. doi: 10.3389/fphys.2012.00299. URL http://www.pubmedcentral.nih.gov/
articlerender.fcgi?artid=3429070&tool=pmcentrez&rendertype=abstract.
[157] Daniel Segre`, Dennis Vitkup, and George M Church. Analysis of optimality in natural and perturbed metabolic networks. Proc. Natl. Acad.
Sci. U. S. A., 99(23):15112–7, November 2002. ISSN 0027-8424. doi: 10.1073/pnas.232349399. URL http://www.pubmedcentral.
nih.gov/articlerender.fcgi?artid=137552&tool=pmcentrez&rendertype=abstract.
170
[158] Stephen Boyd and Lieven Vandenberghe. Convex Optimization. Cambridge University Press, New York, 2004. ISBN 978-0-521-83378-3.
URL http://www.stanford.edu/˜boyd/cvxbook/.
[159] Christoph Ju¨schke, Ilse Dohnal, Peter Pichler, Heike Harzer, Remco Swart, Gustav Ammerer, Karl Mechtler, and Juergen A Knoblich.
Transcriptome and proteome quantification of a tumor model provides novel insights into post-transcriptional gene regulation. Genome
Biol., 14(11):1–33, 2013. ISSN 1465-6906. doi: 10.1186/gb-2013-14-11-r133. URL http://genomebiology.com/2013/14/11/R133.
[160] Stuart Russell and Peter Norvig. Artificial Intelligence: A Modern Approach, 3rd edition. Prentice Hall, 2009. ISSN
0269-8889. doi: 10.1017/S0269888900007724. URL http://portal.acm.org/citation.cfm?id=1671238&coll=
DL&dl=GUIDE&CFID=190864501&CFTOKEN=29051579$\delimiter"026E30F$npapers2://publication/uuid/
4B787E16-89F6-4FF7-A5E5-E59F3CFEFE88.
[161] Jeffrey D Orth, Tom M Conrad, Jessica Na, Joshua a Lerman, Hojung Nam, Adam M Feist, and Bernhard Ø Palsson. A comprehensive
genome-scale reconstruction of Escherichia coli metabolism2011. Mol. Syst. Biol., 7(535):1–9, October 2011. ISSN 1744-4292. doi:
10.1038/msb.2011.65. URL http://www.nature.com/doifinder/10.1038/msb.2011.65.
[162] Hnin W Aung, Susan A Henry, and Larry P Walker. Revising the Representation of Fatty Acid, Glycerolipid, and Glycerophospholipid
Metabolism in the Consensus Model of Yeast Metabolism. Ind. Biotechnol., 9(4):215–228, August 2013. ISSN 1550-9087. doi: 10.1089/
ind.2013.0013. URL http://online.liebertpub.com/doi/abs/10.1089/ind.2013.0013.
[163] Paola Picotti, Mathieu Clement-Ziza, Henry Lam, David S Campbell, Alexander Schmidt, Eric W Deutsch, Hannes Rost, Zhi Sun, Oliver
Rinner, Lukas Reiter, Qin Shen, Jacob J Michaelson, Andreas Frei, Simon Alberti, Ulrike Kusebauch, Bernd Wollscheid, Robert L
Moritz, Andreas Beyer, and Ruedi Aebersold. A complete mass-spectrometric map of the yeast proteome applied to quantitative trait
analysis. Nature, 494(7436):266–270, February 2013. ISSN 0028-0836. URL http://dx.doi.org/10.1038/nature11835http:
//www.nature.com/nature/journal/v494/n7436/abs/nature11835.html#supplementary-information.
[164] Amin Moghaddas Gholami, Hannes Hahne, Zhixiang Wu, Florian Johann Auer, Chen Meng, Mathias Wilhelm, and Bernhard Kuster.
Global Proteome Analysis of the NCI-60 Cell Line Panel. Cell Rep., 4(3):609–620, August 2013. URL http://linkinghub.elsevier.
com/retrieve/pii/S221112471300380X.
[165] Benjamin D Heavner, Kieran Smallbone, Brandon Barker, Pedro Mendes, and Larry P Walker. Yeast 5 - an expanded reconstruction of the
Saccharomyces cerevisiae metabolic network. BMC Syst. Biol., 6(1):55, January 2012. ISSN 1752-0509. doi: 10.1186/1752-0509-6-55.
URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3413506&tool=pmcentrez&rendertype=abstract.
171
[166] Bryson D Bennett, Elizabeth H Kimball, Melissa Gao, Robin Osterhout, Stephen J Van Dien, and Joshua D Rabinowitz. Absolute metabolite
concentrations and implied enzyme active site occupancy in Escherichia coli. Nat. Chem. Biol., 5(8):593–599, August 2009. ISSN
1552-4450. URL http://dx.doi.org/10.1038/nchembio.186http://www.nature.com/nchembio/journal/v5/n8/suppinfo/
nchembio.186_S1.html.
[167] Victor Chubukov, Markus Uhr, Ludovic Le Chat, Roelco J Kleijn, Matthieu Jules, Hannes Link, Stephane Aymerich, Jorg Stelling, and
Uwe Sauer. Transcriptional regulation is insufficient to explain substrate-induced flux changes in Bacillus subtilis. Mol. Syst. Biol., 9,
November 2013. URL http://dx.doi.org/10.1038/msb.2013.6610.1038/msb.2013.66.
[168] Jennifer L Reed, Trina R Patel, Keri H Chen, Andrew R Joyce, Margaret K Applebee, Christopher D Herring, Olivia T Bui, Eric M Knight,
Stephen S Fong, and Bernhard Ø Palsson. Systems approach to refining genome annotation. Proc. Natl. Acad. Sci., 103(46):17480–17484,
2006. doi: 10.1073/pnas.0603364103. URL http://www.pnas.org/content/103/46/17480.abstract.
[169] Koyel Mitra, Anne-Ruxandra Carvunis, Sanath Kumar Ramesh, and Trey Ideker. Integrative approaches for finding
modular structure in biological networks. Nat. Rev. Genet., 14(10):719–732, October 2013. ISSN 1471-0056. URL
http://dx.doi.org/10.1038/nrg355210.1038/nrg3552http://www.nature.com/nrg/journal/v14/n10/abs/nrg3552.
html#supplementary-information.
[170] Germa´n Plata, Tobias Fuhrer, Tzu-Lin Hsiao, Uwe Sauer, and Dennis Vitkup. Global probabilistic annotation of metabolic networks enables
enzyme discovery. Nat. Chem. Biol., 8(10):848–854, October 2012. ISSN 1552-4450. URL http://dx.doi.org/10.1038/nchembio.
1063http://www.nature.com/nchembio/journal/v8/n10/abs/nchembio.1063.html#supplementary-information.
[171] Motoo Kimura. The neutral theory of molecular evolution and the world view of the neutralists. Genome, 31(1):24–31, January 1989.
ISSN 0831-2796. doi: 10.1139/g89-009. URL http://dx.doi.org/10.1139/g89-009.
[172] H Allen Orr. The Distribution of Fitness Effects Among Beneficial Mutations. Genetics, 163(4):1519–1526, April 2003. URL http:
//www.genetics.org/content/163/4/1519.abstract.
[173] Hsin-Hung Chou, Hsuan-Chao Chiu, Nigel F Delaney, Daniel Segre`, and Christopher J Marx. Diminishing returns epistasis among
beneficial mutations decelerates adaptation. Science, 332(6034):1190–2, June 2011. ISSN 1095-9203. doi: 10.1126/science.1203799.
URL http://www.ncbi.nlm.nih.gov/pubmed/21636771.
172
[174] Daniel M Weinreich, Nigel F Delaney, Mark A Depristo, and Daniel L Hartl. Darwinian Evolution Can Follow Only Very Few Mutational
Paths to Fitter Proteins. Science (80-. )., 312(7):111–114, 2006.
[175] Zhenyu Xu, Wu Wei, Julien Gagneur, Fabiana Perocchi, Sandra Clauder-Munster, Jurgi Camblong, Elisa Guffanti, Francoise Stutz, Wolf-
gang Huber, and Lars M Steinmetz. Bidirectional promoters generate pervasive transcription in yeast. Nature, 457(7232):1033–1037,
February 2009. ISSN 0028-0836. URL http://dx.doi.org/10.1038/nature07728http://www.nature.com/nature/journal/
v457/n7232/suppinfo/nature07728_S1.html.
[176] Joo Sang Lee, Takashi Nishikawa, and Adilson E Motter. Why optimal states recruit fewer reactions in metabolic networks. Discret.
Contin. Dyn. Syst. - Ser. A, 32(8):2937 – 2950, 2012. doi: 10.3934/dcds.2012.32.2937.
[177] Frank J Poelwijk, Daniel J Kiviet, Daniel M Weinreich, and Sander J Tans. Empirical fitness landscapes reveal accessible evolutionary
paths. Nature, 445(7126):383–386, January 2007. ISSN 0028-0836. URL http://dx.doi.org/10.1038/nature05451.
[178] Aisha I Khan, Duy M Dinh, Dominique Schneider, Richard E Lenski, and Tim F Cooper. Negative epistasis between beneficial mutations
in an evolving bacterial population. Science, 332(6034):1193–6, June 2011. ISSN 1095-9203. doi: 10.1126/science.1203801. URL
http://www.ncbi.nlm.nih.gov/pubmed/21636772.
[179] Mark Lunzer, Stephen P Miller, Roderick Felsheim, and Antony M Dean. The Biochemical Architecture of an Ancient Adaptive Landscape.
Science (80-. )., 310(5747):499–501, October 2005. doi: 10.1126/science.1115649. URL http://www.sciencemag.org/content/
310/5747/499.abstract.
[180] H Allen Orr. ADAPTATION AND THE COST OF COMPLEXITY. Evolution (N. Y)., 54(1):13–20, February 2000. ISSN 1558-5646.
doi: 10.1111/j.0014-3820.2000.tb00002.x. URL http://dx.doi.org/10.1111/j.0014-3820.2000.tb00002.x.
[181] Guillaume Martin, Santiago F Elena, and Thomas Lenormand. Distributions of epistasis in microbes fit predictions from a fitness landscape
model. Nat. Genet., 39(4):555–560, April 2007. ISSN 1061-4036. doi: 10.1038/ng1998. URL http://www.ncbi.nlm.nih.gov/
pubmed/17369829.
[182] H Allen Orr. THE GENETIC THEORY OF ADAPTATION : A BRIEF HISTORY. Nat. Rev. Genet., 6(February):119–127, 2005. doi:
10.1038/nrg1523.
173
[183] Guillaume Martin. Fisher’s Geometrical Model Emerges as a Property of Complex Integrated Phenotypic Networks. Genet., February
2014. doi: 10.1534/genetics.113.160325. URL http://www.genetics.org/content/early/2014/02/28/genetics.113.160325.
abstract.
[184] Jonathan Monk. Available predictive genome-scale metabolic network reconstructions. URL http://systemsbiology.ucsd.edu/
InSilicoOrganisms/OtherOrganisms.
[185] Stephen S Fong and Bernhard Ø Palsson. Metabolic gene-deletion strains of Escherichia coli evolve to computationally predicted growth
phenotypes. Nat. Genet., 36(10):1056–8, October 2004. ISSN 1061-4036. doi: 10.1038/ng1432. URL http://www.ncbi.nlm.nih.
gov/pubmed/15448692.
[186] Esmaeil Mehrara, Eva Forssell-Aronsson, Håkan Ahlman, and Peter Bernhardt. Quantitative analysis of tumor growth rate and changes in
tumor marker level: Specific growth rate versus doubling time. Acta Oncol. (Madr)., 48(4):591–597, January 2009. ISSN 0284-186X. doi:
10.1080/02841860802616736. URL http://dx.doi.org/10.1080/02841860802616736.
[187] Edward J O’Brien, Joshua A Lerman, Roger L Chang, Daniel R Hyduke, and Bernhard Ø Palsson. Genome-scale models of metabolism
and gene expression extend and refine growth phenotype prediction. Mol. Syst. Biol., 9, October 2013. URL http://dx.doi.org/10.
1038/msb.2013.5210.1038/msb.2013.52.
[188] Brandon Barker, Narayanan Sadagopan, Yiping Wang, Kieran Smallbone, Myers R Christopher, Hongwei Xi, Jason W Locasale, and
Zhenglong Gu. A robust and efficient method for estimating enzyme complex abundance and metabolic flux from expression data. URL
http://arxiv.org/abs/1404.4755.
[189] H Allen Orr. The distribution of fitness effects among beneficial mutations in Fisher’s geometric model of adaptation. J. Theor. Biol., 238(2):
279–85, January 2006. ISSN 0022-5193. doi: 10.1016/j.jtbi.2005.05.001. URL http://www.ncbi.nlm.nih.gov/pubmed/15990119.
[190] Nagarjuna Nagaraj, Jacek R Wisniewski, Tamar Geiger, Juergen Cox, Martin Kircher, Janet Kelso, Svante Paabo, and Matthias Mann.
Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol., 7, November 2011. URL http://dx.doi.org/
10.1038/msb.2011.81http://www.nature.com/msb/journal/v7/n1/suppinfo/msb201181_S1.html.
[191] George Oster and Hongyun Wang. Rotary protein motors. Trends Cell Biol., 13(3):114–121, March 2003. URL http://linkinghub.
elsevier.com/retrieve/pii/S0962892403000047.
174
[192] Ida Schomburg, Antje Chang, Sandra Placzek, Carola So¨hngen, Michael Rother, Maren Lang, Cornelia Munaretto, Susanne Ulas, Michael
Stelzer, Andreas Grote, Maurice Scheer, and Dietmar Schomburg. BRENDA in 2013: integrated reactions, kinetic data, enzyme function
data, improved disease classification: new options and contents in BRENDA. Nucleic Acids Res., 41(D1):D764–D772, January 2013. doi:
10.1093/nar/gks1049. URL http://nar.oxfordjournals.org/content/41/D1/D764.abstract.
[193] David L Nelson and Michael M Cox. Lehninger Principles of Biochemistry. W.H. Freeman, New York, NY, USA, 5 edition, 2008. ISBN
071677108X. URL http://www.amazon.com/Lehninger-Principles-Biochemistry-Fourth-Nelson/dp/0716743396.
[194] Gurobi Optimization Inc. Gurobi Optimizer Reference Manual, 2013. URL http://www.gurobi.com.
175
